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ABSTRACT
Candida albicans is an important cause of systemic infections in the immune
compromised population. However, drug resistance and toxicity have put limits on
antifungals efficacy. The C. albicans cell wall is considered a good therapeutic
target due to its role in fungal pathogenicity. Thus, a potential method for improving
antifungal drugs could be to enhance the detection of fungal cell wall antigens by
host immune cells. Detection of C. albicans largely occurs through the receptor
Dectin-1 that can recognize β [beta] (1,3)-glucan, an important component of
fungal cell walls. However, a layer of glycosylated proteins masks the β (1,3)glucan, hiding it from immune detection. In order to better understand possible
mechanisms of unmasking β (1,3)-glucan, we must develop a deeper
comprehension of the mechanism behind unmasking.
The phosphatidylserine (PS) synthase enzyme (Cho1) was reported to
control β (1,3)-glucan exposure. In this dissertation, I utilized classical genetics
and biochemical methods to identify the potential protein(s) involved in causing
this phenotype. Several fungal cell wall associated signaling pathways are overly
activated when CHO1 is disrupted, including GTPase Cdc42, a central regulator
of cellular polarity and morphological development, and its regulated protein kinase
Cek1. When Cek1 is activated independent of CHO1, it leads to β (1,3)-glucan
exposure. To understand thoroughly how Cek1 and its associated pathway govern
β (1,3)-glucan exposure, I further screened the upstream signaling protein(s)
causing Cek1 over-activation. A novel signaling cascade was identified where the
predicted GTPase activating protein (GAP) Lrg1 represses Cek1 activity by
downregulating the GTPase Cdc42 and its downstream MAPKKK, Ste11. The
consequences to virulence for upregulation of Cek1 are that pathogenicity is
diminished in the mouse model of systemic infection, and this correlates with
increased cytokine responses from macrophages. Data from RNA-sequencing
demonstrates that a number of cell wall associated genes are significantly upregulated transcriptionally when Cek1 is hyper-activated, which might be
responsible for the cell wall exposure. Thus, we propose a model that Cek1
hyperactivation causes β (1,3)-glucan exposure by upregulating cell wall proteins
v

and leads to a more robust immune detection in vivo, promoting more effective
clearance.
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CHAPTER I: Introduction
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Candida species are the most common human fungal pathogens and are also
ranked as the fourth-greatest cause of hospital-acquired bloodstream infections,
with up to 40% mortality in epidemiological studies [1, 2]. Candida species colonize
the human gastrointestinal tract and skin asymptomatically in immuno-competent
individuals. Under certain condition, however, Candida species can cause
mucosal and systemic infections. Risk factors include central venous catheter
implants, major surgeries such as organ transplants, neutropenia, cancer therapy,
and HIV infection. Current anti-fungal drugs include three major classes –azoles,
polyenes, and echinocandins, and each of them has its specific drug target [3, 4].
However, drug toxicity and drug resistance have limited the efficacy of current antifungal medicine.
The majority of life-threatening fungal infections are opportunistic in nature,
and a novel approach that may be necessary to complement current antifungals
will be to simultaneously improve host immune efficacy. This can include cytokine
therapy and other adjunctive therapy approaches [5]. A related strategy to improve
adjunctive therapy will be to make the fungi more recognizable to the host immune
effector cells. A better understanding of the interaction of Candida species with
their cognate host receptors, particularly of how different cell wall components are
recognized by their receptors on immune cells, will provide new insights that will
facilitate such an approach. It will also improve our understanding of the process
of fungal pathogenesis.
The immune recognition of fungal pathogens is the first step in determining
the host response to fungal infection, which also plays an important role in shaping
fungal colonization and the subsequent induction of disease. Cell wall composition
and architecture are critical in modulating host immune responses. This review will
summarize various conditions leading to the modification of cell wall structure, and
their immune-modulatory significance.

Construction of the bi-layered C. albicans cell wall
The C. albicans cell wall is a firm, but dynamic structure which is essential for
fungal viability since it serves as a tough, but malleable barrier that sustains cell
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shape and prevents osmotic lysis. It is also important for fungal virulence because
it is the interface between the fungus and the host, and the architecture of its
antigenic polysaccharides, lipids, and proteins presents virulence factors and
dampens host responses. As a result, some cell wall impaired mutants (e.g.
cho1Δ/Δ, sun41Δ/Δ, kre5Δ/Δ, phr1Δ/Δ) exhibit avirulence in the mouse systemic
infection model [6-9]. When exposed to the immune system, cell wall components
modulate host immune recognition in a variety of ways [10]. For instance, Dectin1, a C-type signaling lectin, located at the surface of myeloid-derivative immune
cells, specifically recognizes the immunogenic polysaccharide β (1,3)-glucan and
initiates pro-inflammatory antifungal responses including TNF-α secretion [11].
Chitin, a type of polysaccharide composed of N-acetylglucosamine subunit, is
shown to have immune-inhibitory effects in a concentration- and size- dependent
manner [10]. However, the cell wall is a multi-layered structure that minimizes the
exposure of some of these components to the immune system. The C. albicans
cell wall is composed of an outer layer of N- and O-linked glycosylated proteins
with 80%-90% mannose content [12], as well as an inner layer of the core
polysaccharides β (1,3)-glucan, β (1,6)-glucan and chitin. Each layer serves
different roles in fungal physiology and virulence and have different components
(Figure 1. 1).
Inner layers
β-glucans
β-glucans are the main cell wall components in C. albicans and account for about
60% by weight of the cell wall [8]. β (1,3)-glucan is present in the cell walls of
plants, bacteria and fungi. It is a crucial cell wall structural polysaccharide residing
in the inner layer of the cell wall and represents about 40% of cell wall weight [13].
This polysaccharide is synthesized by a plasma membrane-bound glucan
synthase complex and uses UDP-glucose as a substrate to create a linear polymer
of glucose covalently linked at 1-, 3- position through glycosidic bonds. The
resultant β (1,3)-glucan is extruded into the periplasmic space where it is released
from membrane and covalently attached to other cell wall components by various
3

Figure 1. 1. The structure of C. albicans cell wall.
C. albicans has layered cell wall structure, where the inner layer is comprised of chitin and β-glucan,
and the outer layer is made of glycosylated proteins. Chitin is synthesized by chitin synthases using
substrate UDP-GlcNAc, and β (1,3)-glucan is synthesized by its synthase and substrate UDPGlucose. Glycosylated proteins (glyco-proteins) are modified by N- and O-mannans with 80%-90%
mannose content

4

trans-glycosidase enzymes in the periplasmic space and/or cell wall [14] (Figure
1.1). The C. albicans glucan synthase complex include two subunits: a catalytic
subunit Fks1 and a regulatory subunit Rho1 [15]. Rho1 and Fks1 are essential in
C. albicans [16], and this enzyme complex is the target of the echinocandin antifungal drug class, which acts by inhibiting β (1,3)-glucan synthesis. Fks1 encodes
a 210-kDa transmembrane protein, and is important for echinocandin resistance,
as the mechanism involves point mutations clustered in two hotspot regions within
this protein, encoding residues 641-649 and 1345 to 1365, respectively [4, 17].
The C. albicans genome harbors two other FKS homologs FKS2 and FKS3, which
also play roles in echinocandin resistance. Cells lacking FKS2 or FKS3 contain
increased amount of glucan and are more resistant to cell wall-damaging agents,
suggesting that Fks1 expression is negatively regulated by the other two homologs
[18].
The small GTPase Rho1 was first identified as a regulatory subunit of the
β-glucan synthase complex in S. cerevisiae [19]. In this organism, temperaturesensitive mutants in ScRHO1 display thermolabile glucan synthase activities,
which could be restored by adding purified wild-type ScRho1 protein along with
GTP [19]. ScRho1 can be co-purified with the catalytic subunit Fks1, and is colocalized to cell wall remodeling sites, i.e., to the bud tip during growth and to
septum during cytokinesis [19]. CaRho1 was later identified to act in the same
manner as ScRho1, being the regulatory subunit of glucan synthase [20]. This is
also reflected in the sequence similarity between these two species, where
CaRho1 shares 82.9% identity to ScRho1 in the amino acid level, and CaRHO1
can rescue the glucan synthase activity in a Scrho1-deficient mutant.
β (1,6)-glucan is another critical cell wall component and plays an important
role in stabilizing fungal cell wall integrity since it acts as linker for the attachment
of chitin and mannan proteins to β (1,3)-glucan [8]. It accounts for ~20% of the cell
wall weight in yeast form cells and increases to about 27% in hyphae; almost
double the amount in S. cerevisiae [8]. The biosynthesis of β (1,6)-glucan is not
fully understood at the biochemical level, while genetic work reveals that several
genes appear to be involved in this process, including the KRE family and BIG1.
5

Kre5 and Kre9 are the well-studied members in this family, and they play roles in
morphogenesis and fungal virulence. Unlike ScKRE5, deletion of both alleles of
CaKRE5 does not affect viability, but the Cakre5Δ/Δ mutation does cause aberrant
morphology including cell aggregation and enlarged vacuoles. Moreover, the
individual null mutants of kre5Δ/Δ, kre9Δ/Δ, or big1Δ/Δ display a great reduction
of β (1,6)-glucan, suggesting they are all required for the polymer’s biosynthesis
[8, 21, 22]. It is also reported that the remaining β (1,6)-glucan polymer displays
characteristic structural features when KRE5 is disrupted [8]. This suggests that
Kre5 might play an indirect role in polysaccharide synthesis.
Chitin
Chitin is an essential polysaccharide in most fungal cell walls [23], and this polymer
normally resides at the innermost layer, with a content of less than 10% of cell wall
weight [23]. Chitin is a homopolymer of β (1,4)-linked N-acetylglucosamine
(GlcNAc) [24]. A family of four chitin synthases encoded by CHS1, CHS2, CHS3
and CHS8 are responsible for chitin biosynthesis with uridine diphosphate (UDP)GlcNAc as its substrate (Figure 1. 1). Chs1 is an essential chitin synthase that is
required for septa formation, cell wall integrity and virulence [25]. Loss of CHS1
prevents the daughter cells from separating from the parents, and therefore forms
a chain of daughter cells with continuous constrictions but no septa [25]. Chs2
preferentially expresses in hyphal cells, and disruption of CHS2 decreases chitin
by about 40% in hyphal cells compared to the parental strain. The CHS2 null
mutant is also prototrophic and does not exhibit attenuated virulence [26]. Chs3 is
not required for growth, germ-tube formation, septation, but is essential for overall
chitin synthesis, bud scar formation, virulence and stress responses [27-29]. Chs8
is a non-essential chitin synthase in C. albicans, reflected by normal cell growth,
morphologies and chitin content in the homozygous knockout mutant [30].
However, individual disruption of CHS2 and CHS8 increases the calcofluor white
sensitivity and correlates with increased glucan content and decreased mannan
content [30]. Two chitin microfibril architectures have been reported: long- and
short- chitin fibrils, and they are primarily located at the septa and lateral cell walls,
6

respectively [31]. Each chitin synthase plays an individual role in synthesizing
differing microfibril structures at specific locations in the cell wall [24]. Chitin can
also be remodeled through the actions of four chitinases (Cht1-4), which cleave
the glycosidic bonds in chitin, therefore the resultant short fibril can be better
embedded in the cell wall.
Outer layer
The outer layer of the cell wall consists of highly glycosylated mannoproteins that
are modified by O-linked and N-linked mannosylation and phosphomannosylation
[23] (Figure 1. 2). The glycoproteins serve a variety of functions, including
adhesion,

morphogenesis

and

biofilm

formation.

The

protein

O-

mannosytransferase (Pmt) family of enzymes catalyze the first step of Omannosylation on secretory proteins at specific serine or threonine residues during
transit through the endoplasmic reticulum (ER), and further mannose residues can
be added by Mnt1/2 family proteins in the Golgi [32]. Five Pmt isoforms (Pmt1-5)
have been identified in C. albicans, where Pmt1, Pmt2 and Pmt4 are the major
enzymes of O-mannosyl transferase, and each of them has different expression
profiles to counteract cell wall stress. For instance, when cells are treated with the
N-glycosylation inhibitor tunicamycin, Pmt1 expression is de-repressed, whereas
the other two are inhibited compared to non-stressed conditions, suggesting that
PMT isoforms play distinct roles in Candida cells for better adaptation to cell wall
insults [33].
The N-glycosylation processes occur as proteins cross through the ER [34].
The N-mannan precursor is attached to asparagines at the sequence N-X-S/T,
where X is any amino acid, and the sugar core is further processed in the ER by
glycosidases, resulting in a mature yet shorter N-mannan core. As proteins pass
through the Golgi, a single mannose is attached to the core by the α (1,6)mannosyl transferase Och1, and further elaborated with α (1,6)-mannose by what
is believed to be two complexes consisting of M-Pol I (Mnn9 and Van1), and then
M Pol II (Mnn9, Mnn10, Mnn11, Anp1, and Hoc1), respectively, to form the linear
α (1,6)-mannan backbone [35]. The branched chains are built on this backbone
7

Figure 1. 2. A model of N- and O-glycosylation of C. albicans cell wall proteins.
N-glycosylation initiates at the ER, where the N-mannan is attached to asparagines at the sequence N-X-S/T. When the protein passes
through the Golgi, a single mannose is attached to the core by Och1, and further elaborated with α (1,6)-mannose by M-Pol I and then M
Pol II complex to form the linear α (1,6)-mannan backbone. The branched chains consist of α (1,2)- residues that are added by α (1,2)mannosyl transferases Mnt4 and Mnt5, Mnn2 family, and Mnn5. β (1,2)-mannan and α (1,3)-mannose are found to cap the branched chain
by Bmt family and transferase Mnn1, respectively. The Pmt family enzymes catalyze the first step of O-mannosylation at specific serine or
threonine residues and mannose residues are further added by Mnt1/2 family proteins in the Golgi. Phosphomannan is attached to the outer
chain via a phosphodiester bond through transferase Mnn4 and family members, and capped with β (1,2)-mannan by Bmt family.
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and consist of α (1,2)-residues that are added by α (1,2)-mannosyl transferases
Mnt4 and Mnt5, Mnn2 family, and Mnn5. In C. albicans, β (1,2)-mannan is found
to cap the outer chain and is added by β-mannosyl transferases (Bmt1 and Bmt3)
and alternatively, α (1,3)-mannose is added by transferases like Mnn1 [35, 36].
Phosphomannan can also be attached to the outer chain via a phosphodiester
bond through transferase Mnn4 and family members, and capped with β (1,2)mannan by Bmt2, Bmt3 and Bmt4 [32].
Most of these proteins are glycosylphosphatidylinositol (GPI) anchored, and
GPI-anchored proteins are found ubiquitously across fungi species, and their
functions range from enzymatic to antigenic and adhesion [23]. They are linked at
the C-terminus through a phosphodiester bond to phosphoethanolamine which is
attached to a tri-mannosyl-glucosamine core (Man3-GlcN) that is bound to
phosphatidylinostol (PI) in the membrane. Release of the GPI remnant is
accomplished by hydrolysis of the mannose-GlcN bond, and this carbohydrate
remnant is covalently linked to β (1,6)-glucan in the cell wall [23, 37-39].

Immune-recognition of individual cell wall components
The first step in initiation of an immune response to Candida species is the
recognition of fungal pathogens through pattern-recognition receptors (PRRs).
This process involves the detection of conserved pathogen-associated molecular
patterns (PAMPs) by the cognate PRRs, including C-type lectin receptors (CLRs),
Toll-like receptors (TLR), and Galectin-3. The distinct structures of various
polysaccharides within the Candida cell wall represent conserved PAMPs and are
further recognized by the corresponding PRRs during the development of antifungal immune responses.
β (1,3)-glucan is an important PAMP for detecting fungi
The myeloid-expressed receptor Dectin-1 plays a major role in anti-fungal innate
immune responses [40]. It belongs to the C-type signaling lectin family, and
specifically recognizes β (1,3)-glucan-containing particles by its single extracellular
carbohydrate-recognition-domain (CRD). Upon recognition of β (1,3)-glucan by
9

CRD, Dectin-1 responds through its tyrosine-based activation motif in the
cytoplasmic tail [41, 42], which in turn triggers pro-inflammatory responses
including phagocytosis of the fungal pathogen and induces cytokine secretion for
fungal clearance [43]. Leukocytes derived from Dectin-1-deficient mice are unable
to recognize fungal particles unless opsonized with serum and display impaired
immune responses toward fungal pathogens, including reduced recruitment of
immune cells and decreased production of pro-inflammatory cytokines. The
Dectin-1-deficient mice are therefore susceptible to fungal infection and exhibit
significantly enhanced systemic fungal dissemination and reduced survival rates
when infected with some strains of C. albicans [43]. Leukocytes isolated from wildtype mice are more capable of killing Candida cells with exposed β (1,3)-glucan by
producing increased levels of pro-inflammatory cytokines compared to that of
Dectin-1-deficient mice [44]. In contrast, specific strains of C. albicans did not show
differences in virulence when infecting Dectin-1-/- mice [45], and there was a
correlation between increased chitin levels and decreased dependence on Dectin1. This suggests that chitin levels can influence the relationship between exposed
β (1,3)-glucan and Dectin-1 in the immune response to C. albicans. However, even
in strains that are more resistant to Dectin-1 in their wild-type state, if they are
treated with caspofungin, which exposes β (1,3)-glucan and increases chitin,
Dectin-1 is required for clearance by the drug [45]. This suggests that β (1,3)glucan exposure to Dectin-1 plays an important role in clearance in response to
caspofungin.
While Dectin-1 acts as the major receptor for β (1,3)-glucan recognition,
several other receptors mediate host immune responses to β (1,3)-glucancontaining particles. TLR2 receptors synergize with Dectin-1 signaling in
responses to zymosan, a β (1,3)-glucan preparation from yeast cell wall, by
increasing pro-inflammatory cytokines production in vitro, in spite of the fact that
TLR2 alone does not directly recognize zymosan nor activate immune responses
sufficiently when stimulated by zymosan [42]. In neutrophils, phagocytosis of
zymosan-containing particles is promoted by Dectin-1 in the absence of serum,
but in the presence of serum it is independent [46]. Complement receptor 3 (CR3)
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is also a receptor of β (1,3)-glucan on neutrophils. Neutrophils exhibit reduced
phagocytosis of zymosan when derived from the patients deficient in CR3, and
these patients have higher susceptibility to fungal infections [47].
Fungi can mask β (1,3)-glucan from immune surveillance
Although fungal cells can induce host inflammatory responses by way of β (1,3)glucan detection, it is not surprising that fungal pathogens have evolved
mechanisms for immune avoidance by concealing β (1,3)-glucan in various ways
[23]. In Histoplasma capsulatum, α-glucan and the glycosyl-hydrolyase Eng1 are
important for minimizing β-glucan exposure [48]. Alpha-glucan functions by
concealing β-glucan, while Eng1 hydrolyzes β-(1,3)-glycosyl bonds, and therefore
removes exposed β-glucans [49]. Aspergillus fumigatus Uge3 regulates the
biosynthesis of galactosaminogalactan, which masks hyphal β-glucan from
immune detection [50]. In C. albicans, β (1,3)-glucan is buried underneath the outer
layer of glycosylated proteins in a process referred to as masking [23]. During
infection, unmasking can occur in response to the host environment (Figure 1. 3).
Wheeler et al. described a time-course of β (1,3)-glucan exposure during
disseminated infection of C. albicans in a mouse model [51]. The polymer is
masked by the outer layer of glycoprotein at the beginning of infection and
becomes exposed after several days [51]. The percentage of cells with β (1,3)glucan exposed increases from about 20% (early infection, 16 hours post-infection)
to 80% (late infection, 7 days post-infection) [51]. The exact mechanism by which
unmasking occurs is not fully understood, but it has been observed that when C.
albicans is exposed to neutrophils in vitro, they can damage cell wall and cause β
(1,3)-glucan

unmasking.

Furthermore,

caspofungin

pretreatment

causes

significantly higher levels of β (1,3)-glucan exposure in C. albicans during systemic
infection compared to the non-treated fungal cells. This drug also displays a
filament-bias for unmasking [51]. The mechanism by which filaments are more
readily unmasked is unknown. However, Lowman et al. reported that C. albicans
hyphal glucan exhibited a novel glucan structure, where hyphal glucan has a
unique cyclical structure and an unexpected 2,3 linkage [52]. It has also been
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Figure 1. 3. C. albicans β (1,3)-glucan is an important PAMP for detecting fungi.
Under certain circumstances, β (1,3)-glucan is exposed at cell surface, and this exposure can be
detected by its cognate receptors Dectin-1 on immune cells (macrophages and neutrophils) to
stimulate pro-inflammatory immune responses. Chitin is recognized by the Mannose Receptor and
further initiates anti-inflammatory responses.
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observed that hyphal glucan is more immunogenic than yeast glucan and
stimulates higher levels of pro-inflammatory cytokine production from human
peripheral blood mononuclear cells (PBMCs) and macrophages by a Dectin-1
dependent mechanism [52]. This finding provides evidence that the glucan
architecture can influence how innate immune cells discriminate between the yeast
form and hyphal cells of C. albicans.
Impacts of β (1,3)-glucan exposure on virulence
β (1,3)-glucan is naturally present in the cell wall of bacteria, fungi and plant,
whereas it differs in biomass, structure, solubility and branching structure
depending on the source. This polymer can be used as a fiber supplement,
cosmetic products or medical uses etc. [53]. A large body of work on this
polysaccharide is driven by the immunomodulatory effect it has in animals [13, 54].
Particularly in the medical mycology field, the significance of understanding β (1,3)glucan recognition by Dectin-1 during fungal commensalism and pathogenesis has
been appreciated in gastrointestinal (GI) tract colonization model and a systemic
infection model [43, 54, 55]. The human GI tract contains a large variety of
microbes and the most frequently isolated fungi are Candida species. However,
the factors impacting fungal cells colonization in vivo have not been thoroughly
defined yet. Sem et al. reports that the cell wall β (1,3)-glucan exposure trait, but
not total β (1,3)-glucan level nor other cell wall component levels, critically
determines the ability of Candida species colonizing the GI tract [55]. Several
mutants including the chs3Δ/Δ mutant defective in chitin biosynthesis, or the
mnt1Δ/Δmnt2Δ/Δ double mutant defective in O-mannosylation surprisingly
colonize in mouse GI tract well, although they individually display cell wall
dysfunction. There is no association between in vivo fitness and the ability to grow
under a variety of stressful environments, which the microbes normally encounter
within the host, including organic acid, ox bile, bile salt, low pH, high reactive
oxygen species (ROS), high NO. Instead, the fungal cell wall architecture plays an
essential role in shaping the in vivo fitness, and this trend is also seen in different
Candida species, including C. glabrata, C. tropicalis, and C. dubliniensis. This
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highlights the significance of the dynamics of β (1,3)-glucan structure in shaping
Candida cells as GI commensals or pathogens.
Altogether, considering the crucial immunobiological relevance of β (1,3)glucan exposure and the mechanisms used by many pathogens to mask it, a new
strategy for drug design may be to make fungal pathogens more visible and
susceptible to the host immune attack by exposing β (1,3)-glucan. Goals should
be set to identify signaling pathways that cause β (1,3)-glucan unmasking as these
may serve as targets for novel antifungal drugs to improve adjunctive therapy.
Chitin modulates inflammation based on size and dosage
Chitin plays an important role in modulating pro- and anti-inflammatory immune
responses in a concentration- and size-dependent manner. Low concentrations
(<10 µg/ml) induce anti-inflammatory cytokine production, including IL-10, while
high chitin concentrations (>100 µg/ml) strongly induce TNF-α secretion via
Dectin-1 and TLR-2 receptors [56, 57]. Large chitin particles (>70 µm) are
immunologically-inert, whilst intermediate sized chitins (40-70 µm) induce proinflammatory cytokine production at higher dosages [57]. Small chitin particles
(<10 µm) modulate immune responses based on concentration [56, 57]. The
majority of chitin particles derived from C. albicans are small in size (between 110 µm). Fungal chitin particles in this organism are recognized via a mannose
receptor located on the membrane of immune cells, and chitin further induces antiinflammatory responses via intracellular NOD2- and TLR9- signaling [56] (Figure
1. 3). As mentioned above increased chitin levels seems to correlate with
decreased Dectin-1 dependence for clearance in mice in C. albicans [45].
Conversely, however, increased chitin exposure in response to caspofungin or
some mutations, increases Dectin-1 dependent immune responses in vitro [45, 51,
58]. Thus, the role of chitin levels in modulating immunity seems to be context
dependent and needs further study.
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Glycosylated protein recognition
Glycosylation of cell wall proteins is critical in the immune-modulation during fungal
infection. N-glycan is found to play a dominant role in inducing epithelial immunity
in vitro [59]. Due to the sophisticated biochemical makeup of mannan layer, several
PRRs are involved in the immune recognition. For instance, Mannose receptor
primarily detects N-mannan and TLR-4 targets O-mannan, while Dectin-2 and
Galectin-3 participate in α-mannan and β-mannan recognition respectively [59,
60]. However, immune recognition of glycosylated proteins is not relevant for this
study, but has been extensively studied/reviewed in [34, 36, 60-62]

β (1,3)-glucan unmasking can be induced by manipulation of cell
wall signaling pathways
The process of cell wall biogenesis and remodeling is regulated through complex
signaling pathways including several MAP kinase (MAPK) cascades. The MAPK
pathways are well-conserved signaling cascades in eukaryotes, which are
essential for coping with a wide range of stimuli, including osmotic stress, oxidative
stress, cell wall damage, and changes in glycosylation [11, 63-66]. A conserved
module of three kinases comprises the MAPK signaling cascade: the MAP kinase
kinase kinase (MAPKKK), the MAP kinase kinase (MAPKK) and the MAP kinase
(MAPK). After an upstream signal phosphorylates (activates) the MAPKKK, it in
turn phosphorylates and activates the MAPKK, followed by MAPK phosphorylation
and activation. The activated MAPK further phosphorylates downstream
transcription factors to initiate gene expression for better adaption to the
environment [66]. Three major cell wall MAPK pathways have been discovered in
fungal pathogens, and they each play specific roles in sustaining cell wall
architecture.
Central role of Cek1 activity in controlling β (1,3)-glucan masking
Among these MAPK pathways, Ste11-Hst7-Cek1, comprising the Cek1 MAPK
cascade, serves pivotal functions in maintaining sophisticated cell wall structure in
equilibrium, including masking β (1,3)-glucan from immune detection, thus
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sustaining cell wall glycostructures [33, 64, 67] (Figure 1. 4). In this pathway,
activated Cek1 phosphorylates downstream transcription factors including Cph1
and Ace2 to initiate compensatory transcriptional activities. The activation of Cph1
further stimulates the upstream Cek1 pathway by a positive feedback mechanism
that provides transcription of higher levels of the MAP kinase [68]. Cek1 can be
degraded by the proteasome, and is found to be a short-lived protein, as revealed
by quick degradation to 25% of the starting levels 30mins after being treated with
the protein synthesis inhibitor nourseothricin [69].
Cek1 activity is regulated tightly by multiple stimuli in C. albicans. Several
conditions

induce

Cek1

phosphorylation,

including

disruption

of

phosphatidylserine synthase Cho1 [70], growth resumption from the overnight
culture to fresh media [69], being treated with human salivary fungicidal histatin 5
(Hst5) protein which protects the oral cavity from oropharyngeal candidiasis [71],
hyperactivation of upstream GTPases Cdc42 and Rho1 [70], anti-fungal drug
caspofungin treatment [65], cleavage of the extracellular domain of signaling mucin
Msb2 [72], and activation of filamentous growth [73]. The quorum sensing
molecule farnesol, in contrast, is found to inhibit Cek1 phosphorylation, mediated
by the transmembrane adaptor protein Sho1 [69]. Besides sustaining cell wall
structure, activated Cek1 plays a broad role in establishing fungal infections. Cek1
is involved in the yeast-to-hyphal morphogenesis, a critical step to initiate
pathogenicity of C. albicans. Loss of CEK1 impairs morphogenesis on certain
agar-invasive hyphal growth media, such as Lee’s medium with mannitol as a
carbon source instead of glucose and SLAD medium (low nitrogen) [73]. Although
10% serum, a potent inducer for morphogenesis, induces morphologically normal
hyphae in a cek1Δ/Δ mutant, the growth rate of mycelial colonies of the mutant is
affected [73]. Cek1 also controls the virulence in the mouse disseminated infection
model and the mouse mastitis model [73, 74]. Furthermore, Cek1 is involved in
switching of regular white yeast cells to the mating-competent opaque cells and
induction of mating responses in opaque cells through the transcription factor Cph1
[68].
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Figure 1. 4. The MAPKs pathways in C. albicans that are involved in cell wall construction.
The Cek1, Mkc1 and Hog1 MAPK cascades, and their upstream activating proteins are shown.
The Cek1 pathway is activated by upstream GTPase Cdc42 and PAK kinase Cst20. The Mkc1
pathway is stimulated by GTPase Rho1 and protein kinase C (Pkc1). Two-component phosphorelay system Ypd1p and Ssk1 regulates the downstream Hog1 pathway activation.
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Cek1 disruption causes exposure of cell wall components
The cek1Δ/Δ mutant displays unmasking of β (1,3)-glucan and hyper-sensitivity to
agents that disturb the cell wall such as Congo red, and the N-glycosylation
inhibitor tunicamycin [75, 76]. This mutant also exposes α (1,2)- and β (1,2)mannosides, suggesting the glycostructure is defective in CEK1 disruption.
Exposed β-mannan increases the binding to murine macrophages partially through
the recognition receptor galectin-3, although this receptor itself does not account
for the mutant’s impaired virulence in the mouse systemic infection model [67].
This suggests that pathogen-specific β-mannan is not immunogenic enough to
initiate fungal killing. Transcriptome analysis reveals that in the cek1Δ/Δ mutant,
27 genes are down-regulated, including genes encoding proteins that respond to
drug/chemical stress and cell wall biogenesis. This confirms the significance of the
Cek1 pathway in cell wall construction. The transcriptomic profile of the cek1Δ/Δ
mutant treated with tunicamycin further reveals that a significant number of genes
involved in cell wall biogenesis are differentially expressed. The cell wall genes
that were specifically defective in this condition include CHT2, a chitinase which
causes chitin exposure when repressed [77]; XOG1, an exo-β (1,3)-glucanase that
participates in glucan metabolism [78]; MSB2, a cell wall damage sensor protein
which induces β (1,3)-glucan exposure when disrupted [72]; and EFG1, the key
transcription factor for morphogenesis. This differential expression profile might
account for the C. albicans hypersensitivity to cell wall insults when CEK1 is
disrupted, and also highlights the importance of Cek1 for cell wall stress adaption
transcriptionally.
Ace2, another transcription factor downstream of Cek1, has been shown to
play an important role in sustaining cell wall structure in C. albicans. The ace2Δ/Δ
mutant displays severe β (1,3)-glucan exposure, and transcripts induced by Ace2
upregulation are thought to be responsible for β (1,3)-glucan masking induced by
lactate treatment [67, 79, 80]. This may be related to the role Ace2 plays in
controlling cell wall glycostructure [76]. Damage of N-glycans is sensed by cell wall
proteins Msb2 and Sho1, and results in the activation of Cek1, which in turns
activates cell wall repair activities mediated by Ace2 transcriptionally [76]. In
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addition, Ace2 controls the expressions of O-glycosylation genes in an isoformspecific manner [33]. Under unstressed condition, Ace2 represses Pmt1
expression via transcription factor Zcf21, and de-represses it in response to
tunicamycin [76]. It is possible that the cell wall damage induced by CEK1 deletion
is potentially due to loss of Ace2 transcriptional activity.
Cek1 activation promotes exposure of cell wall β (1,3)-glucan
Davis et al. reported that the phosphatidylserine (PS) synthase enzyme (Cho1)
controls cell wall β (1,3)-glucan exposure [58]. Phospholipids are crucial
components of cellular membranes in eukaryotes, and PS is essential for C.
albicans virulence [6]. A cho1Δ/Δ mutant exhibits greater β (1,3)-glucan exposure
compared to wild-type [58, 81]. This exposure allows increased recognition by
Dectin-1 and elicits a stronger pro-inflammatory response from macrophages [11,
58, 81]. Interestingly, in the cho1Δ/Δ mutant, both the Cek1 and Mkc1 MAPKs are
constitutively activated [70]. Li et al. reported that conditions that induce Cek1,
such as incubation with N-acetylglucosamine (GlcNAc), cause increased β (1,3)glucan exposure in C. albicans [71]. However, this has the caveat that GlcNAc
induces yeast-to-hyphal transition, and filaments have higher level of glucan
exposure due to the intrinsic cell wall architecture differences [52]. Chen et al.
found that hyper-activation of Cek1 via hyperactivation of the upstream Ste11
MAPKKK causes glucan exposure in yeast-form cells in the form of punctate
exposed glucan foci along the periphery. This is similar to the phenotype exhibited
by the cho1Δ/Δ mutant and may be the reason cho1Δ/Δ exhibits β (1,3)-glucan
exposure. Unmasking from hyperactive Cek1 stimulates an immune response, as
up-regulated TNF-α secretion is induced from murine macrophages. The
mechanism by which Cek1 is hyperactivated in the cho1Δ/Δ mutant is not
completely clear but appears to be acting downstream of the small GTPase Cdc42,
which is up-regulated in cho1Δ/Δ [70]. This indicates a model where PS synthase
normally down-regulates Cdc42. This is most likely mediated by synthesis of PS,
which has been shown to be an activator of GTPase activating proteins (GAPs)
that downregulated Cdc42 in S. cerevisiae, such as Rga1 and Rga2 [82]. Thus,
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the model is that loss of PS synthesis leads to hyperactivation of Cdc42, which in
turn activates Cek1 and causes β (1,3)-glucan exposure. However, the mechanism
by which this occurs is not yet known.
Caspofungin, an echinocandin antifungal, causes β (1,3)-glucan exposure
even at sublethal concentrations [83], and this correlates with Cek1 activation [65].
This suggests that Cek1 activation might contribute to β (1,3)-glucan exposure, at
least partially, after caspofungin treatment. This also indicates that improper
activation of Cek1 seems involved in cell wall structure alteration in different
situations.

The

resultant

β

(1,3)-glucan

exposure

promoted

by

Cek1

hyperactivation may be induced by the downstream transcription factor Cph1, an
important regulator for C. albicans filament development [79], and white-to-opaque
switching [68]. Cph1 expression depends on Cek1 and further boosts Cek1
expression in a positive-feedback loop [68]. A Cph1-overexpressing strain under
yeast condition induces pseudo-hyphal structure, and several hyphal-specific
genes are induced transcriptionally [84]. The overall mechanism by which these
proteins might cause unmasking is unknown, but discovery of this could help
explain unmasking under cell wall altering conditions.
The Mkc1 pathway does not appear to cause β-glucan unmasking
In C. albicans, the Mkc1 MAPK cascade, consisting of Bck1-Mkk2-Mkc1, is
activated in response to exogenous cell wall stress, oxidative stimuli, antifungal
drugs, or low-temperature shocks [85] (Figure 1. 4). Mkc1 is also important for
fungal virulence, as loss of MKC1 reduces fungal virulence in the mouse systemic
infection model [86]. Although Mkc1 is central for cell wall construction in C.
albicans, this pathway does not appear to be required for β-glucan masking in C.
albicans, as evidenced by a lack of β-glucan unmasking in mkc1Δ/Δ mutants [87].
In addition, while loss of PS synthase in C. albicans increases Mkc1 activity,
disruption of this MAPK in cho1Δ/Δ does not prevent β (1,3)-glucan exposure, but
in fact exacerbates the phenotype in the cho1Δ/Δ mkc1Δ/Δ double mutant [70].
This suggests that Mkc1 is activated to compensate for cell wall disfunction when
PS synthase is deleted, perhaps in response to hyperactivation of Cek1. Finally, a
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hyperactive GTP-bound form of Rho1 (RHO1Q67L), located upstream of Mkc1
pathway, displays increased β (1,3)-glucan exposure compared to wild-type.
Surprisingly it also exhibits increased phosphorylation of Cek1 along with Mkc1
[70]. This further suggests that the increased β-glucan exposure from the
hyperactive RHO1Q67L mutant may be caused by Cek1 upregulation, instead of
Mkc1.
Hog1 activity contributes to neutrophil-driven β (1,3)-glucan exposure
The Hog1 pathway, comprised of Ssk2-Pbs2-Hog1, is well-known for its response
to osmotic stress, oxidative stress and morphogenesis [66, 88, 89] (Figure 1. 4).
This pathway is also involved in cell wall biosynthesis, as HOG1 disruption
increases resistance to certain cell wall inhibitors such as Congo red (a dye
interacting with the fungal cell wall), and Nikkomycin Z (an inhibitor of chitin
biosynthesis) [89] and enhances susceptibility to cell wall digestion by β (1,3)glucanase [88]. Hopke et al. discovered that the C. albicans Hog1 pathway is
necessary for hyphal cells to respond to damage from neutrophils. Hyphae
damaged by neutrophils exhibit increased β (1,3)-glucan exposure, but unmasking
does not occur in the hog1Δ/Δ mutant. [11]. Neutrophil-damage of hyphae results
in remodeling during which the outer layer of glycosylated proteins is damaged
within seconds upon neutrophils attack, followed by chitin deposition 30 mins postinsult, and β-glucan unmasking takes place even later. HOG1 disruption greatly
impairs the ability of fungal cells to adapt to neutrophil attack [11]. Increased chitin
synthesis can rescue fungal cells from cell wall stress, and chitin synthase (Chs) 3
is shown to be essential for most of the localized chitin deposition and glucan
unmasking during cell wall remodeling triggered by neutrophils insult. Although
Chs2 and Chs8 are also induced, they are not responsible for β-glucan exposure
[11]. Of note, the cell wall associated Cek1- and Mkc1- pathways are not required
for this response. This demonstrates the specificity of individual MAPK pathways
in coping with distinct cell wall stresses.
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Caspofungin treatment remodels cell wall architecture
Wheeler et al. identified that sub-lethal dosages of caspofungin upset the intricate
cell wall structure and causes β (1,3)-glucan exposure without killing the fungi, and
this elicits more potent proinflammatory responses including TNF-α secretion from
the macrophages through Dectin-1 [83]. A genetic network responsible for masking
β (1,3)-glucan was identified in a screen of the S. cerevisiae non-essential gene
deletion mutant library. Most of the genes within the network are involved in
regulating polarized cell wall remodeling, (i.e. polarized actin). The S. cerevisiae
genetic network for concealing β (1,3)-glucan is partially conserved in C. albicans
[83]. For instance, CaPHR2, the sole homolog of ScGAS1, a β-glucan
transglycosylase, plays a role for concealing glucan in both organisms. In contrast,
ScSLT2, a homolog of CaMKC1, is required for masking in S. cerevisae, but does
not cause β (1,3)-glucan exposure when deleted in the pathogen.
Badrane et al. determined that sublethal concentrations of caspofungin
treatment causes fundamental cell wall re-arrangements, but also leads to rapid
responses at the plasma membrane in components related to the actin
cytoskeleton [90]. This includes redistribution of both phosphatidylinositol-(4,5)bisphosphate (PI (4,5) P2), a signaling phospholipid, and septins, which serve as
scaffolds for cytokinesis events [90]. PI (4,5) P2 and septins are re-localized 5 mins
after exposure to caspofungin, which represents an early event in response to drug
treatment, and further re-direct chitin and cell wall proteins to deposit at the site of
co-localization [90]. This response might be important for membrane localized cell
wall repair proteins like chitin synthases to fix the damage caused by β (1,3)-glucan
biosynthesis inhibition. In fact, chitin production also increases in response to
caspofungin treatment [58, 81, 90].
Acidic pH induces cell wall structure remodeling
Sherrington et al. revealed that C. albicans adaptation to an acidic pH of 2
promotes cell wall remodeling, exposure of both chitin and β (1,3)-glucan, and
reduced thickness of the outer mannan layer [77]. The mechanism by which β
(1,3)-glucan exposure is induced by acidic pH remains to be fully defined. The
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major signaling cascades such as the Mkc1 and Hog1 pathways are not involved
in this pH driven glucan unmasking mechanism, suggesting a non-canonical cell
wall remodeling pathway is involved. In contrast, Chitinase 2 (Cht2) regulates chitin
exposure in a pH-dependent manner by cleaving the glyosidic bonds in the longchain of chitin and allowing correct incorporation of chitin short fibril into the inner
layer for better masking. In alkaline environments, CHT2 expression is dependent
on the transcription factors Bcr1 and Rim101, while in the acidic environment, the
Rim101 signaling pathway is inactivated and Cht2 expression is repressed.
Decreased Cht2 results in longer chitin fibrils and less efficient remodeling of the
inner layer, thus enhancing exposure of chitin at the cell surface.
Physiological-relevant L-lactate enhances β (1,3)-glucan masking
Ballou et al. has reported that changes in carbon sources alters cell wall
architecture, particularly by using physiologically-relevant levels of L-lactate as a
carbon source that stimulates β (1,3)-glucan masking [80]. The G-protein coupled
receptor Gpr1, the key lactate binding receptor in C. albicans, is found to sense
environmental lactate and plays a role in lactate-driven β (1,3)-glucan masking
[80]. While Gpr1 is the upstream regulator of cyclic adenosine monophosphate
(cAMP) pathway responsible for morphogenesis in this organism, neither this
pathway nor other key morphogenetic signaling modules like Efg1 or Cph1, are
responsible for the cell wall remodeling in lactate condition [80, 91]. Instead, the
transcription factor Crz1, which is important for cell wall integrity, antifungal
resistance, and cation homeostasis, is found to mediate masking induced by
lactate in a calcineurin-independent manner [80]. This is interesting since in C.
albicans Crz1 is thought to be regulated by calcineurin when stimulated by
exogenous Ca2+, suggesting Gpr1 is another regulator of Crz1 activation that acts
independently of the canonical pathway [92]. A significant number of cell wall
genes are altered transcriptionally and some of these may facilitate the glucan
masking process [80]. Strikingly, major changes in mannan distribution or
disruption of several cell wall crosslinking enzymes do not appear to account for
lactate-induced β (1,3)-glucan masking. For instance, deletion of MNN22 (α(1,2)23

mannosyltransferase) or EXG2 (exo-1,3-beta-glucosidase) does not block
masking caused by lactate [80].
Contribution of mannan layer to β (1,3)-glucan (un)cloaking
A number of studies have been conducted to determine if structural alterations in
the mannan layer result in β (1,3)-glucan (un)masking under various condition [77,
80]. Thus far, no definitive conclusion has been reached. Mnn4 is the regulator of
mannosyl-phosphorylation of N-linked mannans to cell wall proteins [32] (Figure 1.
3). It is reasoned that disruption of MNN4 might reduce the mannan complexity
and therefore results in a porous mannan layer, which makes the glucan layer
more accessible to the immune detection. However, loss of MNN4 does not cause
higher levels of β (1,3)-glucan exposure compared to the parental strain. Some
other characteristics such as cell growth, morphogenesis, and fungal virulence are
not affected either [61]. This suggests that loss of phosphomannan is not sufficient
to cause glucan exposure. In contrast, the MNN2 α (1,2)-mannosyltransferase
family, responsible for the formation of N-glycan outer chains by addition of α (1,2)mannose to the α (1,6)-backbone (Figure 1. 3), is required for maintaining β (1,3)glucan cloaking. Loss of this family results in 70% reduction in the relative
proportion of mannan in the cell wall, which then unmasks the β (1,3)-glucan,
despite no changes in the overall β-glucan levels [34]. Och1, an important α (1,6)mannosyltransferase that initiates the outer N-glycan chain branching (Figure 1.
3), plays a role in masking the underlying β-glucan layer. Loss of OCH1 results in
significantly increased amounts of β-glucan and reduced mannan contents, and
also causes β-glucan architectural changes [55, 93]. This further indicates that
glycosylation is essential for maintaining C. albicans cell wall structure and β (1,3)glucan masking.
Most of the N- and O-linked glycosylation are glycosylphosphatidylinositol
(GPI) anchored. Due to the requirement of cell wall protein modification by GPI
remnants, it provides an important strategy to attack the fungal pathogen. A novel
chemical compound named gepinacin is found to specifically inhibit the activity of
a critical acyltransferase Gwt1 in yeast, which initiates inositol acylation of GPI
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anchor biosynthesis within the ER [94]. Incubation of C. albicans wild-type cells
with a sublethal dose of gepinacin impairs filamentation, increases β (1,3)-glucan
exposure and strain immunogenicity which induces higher levels of TNF-α
secretion from murine macrophages [95]. Alternatively, disruption of CaGPI7, a
protein essential for GPI anchor biosynthesis, blocks the decoration of the second
mannose in the glycan with phosphoethanolamine, and subsequently unmasks β
(1,3)-glucan [44]. The gpi7 deletion mutant further promotes the inflammatory
response through the recruitment of immune cells in a Dectin1-dependent manner
in vivo [44].
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Summary
My dissertation focuses on the identification of signaling proteins that cause cell
wall β (1,3)-glucan exposure in the fungal pathogen C. albicans, thus enhancing
host immune responses. We previously found disruption of the synthesis of the
phospholipid phosphatidylserine in C. albicans (cho1Δ/Δ mutation), then cho1Δ/Δ
exhibits significantly increased exposure of β (1,3)-glucan to immune detection
compared to wild-type. However, the mechanisms through which CHO1 disruption
results in β (1,3)-glucan exposure are not clear. In Chapter II, I used genetic
approaches to evaluate the effect of cell wall associated signaling pathways on β
(1,3)-glucan unmasking in C. albicans, and found Cek1 MAPK cascade is involved
in the modulation of cell wall remodeling when over-activated. In Chapter III, I
screened the upstream regulators of Cek1 and characterized the impact of Cek1
activity on fungal virulence. In Chapter IV, I performed RNA-sequencing analysis
to assess the whole genome transcription profile when Cek1 is hyper-activated. In
Chapter V, I concluded the findings in this dissertation and proposed future
directions to continue studying the influence of Cek1 activation on fungal cell wall
remodeling.
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CHAPTER II: Unmasking of Candida albicans β (1,3)glucan Is Promoted by Activation of the Cek1 Pathway
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Abstract
Candida albicans is among the most common causes of human fungal infections
and is an important source of mortality. C. albicans is able to diminish its detection
by innate immune cells through masking of β (1,3)-glucan in the inner cell wall with
an outer layer of heavily glycosylated mannoproteins (mannan). However,
mutations or drugs that disrupt the cell wall can lead to exposure of β (1,3)-glucan
(unmasking) and enhanced detection by innate immune cells through receptors
like Dectin-1, the C-type signaling lectin. Previously, our lab showed that the
pathway for synthesizing the phospholipid phosphatidylserine (PS) plays a role in
β (1,3)-glucan masking. The homozygous PS synthase knockout mutant, cho1Δ/Δ,
exhibits increased exposure of β (1,3)-glucan. Several Mitogen Activated Protein
Kinase (MAPK) pathways and their upstream Rho-type small GTPases are
important for regulating cell wall biogenesis and remodeling. In the cho1Δ/Δ
mutant, both the Cek1 and Mkc1 MAPKs are constitutively activated, and they act
downstream of the small GTPases Cdc42 and Rho1, respectively. In addition,
Cdc42 activity is up-regulated in cho1Δ/Δ. Thus, it was hypothesized that activation
of Cdc42 or Rho1 and their downstream kinases cause unmasking. Disruption of
MKC1 does not decrease unmasking in cho1 Δ/Δ, and hyperactivation of Rho1 in
wild-type cells increases unmasking and activation of both Cek1 and Mkc1.
Moreover, independent hyperactivation of the MAP kinase kinase kinase Ste11 in
wild-type cells leads to Cek1 activation and increased β (1,3)-glucan unmasking.
Thus, upregulation of the Cek1 MAPK pathway causes unmasking, and may be
responsible for unmasking in cho1 Δ/Δ.

38

Introduction
Candida albicans is a human commensal that is part of the natural flora of the oral,
genital and gastrointestinal tracts. Candida species are also the most common
fungal pathogens of humans and cause diseases ranging from superficial
infections of mucosal surfaces to severe systemic bloodstream infections in
immune-compromised patients [1-4], with a mortality rate of approximately 30%
[2]. Three major classes of antifungals are used to treat systemic infections
including azoles, echinocandins, and polyenes [5-7]. However, drug resistance or
toxicity has put limits on these agents.
The C. albicans cell wall is considered a good therapeutic drug target due
to its role in fungal pathogenicity as it presents important virulence factors,
antigenic cell wall proteins and polysaccharides, and serves as the intermediate
for fungal-host interactions [3, 8, 9]. One potential method for improving anti-fungal
strategies could be to enhance the detection of fungal cell wall antigens by host
immune cells. A major innate immune receptor for fungi like C. albicans is Dectin1, a C-type signaling lectin that can recognize β (1,3)-glucan, which is an important
component of fungal cell walls [8, 10, 11]. This recognition can initiate protective
antifungal immune responses in innate immune cells like macrophages, dendritic
cells and neutrophils. The fungal cell wall consists of an inner layer that is enriched
in β (1,3)-glucan and underlying chitin, and an outer layer of mannosylated proteins
[8]. Under normal conditions, C. albicans masks β (1,3)-glucan from Dectin-1
detection via the outer layer of mannosylated proteins [12, 13]. However,
unmasking of β (1,3)-glucan can be induced through treatments with drugs such
as echinocandins [12] or by certain genetic mutations that disrupt cell wall integrity
[12-15].
It has been previously reported that the phosphatidylserine (PS) synthase
enzyme (Cho1) controls cell wall β (1,3)-glucan exposure [13]. Phospholipids are
crucial components of cellular membranes in eukaryotes. Cho1 synthesizes PS
that can act as an end product, but also can be further decarboxylated to form
phosphatidylethanolamine (PE). PS and PE are both essential for C. albicans
virulence [16]. We found that the homozygous CHO1 mutant, cho1Δ/Δ, exhibits
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greater β (1,3)-glucan exposure compared to wild-type [13, 14]. This exposure
allows increased recognition by Dectin-1 and elicits a stronger pro-inflammatory
response [13, 14, 17]. However, the detailed mechanism by which β (1,3)-glucan
exposure is caused by CHO1 disruption remains unknown.
The process of cell wall biogenesis and remodeling is governed through
complex signaling pathways, including several mitogen-activated protein kinase
(MAPK) cascades and their upstream Rho-type GTPases (Figure 2. 1). MAPK
pathways are conserved signaling cascades in eukaryotes that are important for
dealing with a wide range of stimuli, including osmotic stress, oxidative stress, cell
wall damage, and changes in glycosylation [9, 15, 17-19]. This signaling cascade
is composed of a conserved module of three kinases: the MAP kinase kinase
kinase (MAPKKK), the MAP kinase kinase (MAPKK) and the MAP kinase (MAPK).
The MAPK activates downstream transcription factors and effectors to initiate gene
expression for better adaptation to the environment [19]. Among these MAPK
pathways, Ste11-Hst7-Cek1 composes the Cek1 MAPK cascade, and is reported
to control β (1,3)-glucan masking in C. albicans [15, 20, 21]. CEK1 null mutants
display unmasking of β (1,3)-glucan and hyper-sensitivity to agents that disturb the
cell wall such as Congo red [15]. The Mkc1 MAPK route, consisting of Bck1-Mkk2Mkc1, is primarily involved in cell wall construction, as well as responding to
exogenous cell wall stress, oxidative stimuli, antifungal drugs, and lowtemperature shocks [22, 23]. Yet, this pathway does not appear to be required for
masking in C. albicans [24], although it is hypersensitive to specific cell wall insults
such as echinocandins or calcofluor white.
The upstream small GTPases Cdc42 and Rho1 transmit the signal toward
Cek1- and Mkc1- associated MAPK cascades, respectively (Figure 2. 1) [18, 23].
They are also important in remodeling the rigid structure of the cell wall during
vegetative growth and during pheromone-induced morphogenesis [25]. Rho1 is a
well-known major regulator of the cell wall integrity signaling cascade through
several downstream effectors [23, 25-30]. Rho1 is also the regulatory subunit of β
(1,3)-glucan synthase, and therefore directly controls cell wall biosynthesis via the
binding and activation of its catalytic subunits, such as Fks1 [26, 31]. Cdc42 is
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Figure 2. 1. The Cek1 and Mkc1 MAP kinase signaling cascades in C. albicans are involved
in cell wall biogenesis.
The Cek1 and Mkc1 MAP kinase cascades, and their respective upstream activator signaling
proteins are shown. Rho1 activates protein kinase C (Pkc1), which activates the Mkc1 MAP kinase
cascade. Cdc42 activates the PAK kinase Cst20 which activates the Cek1 MAP kinase cascade.
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essential for cellular polarized growth through a variety of downstream effector
proteins in C. albicans, including the actin cytoskeleton regulator Bni1, and kinases
such as PAK kinase family members Cst20/Cla4 [32-37].
Given the role of the GTPase-associated signaling pathways in cell wall
remodeling and regulation, we studied the impact of these signaling routes in
affecting β (1,3)-glucan masking in the C. albicans cho1Δ/Δ PS synthase mutant.
We found that in the cho1Δ/Δ mutant there is upregulation of the activity of both
Cek1 and Mkc1 MAPKs. Furthermore, we present data indicating that activation of
the Cek1 pathway, in particular, is sufficient to cause β (1,3)-glucan exposure in
the cho1 Δ/Δ mutant.

Methods
Strains and growth media
All of the strains and plasmids used for these experiments are described in Table
S.2. 1 and Table S.2. 2. All the primers used in this study were described in Table
S.2. 3. The medium used to culture strains was yeast extract-peptone-dextrose
(YEPD) medium (1% yeast extract, 2% peptone, and 2% dextrose (Thermo Fisher
Scientific) (unless otherwise stated) [38]. To express the gene from the promoter
of the gene for ATP sulfurylase (MET3), SD minimal medium (2% dextrose, 0.67%
Yeast nitrogen base without amino acids) with 1mM ethanolamine (to support
cho1Δ/Δ) was used [39]. For the induction of genes under the control of the MAL2
maltase promoter, YPM (1% yeast extract, 2% peptone, and 2% maltose (Thermo
Fisher Scientific)) [40] was used. To induce hyphal formation, cells were subcultured in Gibco RPMI 1640 medium (Thermo Fisher Scientific).
Strain construction
For the generation of strains that conditionally express green fluorescent protein
(GFP) tagged Cdc42 under the regulation of PMET3, we used the plasmid pTC1
composed of PMET3-yEGFP-CDC42, which was constructed as follows. yEGFP
was amplified with primers TRO988+TRO989 with BamHI flanking at both ends,
and CDC42 was amplified from SC5314 genomic DNA with primers
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TRO995+TRO996 with SacI flanking both ends. Both fragments were cloned into
pYLC314 [41] 3-end to the MET3 promoter, where yEGFP is in frame and 5-end
to CDC42 and connected by a sequence that encodes an 8-alanine linker.
CDC42K183-187Q was chemically synthesized by Genescript Inc. with SacI sites. It
was used to replace wild-type CDC42 in pTC1 to create pTC14. The pYLC314
plasmid was made by amplifying a SAT1-PMET3 fragment from pYLC229 [41] with
primers JCO165 + JCO166 that introduced EcoRI sites and cloning it into the
EcoRI site in pBluescript II SK+. Both pTC1 and pTC14 were linearized within
PMET3 using AflII, and then transformed into the strains of interests by
electroporation. The transformation methods have been previously described [42].
TCO1+TCO2 were used to validate if the fragment was integrated into PMET3 locus
in the chromosome.
To generate the strain CaTC11 that conditionally expresses STE11ΔN467
under the regulation of MAL2 promoter, we constructed the plasmid pTC20 that
consists of PMAL2- STE11ΔN467-TTEF3. First, pTC19 containing the PMAL2 promoter
was generated from pYLC314 [41]. The PMET3 was removed from pYLC314 by
restriction with PstI. The regulatable promoter PMAL2 was amplified from wild-type
C. albicans genomic DNA using the primers TCO36+TCO37. The promoter was
then cloned into the PstI site of the linearized pYLC314 to create pTC19. Then,
the hyperactive domain of STE11ΔN467 with a TEF3 terminator was amplified from
the PTET-ON - STE11ΔN467 plasmid (generously provided by Dr. Joachim
Morschhausser) [43] with primers TCO42+TCO43, with BamHI at both ends and it
was cloned into pTC19. The resultant pTC20 was then linearized with XcmI and
transformed into wild-type SC5314.
To generate the heterozygous deletion of PKC1, ~500 bp 5- and 3untranslated regions (UTRs) flanking PKC1 were amplified as KpnI-XhoI and NotISacI fragments, by using the primers TCO59+TCO60 and TCO62+TCO110,
respectively. The 5- and 3- UTR fragments were cloned into the corresponding
sites of the SAT1 flipper in the plasmid pSFS2A [44], respectively. The resulting
plasmid pTC041 was digested with KpnI and SacI, and the larger fragment was
gel purified (Qiagen Inc.) and transformed into the strains of interest. The
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nourseothricin-resistant transformants were further cultured in medium containing
maltose as a carbon source to induce caFLP expression, which is under MAL2
promoter regulation. The confirmation of a PKC1 allele being deleted was verified
with TCO63+JCO95.
To introduce the Q67L mutation into RHO1, first the RHO1 gene was PCR
amplified with primers TCO8+TCO72 from SC5314 genomic DNA as a SacI-NotI
fragment and cloned into vector pBT1 to generate pTC35. To generate the pBT1
plasmid, the MET3 promoter was removed from pYLC314 by cutting with PstI. The
ENO1 promoter was amplified with primers BTO30+BTO31 as a BamHI-NotI
fragment and cloned into pYLC314 to generate pBT1. Then primers
TCO74+TCO75 were used to create pTC38 from pTC35 by point mutating RHO1
using site-directed mutagenesis. A similar site directed mutagenesis protocol was
used to introduce the G12V mutation into CDC42. TRO996+TCO101 were used
for CDC42 PCR amplification and it was cloned into pBT1 to create pTC34. Then
TCO76+TCO77 were used to introduce the G12V mutation to CDC42 to result in
pTC37 which expresses PENO1-CDC42G12V. pTC37 and pTC38 were linearized with
MscI and transformed into SC5314.
To create the strain that has GFPCRIB (Cdc42-Rac1 interactive binding
motif) to probe the localization of GTP-Cdc42, RAC1 was disrupted in SC5314
using C. albicans CRISPR-Cas9. This was to exclude GFPCRIB binding with
Rac1. Primers TCO38+TCO39 were annealed to generate a RAC1 sgRNA flanked
with BsmbI, which were then ligated with the deletion construct pV1393 [45] to
create the plasmid pTC18. TCO40+TCO41 were used to generate the repair
template that spanned the Cas9 cut site in order to introduce 3 stop codons to
prevent RAC1 expression and a new HindIII cut site to allow quick genotyping of
the transformants. pTC18 was digested with KpnI and SacI, and the larger
fragment was transformed into both SC5314 and cho1Δ/Δ together with repair
template. TCO51+TCO52 were used for colony PCR to test if the repair template
had integrated into the Cas9 cut site. The positive rac1Δ/Δ transformant was then
transformed with linearized pTC029. The pTC029 plasmid was created from
pExpArg-pADH1CRIBGFP [46] by cutting it with NotI and ligating it with a Candida44

adapted hygromycin B resistance marker amplified with primers TCO92/TCO93
from pRB436 (a gift from Dr. Richard Bennett). CRISPR/Cas9 was also utilized to
knock out MKC1 and PKC1 in the strains of interests. TCO32+TCO33 and
TCO44+TCO45 were used to generate the sgRNA for MKC1 and PKC1,
respectively. TCO34+TCO35, TCO46+TCO47 were used to create the repair
templates for MKC1 and PKC1 with EcoRI and BglII introduced, respectively.
TCO28+TCO29 and TCO49+TCO50 were used for colony PCR on transformants
respectively to check if the repair template integrated into the Cas9-cut region.
To generate strains that have GFPRID (Rho1 Interactive Domain) to probe
the localization of GTP-Rho1, each strain was transformed with pTC033. The
pTC033 plasmid consists of pExpArg-pACT1GFPRID [46] with a SAT1 marker
cloned into the Not I restriction site following amplification with TCO15+TCO16.
The pTC033 plasmid was linearized with StuI and transformed into the strains of
interest.
Western blotting
Cells were grown overnight in liquid YPD at 30°C, diluted to an OD600 of 0.2 in
fresh YPD medium and allowed to grow for 3 hours. For the STE11ΔN467 strain
under the MAL2 promoter regulation, cells were grown overnight in liquid YPM at
30°C and diluted back to OD600 of 0.1 into fresh YPM medium and grown to log
phase. Cells were pelleted by centrifugation and resuspended in 250μl phosphate
buffered saline (PBS) supplemented with protease inhibitor cocktail (PMSF,
leupeptin, and pepstatin (RPI, Corp., Mount Prospect), complete Protease Inhibitor
tablet and PhosStop Phosphatase Inhibitor tablet (Roche Diagnostics GmbH,
Mannheim, Germany). An equal volume of 150-212μm acid-washed beads (Sigma
Aldrich, MO, USA) was added to each tube. Cells were mechanically disrupted in
a Biospec Mini-BeadBeater (Bio Spec Product Inc., USA) with 6 rounds of 1min
homogenization at 4°C and 1min intervals for each cycle. Samples were
centrifuged at 5,000×rpm for 10 min at 4°C, the supernatant was collected, and
the protein concentration was quantified using the Bradford protein assay (Bio-Rad
Laboratories Inc., USA). Extracts were heated for 3 min at 95°C, and equal
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amounts of protein from each sample were separated on an SDS-12%
polyacrylamide gel. Separated proteins were transferred onto a polyvinylidene
difluoride (PVDF) membrane with a Hoefer MiniVE vertical electrophoresis unit
(Amersham Biosciences Inc., USA). Membranes were blocked in blocking buffer
(LI-COR biosciences Inc., USA) at room temperature for 1hour and subsequently
incubated overnight at 4°C with Anti-phospho-p44/p42 MAPK (Thr202/Tyr204)
antibody at a 1:2000 dilution (Cell Signaling Technology, Inc., USA) to detect
phosphorylated Mkc1 and Cek1 MAPKs. The expression of total Mkc1 was
detected with the primary antibody against total Mkc1. The expression of total
Cek1 was measured with an antibody to total Cek1. The secondary antibody
against Phospho-p44/42 Ab, Mkc1 Ab and Cek1 Ab was IRye800CW goat anti–
rabbit IgG (H+L) conjugate (green, 1:10,000 dilution; LI-COR Biosciences)
incubated in the dark followed by extensive washing and quantitation using an
Odyssey IR imaging system (LI-COR Biosciences). Phosphorylated and total
proteins levels were quantitated using ImageJ (National Institutes of Health,
Bethesda, MD). As a control protein, tubulin was detected with rat anti-tubulin
primary antibody (Bio-Rad Laboratories Inc., USA) at a 1:1000 dilution and IRDye
680RD Goat-anti-Rat IgG (H+L) (red, 1:10,000 dilution; LI-COR Biosciences).
Pull-down assay for active Cdc42
Cells were grown in YPD to log phase, and pelleted by centrifugation, and resuspended in Lysis/Binding/Wash buffer, provided by Active Cdc42 Pull-Down and
Detection Kit (Thermo Fisher Scientific) with protease inhibitors cocktail (PMSF,
leupeptin, and pepstatin) (RPI, Corp., Mount Prospect) and complete phosphatase
inhibitor tablet (Roche Diagnostics GmbH, Mannheim, Germany), and cells were
disrupted with acid-washed glass beads (Sigma-Aldrich Co. LLC., USA) in a
Biospec Mini-Bead Beater with 6 rounds of 1min homogenization at 4°C and 1min
interval for each cycle. The protein concentration was quantified using the Bradford
protein assay (Bio-Rad Laboratories Inc., USA).
1,500 μg of total protein were used for the pull-down procedure following
the instruction from Active Cdc42 Pull-Down and Detection Kit (Thermo Fisher
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Scientific). 50ul of the pull-down samples containing active Cdc42 were separated
by SDS-PAGE, transferred to PVDF with the Hoefer MiniVE vertical
electrophoresis unit (Amersham Biosciences Inc., USA), and detected with mouse
monoclonal anti-Cdc42 antibody at a 1:250 dilution (Cytoskeleton Inc., USA),
followed by secondary detection with IRye800CW goat anti–mouse IgG (H+L)
conjugate (1:10,000; LI-COR biosciences). As a control protein, tubulin was
detected with rat anti-tubulin primary antibody (Bio-Rad Laboratories Inc., USA)
and IRDye 680RD Goat-anti-Rat IgG (H+L) (LI-COR biosciences). Densitometry
quantification of Cdc42 bands was performed with ImageJ (National Institutes of
Health, Bethesda, MD).
Immunofluorescent imaging of β (1,3)-glucan exposure
This procedure was done as described in [13] with minor modification. C. albicans
cells were grown overnight in YPD or YPM medium at 30°C. Mouse anti-β (1,3)glucan antibody (Biosupplies Australia Pty Ltd., Australia) at a 1:800 dilution was
used as the primary antibody, and a goat anti-mouse antibody conjugated to Cy3
(Jackson ImmunoResearch Inc., USA) at 1:300 dilution was used as secondary
antibody. For imaging, Candida cells were resuspended in 100 μL of PBS and
visualized with LEICA DM5500B epi-fluorescent microscope with Hamamatsu
Orca-ER CCD digital camera (Model#C4742-80-12AG). The pictures were taken
through Leica Application Suite AF (Advanced Fluorescence) software.
Fluorescence imaging
For imaging GFP-Cdc42 expressed under the MET3 promoter, Candida cells were
cultured overnight in SD minimal medium plus 1mM ethanolamine at 30°C, diluted
to an OD600 of 0.2 in the fresh SD medium and allowed to grow for about 4-5 hours
to reach the OD600 of 0.6-0.8. Cells carrying the CRIB-GFP or GFP-RID constructs
(the expression of each is under the constitutive ADH1 and ACT1 promoters,
respectively), were cultured in YPD medium. The overnight culture at 30°C was
diluted back to an OD600 of 0.2 in fresh YPD medium and grown for 3 hours to
reach log phase. 1mL of cells was collected and re-suspended in 100μl of PBS.
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3μl of samples were mounted on the slide and observed under Leica DM RXA epifluorescent microscope with Leica DFC365FX CCD camera (Vashaw Scientific,
Inc.). The pictures were taken through Leica Application Suite (LAS) V4.4 software.
Flow cytometry
To stain the STE11ΔN467 strain (PMAL promoter) and its controls, overnight cultures
in YPM or YPD were collected and blocked in PBS plus 3% bovine serum albumin
(BSA, Thermo Fisher Scientific, USA) for 30mins. Primary and secondary antibody
incubations occurred on ice in PBS plus 3% BSA for 1.5 h and 20mins,
respectively. Soluble human Dectin-1–Fc (sDectin-1-Fc) [8] at 16.5 μg/ml was
used to detect exposed β (1,3) glucan and mouse anti-Als3 antibody with 1:800
dilution was used for staining Als3 on hyphal cells. The Donkey anti-human IgG
(H+L) Alexa Fluor 488 (Jackson Immuno Research) and goat anti-mouse antibody
conjugated to R-Phycoerythrin (R-PE) were used as secondary antibodies,
respectively.
To stain exposed β (1,3)-glucan on CDC42G12V cells, overnight cultures
were collected, and mouse anti-β (1,3)-glucan antibody at a 1:800 dilution and
rabbit anti-mouse IgG (H+L) Alexa Fluor 488 (Jackson Immuno Research) were
utilized as primary and secondary antibodies, respectively. 5ul of eBioscienceTM
propidium iodide dye (Thermos fisher) was then added to the solution for the
live/dead staining and incubated for 5min at room temperature.
To stain β (1,3)-glucan in Candida cells with MKC1 deleted, the overnight
culture was incubated with mouse anti-β (1,3)-glucan antibody at a 1:800 dilution
as primary antibody and followed by goat anti-mouse antibody conjugated to RPhycoerythrin (R-PE) at 1:300 dilution (Jackson ImmunoResearch) as a
secondary antibody. The staining process for RHO1Q67L strains was the same
except that the overnight cultures were diluted back to OD600 at 0.1 and the log
phage cells were collected after 3hrs growth for staining.
For all of the above conditions, after staining, cells were processed by
washing five times with PBS, and samples were resuspended in 500μl of FACS
buffer (PBS, 1% serum, 0.1% sodium azide) for flowcytometry in a FACSCalibur
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LSR II flow cytometer (Becton Dickinson). Singlets were gated by using a forward
scatter area (FSC-A) versus side scatter area (SSA) plot, followed by forward
scatter width (FSC-W) versus forward scatter area (FSC-A) density plot, as well as
a side scatter width (SSC-W) versus side scatter area (SSC-A) plot to exclude
clumping cells. We further compare the PE fluorescence intensity from the P3
singlets population in different Candida cells. Flow cytometry data were obtained
for 100,000 gated events per strain and experiments were performed in triplicate
and analyzed using FlowJo software package with version 10.11 (FlowJo LLC,
OR, USA).
Enzyme-linked immunosorbent assay (ELISA) of TNF-α
RAW264.7 macrophages were plated the day prior at 5×105/well in a 24-well plate.
To activate STE11ΔN467 expression under PMAL regulation, STE11ΔN467 mutant cells
were grown at YPM. Overnight cultures were washed and diluted to an OD600 of
1.25 in 5ml PBS/well in a 6-well plate for UV-kill. To do this, the 6-well plate was
placed in the Spectrolinker XL-1000 UV Crosslinker (Spectroline Inc., USA) and
the ENERGY mode was set to 100,000 µJ/cm2. The UV-killing process was
repeated 5 times. UV-killed Candida cells were then added to the RAW264.7
macrophages and coincubated at a 1:10 ratio for 4 h at 37°C and 5% CO2. The
supernatant of each well was collected and filtered through a syringe filter with
0.2µm pore size (Millipore Sigma, US) to exclude the macrophage debris. The
ELISA kit instructions from the manufacturer (R&D Systems) were followed. Each
sample has three individual wells, and the statistical analysis was performed by
using Two-way analysis of variance ANOVA (GraphPad Prism, v7.04 software).

Results
C. albicans cho1Δ/Δ exhibits activated MAPKs
Given the strong cell wall phenotypes seen in cho1Δ/Δ, we hypothesized that this
mutant might exhibit increased activation of cell wall signaling pathways such as
Cek1 and Mkc1 MAP kinase cascades. As shown in Figure 2. 2A, Western blots
with the Phospho-p42/44 antibody, that labels the phosphorylated (activated)
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forms of both Cek1 and Mkc1, revealed that these kinases were constitutively
phosphorylated in cho1Δ/Δ compared to wild-type and other test strains. No
significant

difference

was

found

between

the

psd1Δ/Δpsd2Δ/Δ

mutant

(synthesizes PE from PS) and wild-type (Figure 2. 2A). This indicates that
disruption of the PS synthase specifically up-regulates the activity of both cell wall
MAPK cascades. Similar trends were also seen under hyphal induction conditions.
When cells were sub-cultured in RPMI 1640 medium (induces filamentation [47]),
cho1Δ/Δ exhibited greater phosphorylation of Cek1 and Mkc1 than wild-type and
other test strains (Figure 2. 2B). Collectively, these results indicate that loss of
Cho1 activates the Cek1 and Mkc1 MAPK pathways.
Activation of the Cek1 pathway causes β (1,3)-glucan masking
Galán-Díez et al. observed that a cek1Δ/Δ homozygous deletion mutant exhibits β
(1,3)-glucan exposure in C. albicans [15]. In contrast, Li et al. reported that Cek1inducing conditions, such as incubation with N-acetylglucosamine (GlcNAc) in the
media, causes increased β (1,3)-glucan exposure in C. albicans [48]. To further
investigate if activation of the Cek1 pathway increases exposure of β (1,3)-glucan
in C. albicans yeast-form cells, we constructed a strain that expresses a hyperactive allele of STE11 (STE11Δ467) under the regulation of the maltose promoter
(PMAL2). Deletion of 467 N-terminal amino acids, including the inhibitory domain of
Ste11, hyper-activates this kinase [43]. Ste11 is upstream of Cek1 and activates it
via sequential phosphorylation through Hst7 (Figure 2. 1). Expression of the
STE11∆N467 allele in YP maltose (YPM) media results in greater phosphorylation
of Cek1 compared to growth of this strain in YPD (represses STE11ΔN467
expression) (Figure 2. 3A). The STE11ΔN467 expressing strain exhibited greater β
(1,3)-glucan exposure in YPM than YPD when stained with anti-β (1,3)-glucan
antibody (Figure S.2. 1).
The Cek1 pathway is involved in inducing the yeast-to-hyphae transition. A
small subset of cells forms filaments in the hyper-activated STE11ΔN467 strain in
YPM, and hyphae exhibit β (1,3)-glucan unmasking more readily than yeast-form
cells [12, 13]. To determine if the yeast-form cells themselves exhibited greater
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Figure 2. 2. Cek1 and Mkc1 MAPKs exhibit increased activation in cho1Δ/Δ yeast cells
compared to wild-type.
(A) Proteins from yeast-form cells growing in log phase in YPD media were extracted and Western
blotting was performed with anti-phospho-p44/42 antibody to detect Phospho-Mkc1 and PhosphoCek1. Anti-Mkc1 was used for total Mkc1, anti-Cek1 for total Cek1, and anti-tubulin as a loading
control. Graphs of quantification by Image J of the phosphorylated forms of each kinase are
expressed as a percent of the wild-type control after being normalized to the total kinase blot for
each respective MAP kinase and the tubulin loading controls for each gel. Quantification is based
on three biological replicates. The statistical analysis was performed by using One-way ANOVA *,
p=0.0308. ***, p=0.0005. (B) Western blotting was performed on extracts from cells grown as
hyphae in RPMI media and probed with antibodies detecting Phospho-Cek1 and Phospho-Mkc1
as well as the tubulin loading control.
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unmasking, we used flow cytometry with a second hyphal-specific probe to gate
out hyphal cells while measuring β (1,3)-glucan exposure. In particular, we stained
strains with soluble Dectin-1 (sDectin-1) protein which binds with exposed β (1,3)glucan and anti-Als3 antibody, which stains the hyphal-specific protein Als3. Thus,
Als3 staining was used as a marker to gate out hyphae by flow cytometry allowing
us to focus on yeast-form cells. This double staining revealed that wild-type yeastform cells expressing hyper-activated Ste11 (STE11ΔN467) in YPM have
significantly increased unmasking compared to yeast cells in YPD (Figure 2. 3B);
compare the 1st quadrants (Q1) of the plots of STE11Δ467 grown in both YPM and
YPD (bottom two plots).
β-1,3-glucan exposure is more intense at bud scars, which presented the
possibility that the higher glucan exposure in STE11ΔN467-YPM is associated with
more bud scars provided that maltose increases growth rate. In fact, a growth
curve demonstrated that both wild-type and STE11ΔN467 cells cultured in YPM grew
slightly better compared to corresponding strains in YPD culture (Figure S.2. 2).
However, when we co-stained cells with β (1,3)-glucan antibody and calcofluor
white, a dye that stains the chitin that is normally concentrated at the bud scar [49],
the exposed β (1,3)-glucan in STE11ΔN467 is scattered along the cell periphery,
whereas the calcofluor white staining is constricted to the division sites (e. g. bud
scars), revealing little overlap (Figure S.2. 3). Furthermore, STE11ΔN467 and wildtype have similar growth rates in YPM (Figure S.2. 2), but STE11Δ467 has
significantly elevated β (1,3)-glucan unmasking in this medium (Figure 2. 3B and
C). Conversely, the strains have similar rates of growth and β (1,3)-glucan
exposure in YPD (Figure 2. 3B and C), a condition where Cek1 is not hyperactived
(Figure 2. 3A). Moreover, wild-type replicates more rapidly in YPM than YPD, but
β (1,3)-glucan exposure is comparable for wild-type in both media (Figure 2. 3B).
Altogether, these data indicate that hyperactivation of the Cek1 pathway leads to
increased β (1,3)-glucan exposure that is not based on increased numbers of bud
scars.
The correlation between increased β (1,3)-glucan exposure and enhanced
immune responses such as upregulated tumor necrosis factor alpha (TNF-α)
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secretion has been studied intensively [12-14, 17, 50, 51]. Exposed β (1,3)-glucan
is recognized by the receptor Dectin-1 on the surface of immune cells including
macrophages and neutrophils, and this recognition activates the host immune
response for fungal clearance including the secretion of TNF-α [12]. To determine
if the increased β (1,3)-glucan exposure in the STE11ΔN467 strain is
immunologically relevant, we performed an enzyme-linked immunosorbent assay
(ELISA) to quantify TNF-α secretion from RAW264.7 macrophages exposed to this
strain. As seen in Figure 2. 3D, TNF-α secretion was significantly upregulated
when the Cek1 MAPK pathway was hyper-activated (STE11ΔN467 in YPM). It
should be considered when examining the data in Figure 2. 3D that production of
TNF-α is reduced in all strains that were grown in YPM, including wild-type and
cho1ΔΔ. Thus, while the increase in TNF-α of cultures of STE11∆N467 grown in
YPM is ~35% greater than that in YPD, the increase of STE11∆N467 over wild-type,
both grown in YPM, is 2-fold. Thus, increased β (1,3)-glucan exposure in the
STE11∆N467 strain increases proinflammatory responses from macrophages.
CHO1 disruption upregulates Cdc42 activity in C. albicans
The above results indicate that hyper-activation of Ste11 can cause unmasking,
and since the Cek1 MAPK pathway, which acts downstream of Cdc42 [18], is
constitutively activated in cho1Δ/Δ, this suggests that Cdc42 activity might be
upregulated in cho1Δ/Δ (Figure 2. 1). To test this possibility, Cdc42 activity was
measured by monitoring the amount of active Cdc42 (GTP-bound) in cells. GTPbound Cdc42 was isolated using agarose beads coated with Cdc42/Rac1
interactive binding (CRIB) domain [46]. As seen in Figure 2. 4A, the concentration
of GTP-bound Cdc42 in cho1Δ/Δ is higher than that in the other two strains. This
confirms our hypothesis that cho1Δ/Δ has a higher concentration of active Cdc42
than wild-type. Thus, Cho1 or its biochemical product PS may impact Cdc42
activity negatively in wild-type cells, although the regulation may be indirect.
We then compared the localization of active Cdc42 in cho1Δ/Δ and wildtype by using a CaCRIB-GFP probe [46]. This motif binds with both Cdc42 and
Rac1 GTPases. As seen in Figure 2. 4B, both wild-type and cho1Δ/Δ cells have
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Figure 2. 3. Hyperactive Ste11 (STE11ΔN467) causes significant increases in β (1,3)-glucan exposure and TNF-α secretion.
(A) The Cek1 MAPK is hyper-activated by transforming wild-type cells with a hyperactive allele of STE11 (PMAL-STE11ΔN467), which is induced
by adding maltose as a carbon source. (B) Both wild-type and STE11ΔN467 expressing cells were cultured overnight (16hrs) in YPD or YPM
individually and then were doubly stained. The Y-axis represents staining with soluble Dectin-1-Fc (sDectin-1-Fc) that binds to exposed β
(1,3)-glucan, and the X-axis represents anti-Als3 antibody, which binds to the hyphal-specific protein Als3. Flow cytometry was performed
to quantify β (1,3)-glucan exposure from the yeast-form population (Q1: sDectin-1 single positive staining; Q2: sDectin-1 & Als3 double
positive staining; Q3: Als3 single positive staining; Q4: double negative staining). Gates were established with an unstained control where
97% of unstained cells gated within Q4. Gating strategies are further described in the Methods. (C) Left graph: Comparison of β (1,3)-glucan
exposure from the yeast-form population of STE11ΔN467 versus that of wild-type, both of which are cultured in YPM. *, p=0.0289. Right graph:
β (1,3)-glucan exposure was compared between these two strains when grown in YPD medium. (D) Expression of STE11ΔN467 significantly
induces TNF-α secretion after growing in YPM overnight. RAW264.7 macrophages were challenged with various C. albicans stains. C.
albicans strains were grown in YPD or YPM, washed, UV-inactivated, and then add to the macrophages for 4hrs. The macrophage
supernatant was collected and assayed by ELISA to quantify TNF-α production. **, P=0.0030; ***, P=0.0002; ****, p<0.0001.
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similarly localized active Cdc42 with the CRIB-GFP probe concentrated at the
growth sites (buds). CRIB-GFP can bind both Rac1 and Cdc42, so to measure
Cdc42 localization alone, we disrupted RAC1 in both wild-type and cho1Δ/Δ by
using a C. albicans CRISPR-Cas9 system [45]. Both rac1Δ/Δ and cho1Δ/Δ
rac1Δ/Δ mutant cells have a similar pattern of CRIB-GFP localization during
budding growth compared to wild-type and cho1Δ/Δ (Figure 2. 4B and C). This
suggests that active Cdc42 is found in its normal localization in cho1Δ/Δ cells.
These results were in potential contrast to those for Cdc42 in a S. cerevisiae
cho1Δ mutant, where PS disruption causes impaired Cdc42 polarization [52].
However, in this study, Fairn et al. used a GFP-Cdc42 construct to examine
localization, which visualizes total Cdc42 rather than just active Cdc42. Therefore,
we examined localization of total GFP-Cdc42 in C. albicans cho1Δ/Δ to determine
how total Cdc42 responds to PS deficiency (Figure 2. 5A). In the wild-type and
reintegrated strains (cho1Δ/Δ::CHO1), Cdc42 is localized to the plasma membrane
and internal membranes, and accumulates in bud necks and bud tips. The
cho1Δ/Δ mutant has impaired polarization of GFP-Cdc42 to bud necks and tips.
There is an overall decrease in plasma membrane binding of GFP-Cdc42, and
instead GFP-Cdc42 accumulates in the cytoplasm. Approximately 80% of wildtype yeast cells have polarized Cdc42 localization, while only 20% of cho1Δ/Δ cells
show polarized localization (Figure 2. 5B). This result indicates that CHO1 is
necessary for the proper localization of total GFP-Cdc42 in C. albicans.
We next examined the mechanism by which PS may impact GFP-Cdc42
localization to buds and bud necks. PS is the most abundant anionic phospholipid
of the plasma membrane, and it is largely restricted to the inner leaflet [52, 53]. A
C-terminal polybasic region in some Rho-family small GTPases is a crucial domain
for lipid interaction, where several positively charged amino acid residues promote
plasma membrane localization and have been suggested to do so via electrostatic
interactions with negatively charged phospholipids including PS [54, 55]. To
elucidate if this domain is crucial for localization of Cdc42 in C. albicans, we
constructed a GFP-Cdc42 mutant where the four C-terminal lysines were mutated
to glutamines (GFP-Cdc42K183-187Q) and observed its localization in C. albicans
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Figure 2. 4. Cdc42 activity is upregulated in cho1Δ/Δ compared to wild-type.
(A) GTP-Cdc42 was pulled-down with beads conjugated with GST-CRIB, which specifically binds with active GTP-Cdc42/Rac1. Cdc42 that
was pulled down was then detected via Western blotting with anti-Cdc42 antibody. The amount of total Cdc42 in the extract was also probed
as a control. The GTP-Cdc42/Total-Cdc42 ratio is expressed as a percentage of wild-type. (B) CaCRIB-GFP localization is not altered upon
CHO1 deletion. The CaCRIB-GFP probe was transformed into Candida strains to investigate the active GTP-Cdc42 localization. The scale
bar represents 10μm. (C) Cells from Figure 2. 4B were analyzed by microscopy for the number that exhibited CaCRIB-GFP localization to
buds. Quantification is of three biological replicates, and each replicate has at least 50 cells.
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wild-type cells. As shown in Figure 2. 5A, most of the GFP-Cdc42K183-187Q was
associated with endomembrane structures instead of the plasma membrane. Of
note, the preferential accumulation of GFP-Cdc42 seen in the buds of normal wildtype yeast was absent in the mutated Cdc42K183-187Q protein. This indicates that
the C-terminal polybasic region of Cdc42p is important for association of total GFPCdc42 with plasma membrane. However, this does not show if the C-terminal
domain is regulating localization by directly interacting with PS, although that is
one possibility.
In contrast, as observed in Figure 2. 4, GTP-bound unmodified Cdc42 is still
able to associate with the bud necks and tips in the absence of CHO1, indicating
that active Cdc42 can still localize to the appropriate places in the cell. The
discrepancy we see between total GFP-Cdc42 localization and localization of
GTP-bound native Cdc42 could be caused by the GFP or reflect differences
between total versus active Cdc42 populations.
Activation of Cdc42 activity contributes to cell wall unmasking
The above results indicate that the GTPase Cdc42 has increased activation in
cho1Δ/Δ (Figure 2. 4). To further investigate if this up-regulated Cdc42 activity
contributes to β (1,3)-glucan exposure, we constructed a mutant strain that
ectopically expresses a CDC42 hyperactive allele (CDC42G12V) in wild-type.
Introduction of CDC42G12V decreases the intrinsic GTPase activity, therefore
increasing the proportion of Cdc42 in an active GTP-bound state [18]. Cells
overexpressing CDC42G12V exhibited decreased proliferation in YPD liquid and
poor growth on YPD agar plates [32]. Similarly, a hyper-activated CDC42G12V
mutant was dominant lethal in S. cerevisiae [56]. Our strain is viable, but does
exhibit growth defects, so we measured β (1,3)-glucan exposure in the CDC42G12V
mutant by staining with anti-β (1,3)-glucan antibody, but also co-stained cells with
propidium iodide to control for cell-viability. Propidium iodide staining revealed that
the overnight CDC42G12V culture contained fewer live cells compared to wild-type
(Figure S.2. 4A). However, within the live cell populations for both strains, there
was a much greater level of β (1,3)-glucan exposure in the CDC42G12V cells
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Figure 2. 5. Cho1 is essential for GFP-Cdc42 polarization at the plasma membrane.
(A) GFP-Cdc42 localization is examined for each strain by microscopy. The red arrows indicate the fluorescence concentrated at the bud
tips or bud necks. The scale bar represents 5μm. (B) Quantification of the degree of polarization of GFP-Cdc42 in Candida cells. A
minimum of 50 cells was counted for each strain and the imaging experiment was repeated three times. The statistical analysis was
carried out by One-way ANOVA. ****, p<0.0001.
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compared to wild-type (Figure S.2. 4B). This suggests that increased Cdc42
activity causes β (1,3)-glucan masking, with the caveat that CDC42G12V is clearly
having pleiotropic effects.
The Rho1-associated signaling pathway does not have a clear role in
causing β (1,3)-glucan exposure
Our data indicate that the Cek1 pathway can cause β (1,3)-glucan exposure when
hyper-activated, and this may help explain the increased β (1,3)-glucan exposure
seen in the cho1Δ/Δ mutant. However, the Mkc1 pathway is also upregulated in
cho1Δ/Δ (Figure 2. 2), and we wanted to determine if activation of this pathway
plays a role in β (1,3)-glucan exposure as well. First, both MKC1 alleles were
disrupted via the C. albicans CRISPR-cas9 system [45] in wild-type and cho1Δ/Δ.
Western blotting was performed to confirm that Mkc1 was not expressed in the
mutants with both MKC1 alleles disrupted (Figure S.2. 5). Immunostaining with
anti-β

(1,3)-glucan

antibody

on

wild-type,

cho1Δ/Δ,

mkc1Δ/Δ

and

cho1Δ/Δmkc1Δ/Δ strains showed that deletion of MKC1 did not rescue the β (1,3)glucan exposure phenotype in the cho1Δ/Δ mutant (Figure 2. 6). In fact, flow
cytometry demonstrated that the mkc1Δ/Δcho1Δ/Δ double mutant cells exhibited
increased levels β (1,3)-glucan exposure compared to cho1Δ/Δ (Figure 2. 6B).
This suggests that Mkc1 MAPK probably plays a role in sustaining cell wall
organization when CHO1 is disrupted.
Pkc1 acts as a signaling module to connect Rho1 to the Mkc1 MAPK
cascade [25-27]. We deleted one PKC1 allele in cho1Δ/Δ, and this did not
suppress

the

β

(1,3)-glucan

exposure

phenotype

(Figure

S.2.

6).

Attempts to make a complete cho1Δ/Δ pkc1Δ/Δ double mutant failed. This does
not completely test for a role for Pkc1 in unmasking but is consistent with those
above indicating that increased activation of the Mkc1 pathway does not cause β
(1,3)-glucan exposure.
We then examined if Rho1 might play a role in increased β (1,3)-glucan
exposure in cho1Δ/Δ. Total, but not active, Cdc42 is mis-localized in the cho1Δ/Δ
(Figure 2. 4 and Figure 2. 5), therefore, we tested the distribution of active Rho1.
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Figure 2. 6 Deletion of MKC1 in cho1Δ/Δ does not diminish β (1,3)-glucan exposure.
(A) Cells were stained with primary anti-β (1,3)-glucan antibody and Cy3-conjugated secondary antibody and imaged by epi-fluorescent
microscopy. The scale bar indicates 10μm. (B) Flow cytometry was carried out to quantify β (1,3)-glucan exposure. Cells were incubated
with primary anti-β (1,3)-glucan antibody and PE-conjugated secondary antibody. The statistical analysis was carried out by doing One-way
ANOVA analysis. *, P=0.0485; **, P=0.0024.
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This was achieved using a probe for active Rho1, that consists of a GFP tagged
C. albicans Pkc1 Rho Interactive Domain (GFP-RID) [46]. In wild-type and
cho1Δ/Δ::CHO1, GFP-RID is localized to the growth sites (i.e. buds and sites of
cell division) (Figure 2. 7), however the signal in cho1Δ/Δ is delocalized. This
suggests that the Rho1 cell wall remodeling system might be re-localized when
Cho1 is disrupted. Rho1 also has multiple lysines on its extreme C-terminus,
similar to Cdc42, thus its mislocalization in cho1Δ/Δ could be affected for similar
reasons as observed for total GFP-Cdc42 (Figure 2. 5). Due to the lack of GFPRho1, we have not examined GFP-Rho1 to find the exact localization of total Rho1
in cho1Δ/Δ. The increased activation of Mkc1 in cho1Δ/Δ suggests that its
upstream regulator, Rho1, might exhibit a similar increase in activation. To test if
up-regulated Rho1 can cause β (1,3)-glucan exposure, we constructed a strain
that ectopically expresses a hyperactive allele of RHO1Q67L in wild-type.
Introduction of the RHO1Q67L allele decreases the ability of Rho1 to cleave GTP to
GDP, therefore increasing the level of GTP-Rho1 [25]. As shown in Figure 2. 8A
and B, hyper-activated RHO1Q67L did cause a significant increase in cell wall
unmasking compared to wild-type, but not as great as that seen with STE11∆N467.
However, examination of MAPK phosphorylation revealed that active Cek1 was
unexpectedly upregulated along with active Mkc1 (Figure 2. 8C). Thus, the β (1,3)glucan exposure in the RHO1Q67L strain could be due at least in part to Cek1
activation rather than Mkc1 (Figure 2. 8C).

Discussion
Previously, our lab showed that the enzyme for synthesizing PS, Cho1, plays a
role in controlling β (1,3)-glucan exposure [13]. The homozygous PS synthase
knockout mutant, cho1Δ/Δ, exhibits increased β (1,3)-glucan exposure compared
to wild-type [13]. However, the mechanism by which cho1Δ/Δ displays the β (1,3)glucan exposure phenotype was unclear.
In this report, we identify two MAPK signaling pathways (Cek1 and Mkc1)
that are activated in the cho1Δ/Δ mutant (Figure 2. 2), and we hypothesized that
one or both may contribute to increased β (1,3)-glucan exposure in cho1Δ/Δ.
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Figure 2. 7. Active GTP-Rho1 is de-localized in cho1Δ/Δ.
(A-C) GFP-RID localization was used as proxy for active (GTP-bound) Rho1 in cells and was
analyzed by epifluorescent microscopy. (D) Quantification of the degree of polarization of GTPRho1 in Candida cells. A minimum of 50 cells were counted for each strain and this repeated three
times. The statistical analysis was done by One-way ANOVA. *, p<0.019.
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Figure 2. 8. Hyper-activated Rho1 causes β (1,3)-glucan exposure.
(A-B) Candida cells were stained for β (1,3)-glucan exposure as described in Figure 2. 6. The scale
bar represents 10μm. ***, p=0.0003. (C) Western blotting was performed to examine the effect of
expressing hyperactive RHO1Q67L on the regulation of downstream MAPKs activities. Phosphop44/42 antibody was used to detect Phospho-Cek1 and Phospho-Mkc1 and anti-tubulin, anti-Mkc1,
and anti-Cek1 antibodies were used as controls.
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MAPK signal transduction cascades are essential pathways for C. albicans
adaptation to the host environment [35, 57]. Cek1 and Mkc1 are major MAPK
pathways in this organism that play roles in cell wall regulation. The Mkc1associated pathway is primarily responsible for cell wall integrity, while the Cek1mediated signaling cascade is important for cell wall construction and hyphal
formation [19, 58-60].
Cdc42-Cek1 MAPK pathway activation can increase β (1,3)-glucan exposure
We tested the hypothesis that one or both of these pathways can cause β (1,3)glucan exposure in cho1Δ/Δ by determining if they could contribute to this
phenotype independently of loss of PS. We found confirming evidence for the Cek1
pathway. In particular, a hyperactive form of Ste11 (STE11ΔN467), the MAPKKK that
activates Cek1 (Figure 2. 1), stimulates significant β (1,3)-glucan exposure in
yeast-form cells compared to wild-type cells (Figure 2. 3). This confirms an
assertion that β (1,3)-glucan can be unmasked in Cek1 inducing conditions [48].
The cells with STE11∆N467-induced unmasking also exhibit more TNF-α secretion
from the macrophages (Figure 2. 3D).
Ste11 is downstream of the small GTPase Cdc42 (Figure 2. 1), which has
been well-studied in C. albicans [18, 32, 46, 61]. Cdc42 is involved in cellular
proliferation and bud emergence and activates the downstream protein kinase
Cst20 [32], which also controls the activation of the Cek1 MAPK cascade including
Ste11 [15, 18, 58]. To control accurate cellular function, Cdc42 cycles between an
active GTP-bound and inactive GDP-bound state [61]. By performing pull-downs
of GTP-Cdc42 with CaCRIB-GST and Western blotting, we have evidence that the
level of active GTP-Cdc42 is higher in cho1Δ/Δ compared to wild-type (Figure 2.
4A). This might be responsible for the increased activation of the downstream
Ste11-associated cascade. We did not test to see if disruption of CEK1 in the
cho1Δ/Δ strain would decrease β (1,3)-glucan exposure because cek1Δ/Δ also
exhibits more exposed β (1,3)-glucan than wild-type [15], and this would be
uninterpretable.
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Possible roles of PS in regulating Cdc42 activity and localization
The impact of PS on β (1,3)-glucan exposure is likely indirect, but may be occurring
through its role in regulating Cdc42. The loss of PS correlates with increased
Cdc42 activity, which in turn can lead to activation of the Cek1 pathway, which
does cause β (1,3)-glucan exposure when activated (Figure 2. 3). However, the
mechanism by which loss of PS causes Cdc42 activation is currently unclear, but
possibilities are discussed below.
PS may impact Cdc42 activity indirectly by regulating the GTPase activating
proteins (GAPs) for Cdc42. These GAPs act as repressors of Cdc42 activity.
Previous investigations identified that PS stimulates the GAP activity of Rga1 and
Rga2 toward Cdc42 in S. cerevisiae [62]. Given that C. albicans cho1Δ/Δ lacks PS
[16], this may result in less inhibition of the GAP activity, and in turn results in less
inhibition of Cdc42 activity.
Alternatively, there are data indicating that PS can control the localization
of a subpopulation of Cdc42. For example, we found that GFP-tagged Cdc42 is
mislocalized in C. albicans cho1Δ/Δ. Moreover, mutating the C-terminal lysines to
glutamine in GFP-Cdc42 led to mislocalization of GFP-Cdc42K183-187Q in wild-type
cells (Figure 2. 5). This is similar to what has been observed in S. cerevisiae, where
Cdc42 localization is affected by both PS and the basic lysine residues at the Cterminal domain of Cdc42 [52, 55]. However, in contrast to this, the localization of
active GTP-Cdc42 in C. albicans, as measured by CaCRIB-GFP (binds to GTPCdc42/Rac1) appears to be focused in the bud necks and tips like wild-type (Figure
2. 4B). Therefore, PS might control only a subpopulation of Cdc42 localization. It
is also possible that GFP-Cdc42 does not fully represent endogenous Cdc42 in its
activated state.
The mechanism by which PS controls Cdc42 localization in C. albicans
remains to be fully elucidated. One model suggests that Cdc42 localization is
controlled in part through the interaction between the negatively charged PS head
group and the lysines at the C-terminus of Cdc42 (Figure 2. 5). However, this is
only a model at this point and remains to be tested, as the impact of PS on GFPCdc42 may be indirect. These lysines may interact with another protein that is
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required to localize Cdc42 that itself is impacted by PS. In addition, the correct
localization of active Cdc42 in cho1Δ/Δ indicates that other factors, perhaps GEFs
or GAPs, play an important role in Cdc42 localization, independently of PS (Figure
2. 4).
Activation of the Mkc1 MAPK pathway does not appear to be sufficient to
cause unmasking
The other MAPK pathway upregulated in cho1Δ/Δ is the Mkc1 pathway (Figure 2.
1 and Figure 2. 2). We tested for its role in cho1Δ/Δ-dependent β (1,3)-glucan
exposure by generating a cho1Δ/Δmkc1Δ/Δ double mutant, and this did not
diminish β (1,3)-glucan exposure (Figure 2. 6). Moreover, we disrupted one allele
of the upstream kinase Pkc1, and this also did not diminish β (1,3)-glucan exposure
(Figure S.2. 6). Finally, a hyperactive GTP-bound form of Rho1 (RHO1Q67L) was
generated, and it did lead to modest β (1,3)-glucan exposure compared to wildtype, however surprisingly it also led to increased phosphorylation of Cek1 as well
as Mkc1 (Figure 2. 8), thus the increase may be caused by Cek1 upregulation.
An alternative role for Mkc1 may be to diminish β (1,3)-glucan exposure in
stress conditions. For example, the mkc1Δ/Δ mutant did not exhibit enhanced β
(1,3)-glucan exposure compared to wild-type, but the cho1Δ/Δ mkc1Δ/Δ double
mutant exhibited greater β (1,3)-glucan exposure than cho1Δ/Δ alone. This
coupled with the mislocalization of active Rho1 in cho1Δ/Δ (Figure 2. 7), may
indicate that Mkc1 is activated to compensate for cell wall disfunction that is
caused by the cho1Δ/Δ mutation, perhaps even due to upregulated Cek1.
Surprisingly, our results with the Mkc1 pathways relationship to PS contrast
with what is observed for the orthologous pathway in S. cerevisiae. In baker yeast,
PS has been shown to be necessary for the activation of the C. albicans Mkc1
homolog Slt2 in S. cerevisiae [22, 63]. However, we observed that loss of PS
synthase in C. albicans causes increased Mkc1 activity (Figure 2. 2), suggesting
that there are fundamental differences in the manner through which the Mkc1associated cascade is regulated in pathogenic versus non-pathogenic yeasts. This
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report also sets the stage for better understanding how the phospholipid PS
synthase influences GTPase activity and localization in this pathogenic organism.

Conclusions
Candida albicans is able to diminish its detection by innate immune cells through
masking of β (1,3)-glucan in the inner cell wall with an outer layer of heavily
glycosylated mannoproteins (mannan) [12, 64, 65]. Once exposed, this glucose
polymer antigen can be detected by Dectin-1, a C-type signaling lectin found on
host immune cells [10, 11]. However, it usually takes several days after infection
before β (1,3)-glucan is exposed to the immune system [64]. Therefore, if the β
(1,3)-glucan exposure process could be induced more rapidly, the immune
responses would be expected to improve and clear fungal pathogens more
effectively [12, 64, 66-68].
Identification of specific pathways that contribute to β (1,3)-glucan exposure
when activated could help elucidate future drug targets that can induce β (1,3)glucan exposure to improve immune response. Thus, compounds that specifically
activate Cek1 may be useful in this regard. If such compounds were combined with
the current azole class of antifungals, which act statically, and immune detection
were simultaneously enhanced, this could potentially enhance the clearance of
fungi.
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Appendix
Table S.2. 1. C. albicans strains used in this study
Strain

Parent

Genotype

Source or
reference

SC5314

Clinical

Prototrophic wild type

[69]

isolate
YLC337

SC5314

cho1Δ/Δ

[16]

SED022

YLC337

cho1Δ/Δ::CHO1

[13]

YLC375

SC5314

psd1Δ/Δ psd2Δ/Δ

[16]

TC001

SC5314

Wild-type PMET3-GFP-CDC42

This study

TC002

YLC337

cho1Δ/Δ PMET3-GFP-CDC42

This study

TC003

SED022

cho1Δ/Δ::CHO1 PMET3-GFP-

This study

CDC42
TC004

YLC375

psd1Δ/Δpsd2Δ/Δ PMET3-GFP-

This study

CDC42
TC005

SC5314

mkc1Δ/Δ

This study

TC006

SC5314

Wild-type PMET3-GFP-

This study

CDC42K183-187Q
TC007

SC5314

rac1Δ/Δ

This study

TC011

SC5314

Wild-type PMAL-STE11ΔN467

This study

TC033

YLC337

cho1Δ/Δrac1Δ/Δ

This study

TC034

YLC337

cho1Δ/Δmkc1Δ/Δ

This study

TC046

SC5314

Wild-type GFP-RID

This study

TC064

TC033

cho1Δ/Δrac1Δ/Δ CRIBGFP

This study

TC071

YLC337

cho1Δ/Δ GFPRID

This study

TC072

SED022

cho1Δ/Δ::CHO1 GFPRID

This study

TC073

TC007

rac1Δ/Δ CRIBGFP

This study

TC078

SC5314

Wild-type PENO1-CDC42G12V

This study

TC083

SC5314

Wild-type PENO1-RHO1Q67L

This study

TC107

SC5314

Wild-type PKC1/pkc1Δ

This study

TC110

YLC337

cho1Δ/Δ PKC1/pkc1Δ

This study
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Table S.2. 2. Plasmids used in this study
Strain Name

Description

Source

pYLC314

CaNAT-PMET3, ampR

[41]

pTC001

CaNAT-PMET3-GFP-CDC42, ampR,

This study

pYLC146

FLP-CaNAT, chloraR

This study

pBT1

CaNAT-PENO1, ampR

This study

pExpArg-

pExpArg-pADH1CRIBGFP

[46]

pADH1CRIBGFP
pTC009

pExpArg-pADH1CRIBGFP+HYGR

pTC014

CaNAT-PMET3-GFP-CDC42K183-187Q,

pV1393

FLP-CAS9-CaNAT-SNR52p-sgRNA, ampR

[45]

pTC015

pV1393 CaMKC1-sgRNA, ampR

This study

pTC018

pV1393 CaRAC1-sgRNA, ampR

This study

pTC019

CaNAT-PMAL, ampR,

This study

pTC020

pTC019 CaSTE11ΔN467, ampR

This study

pTC029

pExpArg-pADH1CRIBGFP+HygR

This study

pExpArg-

pExpArg-pACT1GFPRID, ampR

pACT1GFPRID

This study
ampR

This study

[46]

pTC033

pExpArg-pACT1GFPRID+NATR

This study

pTC034

pBT1 CaCDC42, ampR

This study

pTC035

pBT1 CaRHO1, ampR

This study

pTC037

pBT1 CaCDC42G12V, ampR

This study

CaRHO1Q67L,

pTC038

pBT1

pTC041

pYLC146 CaPKC1-KO, chloraR

ampR
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This study
This study

Table S.2. 3. Primers used in this study
Name

Sequence

Description

TCO1

GATTGTGGCTCATAGTAAC

Primer-F to check if pTC1/pTC14 integrated into pMET3 locus

TCO2

AGTAGCATCACCTTCACCT

Primer-R to check if pTC1/pTC14 integrated into pMET3 locus

TCO8

AAAAGAGCTCAAAAGTATAGGATAAAACATAAT

Primer-R for CaRHO1 amplification with SacI flanking

TCO15

AAAGCGGCCGCCGTCAAAACTAGAGAATAATAAG

Primer-F to amplify SAT1 resistance gene with NotI flanking

TCO16

AAAGCGGCCGCGACCACCTTTGATTGTAAA

Primer-R to amplify SAT1 resistance gene with NotI flanking

TCO28

TATATTATGGCAGATCCGTAA

TCO29

AACCCATCTACAGTCTCAAA

TCO32

ATTTGAGAACCCCGACGAAAATGCTG

Primer-F at CaMKC1+602 to amplify MKC1 SgRNA

TCO33

AAAACAGCATTTTCGTCGGGGTTCTC

Primer-R at CaMKC+621 to amplify MKC1 SgRNA

TCO36

AAAACTGCAGTTGATATTTTTGTCTAGTACC

Primer-F at CaMAL2-543 to amplify MAL2 promoter

TCO37

AAAACTGCAGTGTAGTTGATTATTAGTTAAAC

Primer-R at CaMAL2-1 to amplify MAL2 promoter

TCO38

ATTTGAACCAATCAAATTAGGATTAG

Primer-F at CaRAC1 to amplify RAC1 SgRNA

TCO39

AAAACTAATCCTAATTTGATTGGTTC

Primer-R at CaRAC1 to amplify RAC1 SgRNA

TCO42

AAAAGGATCCATGGATTCGAGATCCATAAT

Primer-F to amplify CaSTE11ΔN467 with BamHI flanking

TCO43

AAAAGGATTCCTCGAGGGAAATAACTACTA

Primer-R to amplify CaSTE11ΔN467 with BamHI flanking

TCO44

ATTTGAGTCGAAAATAAGTATTCCGG

Primer-F at CaPKC1 to amplify PKC1 SgRNA

TCO45

AAAACCGGAATACTTATTTTCGACTC

Primer-R at CaPKC1 to amplify PKC1 SgRNA

TCO48

AAGACACGGTATAAAAATGG

TCO49

ACAAGTTGTCAATGATATTAG

Primer-R at CaMKC1+23bp for colony PCR to detect if the
MKC1 repair template integrated into the chromosome
Primer-R at CaMKC1+1097 for colony PCR to detect if the
MKC1 repair template integrated into the chromosome

Primer-F at pMAL2 region of pTC19 to check if pTC19
reintegrated into the chromosome
Primer-F for colony PCR to detect if the PKC1 repair template
integrated into the chromosome
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Table S.2. 3. Continued
Name

Sequence

Description

TCO50

ATCACTTGAAGGAGATACTG

TCO51

AGCATTAAATCAGTCGTAGT

TCO52

TCTTTTCTTACCAGTACCAG

TCO57

TTTCCACAATCAAACATCCAA

TCO59

AAAAGGTACCTACAAGAAAGTAAAGCCAAAG

TCO60

AAAACTCGAGATTGGAATTACACTGATCTC

TCO62

AAAAGAGCTCGATACAAATAGAGAAGTTTCC

TCO63

GCAATAGTAAGTAGCGAATAA

TCO72

AAAAGCGGCCGCATGGTTAACGGTCCAGCTGA

Primer-F for CaRHO1 amplification with NotI flanking

TCO74

ATTATGGGATACTGCTGGTCTAGAAGATTATGATAGATTAA

Primer-F for point mutation of CaRHO1R67L

TCO75

TTAATCTATCATAATCTTCTAGACCAGCAGTATCCCATAAT

Primer-R for point mutation of CaRHO1R67L

TCO76

TGTGTTGTTGTCGGTGATGTTGCCGTTGGTAAAACTTGCT

Primer-F for point mutation of CaCDC42G12V

TCO77

AGCAAGTTTTACCAACGGCAACATCACCGACAACAACACA

Primer-R for point mutation of CaCDC42G12V

TCO92

AAAGCGGCCGCTCGATATTGCTAGAGGCAAA

Primer-F to amplify Hygromycin resistant gene

TCO93

AAAGCGGCCGCATTTTATGATGGAATGAATGG

Primer-R to amplify Hygromycin resistant gene

TCO101

AAAAGCGGCCGCATGCAAACTATAAAATGTGTTG

Primer-F to amplify CaCDC42 with NotI flanking

TCO110

AAAAGCGGCCGCTGATTAAAGTAGATATATAATAATA

Primer-F at +1bp of CaPKC1 3'NTR to amplify CaPKC1
terminator with NotI flanking

TCO988

AAAAGGATCCATGTCTAAAGGTGAAGAATTA

Primer-F to amplify EGFP with BamHI flanking

Primer-R for colony PCR to detect if the PKC1 repair template
integrated into the chromosome
Primer-F at CaRAC1+7bp for colony PCR to detect if the RAC1
repair template integrated into the chromosome
Primer-R at CaRAC1+675bp for colony PCR to detect if the
RAC1 repair template integrated into the chromosome
Primer-R at CaSTE11ΔN467 region of pTC19 to check if pTC19
reintegrated into the chromosome
Primer-F at CaPKC1-501bp to amplify CaPKC1 promoter with
KpnI flanking
Reverse primer at CaPKC1-1bp to amplify CaPKC1 promoter
with XhoI flanking
Primer-R at +700bp of CaPKC1 3'NTR to amplify CaPKC1
terminator with SacI flanking
Primer-F at CaPKC1-688 to check if the linearized pTC41
integrated into chromosome
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Table S.2. 3. Continued
Name

Sequence

Description

TRO989

AAAAGGATTCTTTGTACAATTCATCCATAC

TRO993

TTGGTGATGGTCCAGTCTTGT

TRO994

CAGAACACTCAACATACTTGACAGC

TRO995

AAAAGAGCTCGCAGCTGCAGCTGCAGCTGCAGCTCAAACTA
TAAAATGTGTTGT

TRO996

AAAAGAGCTCTGATTTATATTATGTCTAGAGT

Primer-R to amplify CaCDC42 with SacI flanking

JCO95

GATTATTAGTTAAACCACTGC

Primer-R at pMAL2 of pTC41 to check if the linearized pTC41
integrated into chromosome

BTO30

AAAAGGATTCAGGTCTGTCATATTTCTATC

Primer-F to amplify ENO1 promoter

BTO31

AAAAGCGGCCGCGTTGTAATATTCCTGAATTATC

Primer-R to amplify ENO1 promoter

JCO165

AAAGAATTCCGTCAAAACTAGAGAATAATAAAG

Primer-F to amplify pMET3-SAT1

JCO166

AAAGAATTCGTTTTCTGGGGAGGGTATTT

Primer-R to amplify pMET3-SAT1

TCO34
TCO35
TCO40
TCO41
TCO46
TCO47

Primer-R to amplify EGFP with BamHI flanking

CTTAAAATTTGTGACTTTGGTTTAGCAAGAGGGTTTTCTGAG
AACCCCTAAGAATAAGCTT
CCCTGTACCATCTGGTGGCAACATACTCTGTCATAAACTATT
AAGCTTATTCTTAGGGGTTCT
GTTTTTGATAATTATTCAGCCTCAGTTATGATTGATGGCGAAC
CAATCTAATAAGGATAAGCTT
GTCTTAATCTATCATATTCTGATTGACCAGCGGTATAAGCTTA
TCCTTATTAGATTGGTT
AGATTCAATTTATGTTGCAATATTTGGAATTCAAACTCCAGAT
CTAAAATAAGTAATCCTAA
CCATCCATAAGATAAAGATGAGACAATTTTTTATTGGCTTAG
GATTACTTATTTTAGATCT
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Primer-F at the EGFP region of pTC1 to check if EGFP and
CDC42 ligated in a correct orientation
Primer-R at CaCDC42+463bp to check if EGFP and CDC42
ligated in a correct orientation
Primer-F to amplify Cdc42 with SacI flanking

CaMKC1-F for crispr-cas9 repair template
CaMKC1-R for crispr-cas9 repair template
CaRAC1-F for crispr-cas9 repair template
CaRAC1-R for crispr-cas9 repair template
CaPKC1-F for crispr-cas9 repair template
CaPKC1-R for crispr-cas9 repair template

Figure S.2. 1. STE11ΔN467 exhibited significantly increased β (1,3)-glucan exposure compared
to wild-type cells.
Overnight cultures of Candida cells were incubated with anti-β (1,3)-glucan primary antibody and
PE-conjugated secondary antibody, followed by flow cytometry to quantify the fluorescence
intensity. Data represent three biological replicates. The statistical analysis was done by One-way
ANOVA. ***, P=0.0004; *, p=0.0137.
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Figure S.2. 2. Growth curves were measured to determine the growth rate of strains in YPD
vs YPM.
Cells were grown overnight in YPD, diluted back to 0.1 OD600 and transferred to fresh YPD or
YPM. A growth curve was performed with three replicates per condition, and plotted based on the
growth rate of different strains measured in 48 hrs. The growth at each time-point between YPD
and YPM cultures of STE11ΔN467 were compared by Two-way ANOVA (****, p<0.0001; *,
p=0.0286). The same comparison was made between wild-type YPD and YPM culture (####,
p<0.0001; ###, p=0.0007).
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Figure S.2. 3. The exposed β (1,3)-glucan in STE11ΔN467 YPM cells was not restricted to bud
scars.
Overnight cultures of wild-type and STE11ΔN467 grown in YPM were co-stained with anti-β (1,3)glucan antibody and Cy3 secondary to visualize exposed β (1,3)-glucan and calcofluor white to
visualize chitin.
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Figure S.2. 4. CDC42G12V increases β (1,3)-glucan exposure, but also reduces the viable cell
population.
(A) Propidium iodide staining was performed to quantify the live cells in Candida strains. (B) β (1,3)glucan exposure in live (gated for propidium iodide negative cells) wild-type and CDC42G12V
populations was measured by flow cytometry.
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Figure S.2. 5. MKC1 was knocked out in C. albicans via CRISPR-Cas9.
Western blotting was performed using anti-Mkc1 antibody to confirm the absence of MKC1 in the
MKC1 knockout mutants compared to wild-type (WT) and other strains. Tubulin was probed with
anti-tubulin antibody as a loading control.
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Figure S.2. 6. Deleting one PKC1 allele in cho1Δ/Δ did not rescue β (1,3)-glucan exposure.
One PKC1 allele was deleted through SAT1-flipper method. Cells were then stained with anti-β
(1,3)-glucan primary antibody and phycoerythrin (PE)-conjugated secondary antibody. The
statistical analysis was carried out by doing One-way ANOVA.
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Abstract
Candida albicans is among the most prevalent opportunistic human fungal
pathogens and is an important source of mortality, particularly in immunecompromised patients. The ability to mask the immunogenic polysaccharide β
(1,3)-glucan from immune detection via an outer layer of heavily mannosylated
proteins is a key virulence factor of C. albicans. We previously reported that
hyperactivation of the Cek1 Mitogen Activated Protein Kinase (MAPK) pathway
promotes β (1,3)-glucan exposure and enhances detection of cells by
macrophages. In this communication, we report a novel upstream regulator of
Cek1 activation and characterize the impact of Cek1 activity on fungal virulence.
Lrg1 encodes a GTPase activating protein (GAP) homolog that has been reported
to inhibit the GTPase Rho1. We find that disruption of LRG1 causes Cek1
hyperactivation and β (1,3)-glucan unmasking, but when GTPase activation is
measured for a panel of cellular small GTPases, the lrg1Δ/Δ mutant exhibits
increased activation of the GTPases Cdc42 and Ras1, but not Rho1 or Rac1.
Unmasking and Cek1 activation in lrg1Δ/Δ can be blocked by inhibition of the
Ste11 MAPKKK, indicating that Lrg1 acts through the canonical Cek1 MAPK
cascade. In order to determine how Cek1 hyper-activation specifically impacts
virulence, a doxycycline repressible hyperactive Ste11ΔN467 was generated in C.
albicans and was found to induce production of the pro-inflammatory cytokine
TNF-α from murine macrophages. This in vitro phenotype correlates with
decreased colonization and virulence in a mouse model of systemic infection.
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Introduction
Candida spp. species are the fourth most common cause of bloodstream
infections, and the leading causes of invasive fungal infections in hospitalized
patients in the United States [1]. Despite the presence of several effective
antifungals, the mortality rate of these infections still exceeds 40% [1]. Current antifungal drugs for Candida include polyenes, azoles, and echinocandins, however
mortality rates are unacceptably high even after accounting for limitations like drug
resistance or toxicity. This suggests that other therapeutic approaches need to be
used in conjunction with anti-infectives. One approach is to improve the residual
immune response of patients to these pathogens [2-4]. This could be improved by
making fungal pathogens more visible to the immune system’s sensory cells. The
fungal cell wall is a major focus for this as it is the main interface between the
immune system and the fungus [5].
The C. albicans cell wall is composed of three major layers, where the outer
layer is enriched for glycosylated proteins (mannan), and the inner layer consists
of chitin, β (1,6)-glucan and the highly immunogenic β (1,3)-glucan. Fungal
pathogens have a diversity of mechanisms to manipulate cell wall architecture to
mask pro-inflammatory β (1,3)-glucan epitopes from host recognition. In
Histoplasma capsulatum, α-glucan serves a masking function by concealing the βglucan, while the Eng1 exoglucanase hydrolyzes β-(1,3)-glycosyl bonds and
removes exposed β-glucans not covered by α-glucan [6, 7]. Aspergillus fumigatus
Uge3 regulates the biosynthesis of galactosaminogalactan, a polymer that covers
hyphal β-glucan from immune detection [8]. In C. albicans, β (1,3)-glucan is
masked by the outer layer of mannan. In this organism, certain genetic mutations,
treatment with the cell wall inhibitor caspofungin, or damage by neutrophils can
expose C. albicans β (1,3)-glucan [9-11]. This exposure facilitates recognition by
host immune cells through receptors like Dectin-1, and therefore launches immune
responses more efficiently and rapidly, including induction of pro-inflammatory
cytokines like tumor necrosis factor (TNF)-α for anti-fungal clearance [12]. The
importance of β (1,3)-glucan exposure and resultant enhancement of immune
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detection is becoming better appreciated in medical mycology and may lead to
discoveries that will improve adjunctive therapy approaches [9, 11, 13-16].
We previously identified that the activated GTPase Rho1 (RHO1Q67L)
exhibited β (1,3)-glucan unmasking in C. albicans [17]. The most well-known
contribution of Rho1 in this organism is to maintain sophisticated cell wall
architecture through regulating several downstream effectors including the β (1,3)glucan synthase Fks1, protein kinase C (Pkc1), and the cell wall integrity MAPK
cascade containing Mkc1 [18, 19]. To function accurately, Rho1 serves as a
molecular switch by cycling between active GTP-bound and inactive GDP-bound
state [20]. The regulatory proteins of GTPases generically include guanosine
exchange factors (GEFs), which stimulate GTP to be loaded onto the enzyme and
keep it in the active GTP-bound state, and GTPase-activating proteins (GAPs),
which promote the hydrolysis of GTP and convert the enzyme into the inactive
GDP-bound state [21-24]. In C. albicans, Lrg1 is proposed to act as the Rho1 GAP
based on the evidence that lrg1Δ/Δ mutant and hyper-activated RHO1Q67L mutants
both induce hyphal formation individually and ScLrg1 is a GAP for ScRho1 in
Saccharomyces cerevisiae, suggesting that Lrg1 negatively regulates Rho1
activity [25, 26]. However, GAP activity towards Rho1 in vitro has not been
evaluated in C. albicans [25].
Cdc42 is also an essential GTPase in C. albicans, and it is required for cell
viability, polarized growth, yeast-to-hyphal morphogenesis etc. [27, 28]. Like other
GTPases, CaCdc42 activity is regulated by GAPs negatively and the GEFs
positively [23]. The activated Cdc42 turns on downstream effectors including PAK
kinase Cst20, which further initiates hyphal formation by mediating Cek1 MAPK
cascade signaling [17, 27]. The Cek1 MAPK cascade, comprised of Ste11-Hst7Cek1, is primarily responsible for gene transcription involved in morphogenesis,
cell wall stress adaption, and cell growth [17, 29-31]. In C. albicans, Cek1 has been
reported to respond to several GTPases including Cdc42, Rho1, Ras1, and Rac1,
although most of this data is genetic in nature [17, 32, 33]. Here, we demonstrate
for the first time that in C. albicans, Lrg1 negatively controls Cdc42 and Ras1
activity in vivo, but not Rho1 or Rac1. Moreover, activation of Cek1 downstream of
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lrg1Δ/Δ occurs through the canonical Ste11 MAPKKK. Furthermore, we reveal that
hyperactivation of Cek1 by a Ste11ΔN467 allele compromises fungal virulence in the
mouse model of systemic infection.

Methods
Strains and growth media
All the strains and plasmids in this study are described in Table S.3. 1 and Table
S.3. 2, respectively. Primers used in this study were described in Table S.3. 3. The
media used to culture strains was yeast extract-peptone-dextrose (YPD) medium
(1% yeast extract, 2% peptone, and 2% dextrose (Thermo Fisher Scientific)) [34].
YPM medium (1% yeast extract, 2% peptone, and 2% maltose (Thermo Fisher
Scientific)) was used to flip out SAT1-flipper which is under the control of maltose
(MAL2) promoter. Doxycycline (Sigma-Aldrich, USA) was added with the working
concentration of 0.5 µg/mL as the repressor for the tetracycline-repressing
promoter.
Strain construction
To generate the LRG1 reintegrated strain, primers TCO68 and TCO69 were used
to amplify the LRG1 open reading frame (ORF) and 200bp of terminator as a SacINotI fragment, which was cloned into the pBT1 vector [35] between the constitutive
ENO1 promoter and the SAT1 selective marker. The resultant pTC7 was cut with
MscI and the linearized fragment was transformed to the lrg1Δ/Δ competent cells
by electroporation to create the TC14 mutant. The transformation method has
been described in [36].
To generate the homozygous deletion of STE11, the same protocol was
utilized as described in [37] with minor modification. ~500 bp of 5’ promoter and 3’
terminator flanking the STE11 ORF were amplified as KpnI-XhoI and NotI-SacI
fragments, by using the primers TCO155+TCO156 and TCO157+TCO158,
respectively. These two fragments were cloned to the corresponding ends of the
SAT1-flipper plasmid pSFS2A, respectively [38]. The resulting plasmid pTC71 was
digested with KpnI and SacI, and the larger fragment was transformed into lrg1Δ/Δ.
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The nourseothricin-resistant transformants were further cultured in YPM medium
containing maltose as a carbon source to induce caFLP expression, which is under
MAL2 promoter regulation. Successful deletion of one STE11 allele was confirmed
by PCR with the primers TCO159+JCO95. To delete the second STE11 allele in
the resultant Candida strain TC41, primers TCO162+TCO163 were used to
amplify the tetracycline-repressing promoter PtetOFF with the template of plasmid
pWTF1 [39]. The PtetOFF N-terminal was flanked by 60bp of homology to the STE11
promoter and the C-terminal was flanked by 60 bp of homology to the STE11 open
reading frame (ORF) located at 1402 -1461 bp. The PCR product was gel-purified
(Qiagen Inc., Germany), and transformed into the competent Candida TC41 cells,
and plated on YPD plates with 2mg/ml hygromycin B. The primers
TCO181+TCO57 were utilized for colony PCR to confirm if the pWTF1 fragment
replaced the N-terminal 1401bp of STE11 ORF on the chromosome.
To generate the Candida strain which expresses the doxycycline regulated
PtetOFF–STE11ΔN467, primers TCO162+TCO163 were utilized as mentioned above
to amplify the tetracycline-repressing promoter from the template of plasmid
pWTF1 [39]. The PCR product was transformed to the wild-type DAY286
competent cells, and then plated on the YPD plates with 2mg/ml hygromycin B.
TCO168+TCO169 were used to check if pWTF1 was integrated into the
chromosome.
To generate the GST-RID-6×His construct, primers TCO139+TCO140 were
used to amplify the RID domain located at 1111-1908bp of the CaPKC1 ORF as a
BamHI-SalI fragment by using C. albicans genomics DNA as template, which was
then cloned into the expression vector pGEX to create pTC55. The resultant
plasmid was transformed into competent E. coli BL21 cells for high protein
expression. Primers TCO165+TCO92 were used to amplify a Candida-adapted
hygromycin B resistance marker from pRB436 as a NotI-XbaI fragment. The PCR
product was ligated to the corresponding sites in pYGS1244 [24], in which Rho1
was tagged with 6×myc at the N-terminus. The resultant pTC73 was transformed
into the Candida strains of interest.
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To tag the N-terminus of Rac1 with GFP, TCO170+TCO175 were used to
amplify the RAC1 ORF flanked by RsrII and Mlu, from genomic DNA extracted
from the C. albicans DAY286 strain. The PCR product was digested and inserted
into the corresponding locus of the plasmid pTC33 to replace the RID domain.
TRO993 was used for sequencing to check if the RAC1 was ligated into the
plasmid in the correct orientation. The resultant plasmid pTC76 was linearized by
StuI restriction enzyme, followed by electroporation into Candida competent cells.
The positive transformants selected on YPD with nourseothricin were further
screened for GFP fluorescence by performing microscopy with a LEICA DM5500B
epi-fluorescent microscope with a Hamamatsu Orca-ER CCD digital camera
(Model#: C4742-80-12AG).
To generate the hyperactive RAS1G13V allele, primers TCO185+TCO186
were used to PCR amplify the RAS1G13V allele from the genome of the Ca79 strain
[40].and introduce NotI and SacI restriction sites. The PCR product was digested
and ligated into the plasmid pBT1. TCO185 was used for sequencing to check if
the RAS1G13V allele was inserted with the correct orientation. The resultant plasmid
pTC78 was linearized with BglII and transformed to the C. albicans competent cells
of interest. The positive colonies were selected on YPD plates with nourseothricin
and TCO185 and TCO186 were used to check if the fragment was located on the
chromosome.
Protein purification
To measure Rho1 activity, we first generated a GST-RID-6×His (Rho1 Interactive
Domain) construct that binds with GTP-Rho1 and expressed it in E. coli BL21
strain. The overnight culture was diluted to 1:100 ratio in fresh LB medium and
grown to OD600 0.6-0.9. IPTG (Sigma-Aldrich) was added to the final concentration
of 5mM to induce GST-RID expression at 20°C for 20hrs. The culture was pelleted
by centrifugation and resuspended into cell lysis buffer (50mM Tris-HCl, 500mM
NaCl, 30mM Imidazole, 400ul of 0.25mM PMSF (phenylmethylsulfonyl fluoride),
100ul of BME, 10mM MgCl2, and 1 protease inhibitor tablet (Roche Diagnostics
GmbH, Mannheim, Germany)) was agitated by sonication (Sonic Dismembrator
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F550 Ultrasonic Homogenizer, Fisher Scientific). The liquid was centrifuged for 1hr
at 17,000rpm at 4°C. The protein is soluble and was thus located in the
supernatant. The solution was then slowly run through a Ni-NTA column (QIAGEN
Inc., Germany) for binding, and the beads were then gently washed with wash
buffer (50mM Tris-HCl, PH8.0, 500mM NaCl, 30mM imidazole) to remove the
nonspecific binding protein. To elute out the His-tagged protein, 6 rounds of 250ul
of elution buffer (the same as wash buffer except with 300mM imidazole) was
added. The eluted fractions were then run through a PD-10 column (GE
Healthcare) to remove the imidazole. The product was applied to an Amicon ultra
0.5ml-centrifugal filter unit (Merck KGaA, Darmstadt, Germany) to concentrate the
protein.
Western Blotting
Western Blotting was performed as previously described [17]. To detect the
phosphorylation of Cek1 and Mkc1 MAPKs, rabbit anti-Phospho-p44/42 antibody
(Cell Signaling Technology, Inc., USA) at 1:2,000 dilution was utilized. The
expression of total Mkc1 was detected with the primary rabbit-anti-total Mkc1 Ab
at a 1:1000 dilution. The expression of total Cek1 was measured with a rabbit-antitotal Cek1 Ab at a 1:1000 dilution. The secondary antibody against Phosphop44/42 Ab, Mkc1 Ab and Cek1 Ab was IRye800CW goat anti–rabbit IgG (H+L)
conjugate (green, 1:10,000 dilution; LI-COR Biosciences). Tubulin was detected
as a control with rat anti-tubulin primary antibody (Bio-Rad Laboratories Inc., USA)
at a 1:1000 dilution and IRDye 680RD Goat-anti-Rat IgG (H+L) (red, 1:10,000
dilution; LI-COR Biosciences).
Pull-down assay for active GTPases
GTPase activity assay was performed as previously described [17]. The procedure
of cell wall disruption and protein concentration determination followed the abovementioned Western Blotting protocol. To detect Cdc42 activity, 1,500 μg of total
protein was used for the pull-down procedure following the instruction from the
Active Cdc42 Pull-Down and Detection Kit (Thermo Fisher Scientific, USA). The
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same kit was used to pull down the active GTP-bound GFP-tagged-Rac1 (See
Strain Construction), since the GST-Pak1 provided in the kit can also bind with
active Rac1. GTPase Ras1 activity was evaluated following the protocol from the
Active Ras1 Pull-Down and Detection Kit (Thermo Fisher Scientific, USA). To pulldown the active GTP-bound c-myc-tagged Rho1 (See Strain Construction), the
Active Rho Pull-Down and Detection Kit (Thermo Fisher Scientific, USA) was
purchased and the instruction was followed, except that the purified GSTRhotekin-RBD peptides provided in the kit was replaced with the purified GSTRID-6×His that we generated (See Protein Purification above) for optimized
binding capacity between GTP-Rho1 and the RID domain.
The antibody used to detect Cdc42 was rabbit polyclonal anti-S. cerevisiae
Cdc42 (kindly sent by Dr. Doug Kellogg at University of California, Santa Cruz).
The antibody to detect Ras1 was mouse monoclonal anti-Ras1 antibody (Anti-Ras,
clone RAS10, Millipore Sigma, USA) with the working concentration at 1.5µg/ml.
The antibody for c-myc-Rho1 detection was mouse anti-c-Myc Monoclonal
Antibody (9E10) (Thermo Fisher Scientific, USA) at 1:1000 dilution. The rabbit antiGFP antibody was used for the GFP tagged-Rac1 detection (Sigma Inc., USA).
The antibody to recognize the loading control tubulin was rat anti-tubulin (Bio-Rad
Inc., USA). The secondary antibody included IRye800CW goat anti–mouse IgG
(H+L) conjugate (1:10,000; LI-COR biosciences), IRye800CW goat anti-rabbit
IgG(H+L) conjugate (1:10,000; LI-COR biosciences), and IRye600RD goat anti-rat
IgG(H+L) conjugate (1:10,000; LI-COR biosciences). Densitometry quantification
of active GTP-bound GTPases versus the total GTPases input bands was
performed with ImageJ (National Institutes of Health, Bethesda, MD).
Immunofluorescent imaging of β (1,3)-glucan exposure
To stain the lrg1Δ/Δ mutant, Candida cells were grown overnight in YPD at 30 °C.
The culture was collected and processed to immunostaining. The staining and
imaging protocol were described as [17]
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Flow cytometry
To stain the STE11ΔN467 strain under the regulation of PtetOFF promoter over-time,
overnight cultures in YPD with doxycycline were diluted back to 0.2, and cells were
collected after 1h, 2h, 4h and 6h grown in the fresh YPD medium without
doxycycline. To stain the lrg1Δ/Δ mutant, overnight culture in YPD was collected
for immunostaining. The staining protocol and gating strategy was followed as
described in [17]. Flow cytometry data were obtained for 100,000 gated events per
strain and experiments were performed in triplicate, and the data were analyzed
using FlowJo software package with version 10.11 (FlowJo LLC, OR, USA).
Enzyme-linked immunosorbent assay (ELISA) of TNF-α
To activate Ste11ΔN467 expression under the PtetOFF regulation, the PtetOFFSTE11ΔN467 mutant was grown in YPD without doxycycline overnight. RAW264.7
murine macrophages were in used in this assay. ELISA kit instructions (R&D
Systems, USA) were followed. Each sample has three individual wells, and the
statistical analysis was performed by using Two-way analysis of variance ANOVA
(GraphPad Prism, v7.04 software).
Mouse model
Outbred male ICR mice were used in this study. C. albicans wild-type DAY286 and
PtetOFF–STE11ΔN467 strains were cultured overnight at 30°C in 50ml YPD with 0.5
µg/ml of doxycycline to repress Ste11ΔN467 expression. The overnight culture was
counted via hemocytometer and diluted to 107 cells/ml. The diluted fungal cells
were plated on YPD plate to test the viability. Mice were injected via the lateral tail
vein with 0.1 ml of the fungal cells. Mice were given drinking water either cosupplemented with 2 mg/ml doxycycline plus 5% sucrose to cover the bitter taste
of the antibiotics [41] or given 5% sucrose water alone. Mice were monitored
closely for 21 days for signs of illness. For the fungal burden counting experiment,
mice were sacrificed 4 days post infection. Kidneys were harvested, homogenized
and serial diluted in water, and plated on YPD plate. The plates were incubated at
30°C for 2 days to determine cfu per gram of kidney.
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Ethics statement
All mouse model experiments in this study were performed under an animal
protocol (1083) that was approved by the University of Tennessee Institutional
Animal Care and Use Committee (IACUC) and followed the ethical guidelines set
forth by the National Institute of Health (NIH) for the ethical treatment of animals.

Results
The lrg1Δ/Δ mutation causes β (1,3)-glucan exposure in C. albicans
Lrg1 homologs impact several cell wall-related functions in fungi (e.g. cell wall
integrity, cell fusion, and morphogenesis) [25, 26, 42, 43]. In S. cerevisiae, Lrg1
stimulates the intrinsic GTPase activity of Rho1, and therefore converts Rho1 to
its inactive, GDP-bound state [26, 42, 43]. We previously showed that hyperactive
Rho1 exposes β (1,3)-glucan in the cell wall, but appeared to act through the Cek1
MAPK rather than Mkc1 [17]. Since Lrg1 has been described as the Rho1 GAP in
C. albicans, we hypothesized that disruption of LRG1 would cause β (1,3)-glucan
exposure. To this end, we performed immunofluorescence staining with anti-β
(1,3)-glucan antibody to examine if the lrg1Δ/Δ mutant exhibits increased β (1,3)glucan exposure. As shown in Figure 3. 1A, β (1-3)-glucan is noticeably more
exposed in lrg1Δ/Δ cells than in wild-type or the complemented strain, where Lrg1
expression is under the regulation of constitutive promoter PENO1. Flow cytometry
confirms that lrg1Δ/Δ has significantly increased levels of β (1,3)-glucan
unmasking compared to control strains (Figure 3. 1B). This reveals that Lrg1 acts
as a repressor of cell wall β (1,3)-glucan unmasking in C. albicans.
LRG1 disruption up-regulates the Cek1 MAPK activity
Several MAPKs pathways are involved in the regulation of cell wall architecture in
C. albicans [29, 44], and improper activation of the Cek1 MAPK by upstream
GTPases such as Cdc42 or Rho1 causes β (1,3)-glucan exposure [17]. Lrg1 is a
proposed Rho1 GAP in C. albicans [25], which should upregulate Mkc1 and
possibly Cek1. To this purpose, we performed Western blotting to detect the
activated (phosphorylated) forms of Cek1 and Mkc1 in C. albicans. As seen in
98

Figure 3. 1. Lrg1 represses β (1,3)-glucan unmasking in C. albicans.
(A) Cells cultured overnight in YPD medium were stained with anti-β (1,3)-glucan antibody and
Cy3-conjugated secondary antibody. Cells were imaged by epi-fluorescent microscopy. (B) Cells
were stained with anti-β (1,3)-glucan antibody and Phycoerythrin (PE) –conjugated secondary
antibody. Flow cytometry was performed to quantify β (1,3)-glucan exposure in different Candida
cells. The statistical analysis was performed by doing One-way ANOVA. ****, p<0.0001
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Figure 3. 2, lrg1Δ/Δ does not visibly increase the intensity of phosphorylated Mkc1,
but instead Cek1 was hyper-phosphorylated up to 15-fold compared to wild-type.
This indicates that Lrg1 represses the activity of Cek1 instead of Mkc1 in C.
albicans, and this might be responsible for the cell wall exposure in the lrg1Δ/Δ
mutant.
LRG1 disruption hyper-activates the small GTPases Cdc42 and Ras1
The small GTPase Cdc42 sits upstream of Cek1, and is essential for many cellular
functions, including cellular polarized growth and bud emergence in C. albicans
[27, 45]. Regulation of the GTP/GDP-binding state controls the Cdc42 activation
state [27]. Given that Cdc42 is known to control Cek1 MAPK activity in C. albicans,
we hypothesized that the lrg1Δ/Δ disruption activates Cek1 through Cdc42. To test
this, we measured Cdc42 activity by quantifying the amount of GTP-bound active
Cdc42 in vivo. As seen in Figure 3. 3A and B, the concentration of GTP-bound
Cdc42 was clearly up-regulated compared to that of wild-type DAY286 and the
reintegrated strain. Thus, this suggests that Lrg1 controls Cdc42 activity negatively
in C. albicans. Cdc42 has been shown to control Cek1 phosphorylation in this
organism [17], so LRG1 disruption-dependent Cek1 hyper-activation may be
mediated by Cdc42.
There is a possibility that Lrg1 impacts other Cek1-associated GTPases. To
address this, we measured the activity of the GTPase Rac1, which has been
implied to function upstream of Cek1 [33]. Rac1 activity was assessed by pulling
down the activated GTP-bound GFP-tagged Rac1. The Cdc42/Rac1 interactive
binding (CRIB) protein used in the Cdc42 pull-down assay were used as the probe
to isolate GTP-bound Rac1, while GFP antibody was utilized to detect the amount
of GFP-Rac1 specifically. As shown in Figure S.3. 1, the level of GTP-bound GFPRac1 in the lrg1Δ/Δ mutant is reduced compared to that of wild-type. This suggests
that Rac1 and Cdc42 might work antagonistically when Lrg1 is disrupted in C.
albicans.
Ras1 is an important GTPase for filamentation and controls the cyclic AMP
signaling cascade and protein kinase A. It has been suggested to act upstream of
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Figure 3. 2 .The Cek1p MAPK is hyper-phosphorylated in lrg1Δ/Δ cells compared to wildtype
(A). Proteins were isolated from Candida cells sub-cultured 3 hrs into log phases after grown
overnight in YPD at 30°C. Western blotting was performed with anti-phospho-p44/42 antibody,
which stains both phosphorylated Mkc1 and Cek1, as well as anti-Mkc1 and -Cek1 antibodies,
which stain total Mkc1 and Cek1 proteins, respectively. Phospho-MAPKs signal was expressed as
a percent of wild-type (WT) control after being normalized to the tubulin loading control. (B). The
P-Mkc1 bands were quantified and normalized based on the total Mkc1 bands and tubulin. (C). The
P-Cek1 bands were quantified and normalized based on the total Cek1 bands and tubulin. The
graphs in both cases were based on quantification of 3 blots, and statistical analysis was performed
by doing one-way ANOVA. ****, p<0.0001
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Cek1 in C. albicans [32]. Since Cek1 is hyper-active in the lrg1Δ/Δ mutant (Figure
3. 2), it is reasonable to evaluate if Ras1 activity is upregulated when LRG1 is
disrupted. We performed pull-down assay to isolate active GTP-Ras1 by using its
downstream effector Raf1 as a probe. The ratio of GTP-Ras1 to total Ras1 is
significantly higher in lrg1Δ/Δ than that in other strains, indicating that LRG1
disruption induces Ras1 activity (Figure 3. 3C and D). To biochemically test if Ras1
can cause Cek1 hyperactivation, we performed Western blotting on the PMALRAS1G13V mutant (hyperactive allele) with Phospho-p44/42 antibody recognizing
the phosphorylated Cek1 and Mkc1. Unexpectedly, as seen in Figure 3. 3E,
hyperactivated Ras1G13V does not induce Cek1 activation under the inducing
conditions of using maltose as the carbon source. Similar results were seen in the
RAS1G13V mutant under the constitutive promoter PENO1 (Figure S.3. 2). These
results indicate that in C. albicans Ras1 is not activating Cek1 downstream of the
lrg1Δ/Δ mutation.
Lrg1 does not act as the Rho1 GAP in C. albicans
In S. cerevisiae, Lrg1 represses Rho1, and this has been implied by genetic data
in C. albicans, therefore, we measured Rho1 activity in the lrg1Δ/Δ mutant. Due to
lack of a commercial reagent to pull down active GTP-Rho1, we expressed and
purified a GST-tagged Rho1 interactive domain (RID) protein specific for C.
albicans GTP-Rho1 [46]. Due to lack of available commercial CaRho1 antibody,
CaRho1 was tagged with the c-myc epitope tag for the Western blot detection [24].
However, as shown in Figure 3. 3F and G, the lrg1Δ/Δ mutant does not contain a
higher concentration of GTP-Rho1 compared to wild-type. GTPγS is a nonhydrolysable substrate for these GTPases and therefore acts as positive control to
evaluate if our reagents work. The lack of an induction of Rho1 activity in the
lrg1Δ/Δ mutant suggests that Lrg1 does not act as the Rho1 GAP in C. albicans.
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Figure 3. 3. Lrg1 inhibits the activity of GTPases Cdc42 and Ras1, but not Rho1.
(A). GTP-Cdc42 was pulled-down by glutathione beads conjugated with glutathione S-transferase (GST)-PAK1, which specifically binds active GTPCdc42/Rac1. Western blotting was performed on the isolated GTP-Cdc42 portion with anti-Cdc42 antibody and tubulin was used as loading control.
(B). The GTP-bound Cdc42/Total-Cdc42 ratio compared to WT was calculated. The densitometry of active GTP-Cdc42 band and total Cdc42 band
was quantified by Image J based on 2 blots. *, p=0.0261. (C). The active GTP-Ras1 was pulled down by using the Ras1 binding domain (RBD)
within Raf1 as a probe, followed by Western blotting using anti-Ras1 antibody to evaluate the amount of active Ras1. (D). The ratio of GTP-bound
Ras1/Total-Ras1 compared to WT was calculated as shown in B. ***, P=0.0006. (E). Western blotting was performed with anti-P-p44/42 antibody to
assess the phosphorylation of Cek1 in the hyperactive RAS1G13V mutant under the regulation of maltose promoter. (F). The active c-myc-tagged
Rho1 was isolated by incubating with the purified GST-RID protein. The mixture was incubated with glutathione beads. Western blotting was
performed with anti-c-myc antibody to demonstrate the amount of GTP-bound Rho1 in the pulled-down portion. Total Rho1 was determined by
performing Western blotting on the total protein extract. (G). The ratio of GTP-bound Rho1/Total-Rho1 compared to WT was calculated as shown in
B. NS, no significance.
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Figure 3. 3 Continued
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Ste11 disruption blocks Cek1 hyper-phosphorylation and β (1,3)-glucan
exposure in lrg1Δ/Δ
Our results indicate that Lrg1 negatively controls Cek1 phosphorylation through
Cdc42 (Figure 3. 3), but it is was not clear if the pathway acts through the canonical
Cek1 MAPK cascade. Therefore, we next elucidated which upstream kinase
participates in this signal transduction pathway. The Ste11 MAPKKK sits at the top
of the Cek1 MAPK module, therefore we disrupted STE11 in lrg1Δ/Δ to determine
if this would prevent Cek1 activation. One STE11 allele was deleted in lrg1Δ/Δ
using SAT1-flipper [37]. However, we could not disrupt the second STE11 allele in
lrg1Δ/Δ. Thus, we replaced the second allele with the hyperactive STE11ΔN467
allele under the regulation of tetracycline-repressible promoter (PtetOFFSTE11ΔN467). This resulted in an lrg1Δ/Δste11Δ/Δ::PtetOFF-STE11ΔN467 strain,
indicating that STE11 is not essential in the lrg1Δ/Δ background, but may be
difficult to recover from transformation conditions. The lrg1Δ/Δste11Δ/Δ::Ptet-OFFSTE11ΔN467 mutant was treated with 0.5µg/ml of doxycycline overnight to repress
STE11 expression, followed by sub-culture in fresh YPD medium ±doxycycline for
3 hours. Western blotting was performed to measure Cek1 and Mkc1 activation.
As seen in Figure 3. 4A, failure to express Ste11 in lrg1Δ/Δ
(lrg1Δ/Δste11Δ/Δ::PtetOFF-STE11ΔN467 +doxycycline) blocks Cek1 phosphorylation.
This result indicates that Lrg1 negatively controls Cek1 activity through Ste11. We
next investigated if β (1,3)-glucan exposure can be suppressed in lrg1Δ/Δ when
Ste11

expression

is repressed. The

overnight

cultured

Candida

cells

(±doxycycline) were stained with anti-β (1,3)-glucan antibody, and then measured
by flow cytometry to quantify the unmasking. As seen in Figure 3. 4B, inhibition of
Ste11 expression by adding doxycycline (lrg1Δ/Δste11Δ/Δ::PtetOFF-STE11ΔN467
+doxycycline) completely blocked β (1,3)-glucan unmasking. This indicates that
hyper-activation of the Cek1 MAPK pathway is responsible for exposing β (1,3)glucan in the lrg1Δ/Δ mutant.
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Figure 3. 4. Disruption of LRG1 causes Cek1 over-activation through Ste11 MAPKKK
A. One STE11 allele was deleted in lrg1Δ/Δ using the well-established SAT1-flipper method. The second STE11 allele was replaced by the
PtetOFF-STE11ΔN467 allele. The Candida cells were treated with 0.5µg/ml of doxycycline overnight at 30°C, followed by sub-culture in fresh
YPD medium for 3 hours at 30°C into log phase with or without doxycycline. Western blotting was performed with the anti-P-p44/42 antibody.
B. The Candida cells were cultured overnight with or without doxycycline, followed by immunofluorescent staining with anti-β (1,3)-glucan
antibody and PE-conjugated secondary antibody. The stained cells were measured by flow cytometry for the quantification of β (1,3)-glucan
exposure. Strains were tested three times with 2 technical replicates each time, and statistical analysis was performed by doing one-way
ANOVA. ****, p<0.0001. *, p=0.0142.
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Cells with a lrg1Δ/Δ mutation or expressing the hyperactive STE11ΔN467 allele
induce TNF-α secretion from RAW264.7 macrophages
The relationship between the increased β (1,3)-glucan exposure and more TNF-α
secretion has been studied intensively [9, 11, 13, 15, 17, 30]. Due to the strong β
(1,3)-glucan exposure exhibited by lrg1Δ/Δ (Figure 3. 1), we performed enzymelinked immunosorbent assays (ELISAs) to study if unmasking in lrg1Δ/Δ correlates
with increased TNF-α production. As seen in Figure 3. 5A, loss of LRG1
significantly up-regulates TNF-α secretion released from RAW264.7 murine
macrophages. The cho1Δ/Δ mutant in Figure 3. 5A served as a positive control,
which has shown to cause upregulation of TNF-α production compared to the wildtype SC5314 strain [11, 15, 17]. Cek1 is hyperactivated in multiple conditions
associated with β (1,3)-glucan exposure including caspofungin treatment [47],
cho1Δ/Δ [11], hyperactivation of Cdc42, [17], and lrg1Δ/Δ (Figure 3. 1 and Figure
3. 2). Furthermore, hyperactivation of Cek1 via an activated allele of STE11
(STE11ΔN467) causes unmasking [17]. We suspect that this hyperactivation of Cek1
will lead to decreased virulence. Many of the mutants we have described such as
hyperactive Cdc42 or Rho1, lrg1Δ/Δ, or cho1Δ/Δ have pleotropic effects, which
makes it challenging to assess specific roles in virulence. However, the
STE11ΔN467 mutation causes a more specific upregulation of Cek1 activation [17].
Thus, to test this in vivo, we overexpressed STE11ΔN467 from the
doxycycline repressible promoter (PtetOFF) [39], so we could then use this in the
mouse model of infection and turn the gene on or off in the host after infection. We
transformed the PtetOFF-STE11ΔN467 allele into the wild-type Candida strain DAY286
cells and confirmed that in the absence of doxycycline Cek1 is hyperactivated
(Figure S.3. 3), but in the presence of the drug the strain behaved like wild-type.
Previous overexpression experiments with STE11ΔN467 using the PMAL2STE11ΔN467 construct showed hyperactivation of Cek1, but not Mkc1, however
when we upregulated STE11ΔN467 with the PtetOFF-STE11ΔN467 construct, we
observed stronger hyperactivation of Cek1 and Mkc1. This may be because a
strong enough activation of Cek1 causes a compensatory activation of Mkc1 [17],
although this is not certain.
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Immunofluorescent staining of the PtetOFF-STE11ΔN467 strain for β (1,3)glucan exposure indicates that when cultured in YPD medium overnight without
doxycycline, the mutant exhibits significantly increased β (1,3)-glucan exposure
(Figure S.3. 4). To evaluate the correlation between β (1,3)-glucan exposure
exhibited by STE11ΔN467 expression from the PtetOFF promoter and TNF-α secretion,
we performed ELISAs on overnight cultures of wild-type DAY286 and the PtetOFFSTE11ΔN467 strain in the presence or absence of doxycycline. As seen in Figure 3.
5B, when Ste11ΔN467 is induced in the PtetOFF-STE11ΔN467 strain (-doxycycline),
TNF-α production is significantly up-regulated from RAW246.7 macrophages.
Hyperactivation of Cek1 results in decreased fungal virulence in vivo
We predict that due to increased unmasking, activation of PtetOFF-STE11ΔN467 in
mice will lead to a loss of virulence. To test this, wild-type and PtetOFF-STE11ΔN467
strains were cultured in YPD overnight with doxycycline to repress Ste11ΔN467
expression, and then injected into the tail vein of outbred ICR mice. The mice
injected with the PtetOFF-STE11ΔN467 strain and provided with doxycycline
succumbed to fungal infection in ~10 days. This is similar to mice injected with
wild-type ±doxycycline. However, mice infected with PtetOFF-STE11ΔN467 without
doxycycline (where STE11ΔN467 is overexpressed), survived significantly longer
than mice in the other groups (Figure 3. 6).
Furthermore, when mice were sacrificed at day 4 post-infection, mice
infected with PtetOFF-STE11ΔN467 minus doxycycline exhibited (2.43±1.07) ×102 cfu
g-1 kidney, while the mice infected with the same strain with doxycycline exhibited
(2.51±0.65) ×104 cfu g-1 of kidney (Figure 3. 7). Thus, there was a decrease of ~ 2
logs (P=0.0006) in kidney fungal burden when the gene was expressed. A growth
curve in vitro demonstrated that wild-type and STE11ΔN467 had a similar growth
pattern without doxycycline, and addition of doxycycline did increase the cell
division rate modestly from 90 minutes to ~103 minutes in early log phase,
however, the strain rapidly catches up to wild-type, suggesting only a temporary
decrease in growth as the STE11ΔN467 is turned on (Figure S.3. 5). This suggests
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Figure 3. 5. LRG1 disruption significantly induces TNF-α secretion.
(A). C. albicans cells were grown in YPD overnight at 30°C, UV-inactivated, and then co-cultured
with RAW264.7 macrophages for 4hrs. The RAW264.7 macrophage supernatant was collected
and filtered through a 0.22µm syringe filter to remove cell debris. The filtrates were assayed by
ELISA to quantify the TNF-α production. Samples were tested in triplicate three times for an n of 9.
The statistical analysis was done by one-way ANOVA. ****, P<0.0001. (B). C. albicans wild-type
and PtetOFF-STE11ΔN467 strains were cultured overnight in YPD at 30°C, plus or minus doxycycline.
The UV-kill, incubation with macrophages RAW264.7, filtration and ELISA procedures were the
same as described in A. ****, P<0.0001.
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Figure 3. 6. Activated Cek1 leads to attenuated fungal virulence in the mouse model of systemic infection.
C. albicans strains wild-type (DAY286) and PtetOFF-STE11ΔN467 were cultured overnight at 30°C with doxycycline to repress Ste11ΔN467
expression. The overnight culture was diluted to 106 cells/ml, and 100 µl of the suspension were injected into the lateral tail vein of outbred
ICR mice. Mice were given 2 mg/ml of sucrose in their drinking water either without doxycycline or with doxycycline to repress Ste11ΔN467
expression in vivo. The symptoms of illness were monitored over 21 days. Each group has 10 ICR mice. *, p=0.016
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Figure 3. 7. Ste11 hyper-activation causes decreased kidney fungal burden in the mouse
model of systemic infection.
C. albicans strains wild-type DAY286 and PtetOFF-STE11ΔN467 were cultured overnight at 30°C with
doxycycline to repress Ste11ΔN467 expression. The overnight culture was diluted to 107 cells/ml, and
100 µl of the suspension was injected to the lateral tail vein of outbred ICR mice. Mice were given
sucrose drinking water either with doxycycline to repress Ste11ΔN467 expression in vivo or given
sucrose water alone. The mice were sacrificed 4 days post-infection and the kidneys from each
mouse were taken and homogenized. The homogenates were diluted to 10-3 by performing serial
dilution. 1 ml of the diluted homogenates from each dilution were plated on the YPD plates and
cultured in 30°C for two days. The colony forming unit was counted on each plate. Eight mice were
tested for each strain. ***, p=0.0006; ****, p<0.0001.
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that β (1,3)-glucan exposure driven by PtetOFF-STE11ΔN467 activates the host
immunity more efficiently, which further clears the fungal pathogen more rapidly.

Discussion
Previously our lab determined that hyper-activation of Cek1 promotes β (1,3)glucan exposure in response to loss of phosphatidylserine synthase [17]. This
process involves the activation of the GTPase Cdc42 which positively regulates
Cek1 MAPK activity [17]. In this communication, we characterized a novel
upstream regulator of Cek1 by identifying that the Lrg1 GAP negatively regulates
Cek1 activity. Lrg1 acts through the GTPase Cdc42, but not the GTPase Rho1,
which has been reported as a target of Lrg1 in the literature. Lrg1 disruption
stimulates significantly increased β (1,3)-glucan unmasking, which further induces
a higher level of TNF-α secretion from murine macrophages.
The Lrg1-Cdc42 cascade modulates Cek1 MAPK activity via Ste11 in C.
albicans
In S. cerevisiae, Lrg1 has been shown to interact with the activated form of Rho1
and act as GAP [26, 48]. However, there are discrepancies concerning the
negative regulation of other GTPases by Lrg1 in different studies. Roumanie et. al.
found that Lrg1 acts as GAP for two other GTPases, Rho2 and Cdc42 by
performing spectroscopic measurement in vitro based on 7-methyl-6thioguanosine (MESG)/phosphorylase system [49]. In contrast, Fitch et al. found
Lrg1 is a Rho1-specific GAP in vitro by measuring the amount of Rho1 bound with
[α-32P]-labeled GDP or GTP, after stimulation with purified Lrg1 [26]. Regarding
the effect of Lrg1 on Rho1-mediated cell wall processes, Lrg1 is reported to
negatively regulate glucan synthase activity, whilst controversy appears on its role
in activation of the cell wall integrity Mkc1 pathway [42, 48]. These opposing results
could be due to the different backgrounds of S. cerevisiae strains used. In
Neurospora crassa, Lrg1 was shown to serve as a Rho1-specific GAP and impact
several downstream pathways of Rho1 [43]. In C. albicans, the lrg1Δ/Δ mutant
increases hyphal formation and biofilm development, which are phenotypes
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shared with a RHO1Q67L gain of function mutant. However, in this study there was
no biochemical evidence to demonstrate that Lrg1 acts as Rho1 GAP [25, 50].
In this communication, we provided evidence that in C. albicans loss of Lrg1
increases β (1,3)-glucan masking (Figure 3. 1), and this is likely mediated by hyperactivated Cek1 (Figure 3. 2). Our results also suggest that Lrg1 does not act as a
Rho1 GAP in C. albicans. Lrg1 does not show Rho1 inhibitory activity in vivo, nor
does it inhibit Rac1 activity (Figure 3. 3 and Figure S.3. 1). Instead, Lrg1 exhibits
repression of the activities of both Cdc42 and Ras1, as indicated by significant
induction of both GTPase activities in vivo in the lrg1Δ/Δ mutant (Figure 3. 3). The
unexpected results imply signal rewiring occurs in the pathogenic C. albicans
versus the non-pathogenic S. cerevisiae. Ras1 plays pivotal roles in fungal
morphogenesis, and as a result contributes to virulence [32]. Loss of RAS1 causes
defects in yeast-to-hyphal transition, which nonetheless can be restored by
overexpressing signaling component in the Cek1 pathway in the ras1Δ/Δ mutant
[32]. Although this suggests that Ras1 might be upstream of Cek1, we cannot rule
out the possibility that Cek1 and Ras1 act in a parallel manner. Our western blot
result shows that hyperactive RAS1G13V mutant does not display Cek1
overactivation (Figure 3. 3E and Figure S.3. 2), suggesting that hyperactivation of
Ras1 is not sufficient to induce Cek1 phosphorylation, and that these two proteins
are not in a linear signaling cascade.
The Ste11 MAPKKK is a well-known upstream regulator of Cek1 activity
and the hyperactivated STE11ΔN467 mutant causes β (1,3)-glucan exposure in C.
albicans [17]. Here we show that Ste11 is also involved in the Lrg1-dependent
Cek1 hyperactivation, given that disruption of STE11 rescues both β (1,3)-glucan
exposure and Cek1 hyper-phosphorylation in the lrg1Δ/Δ mutant (Figure 3. 4).
Given the established effect of Cdc42 on Cek1 activation [17], our results indicate
that Lrg1 negatively modulates Cek1 activity via the GTPase Cdc42 (Figure 3. 8).
β (1,3)-glucan exposure compromises fungal virulence
Several cell wall defective mutants have exhibited attenuated fungal virulence in
the mouse model of systemic infection, including the phosphatidylserine synthase
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Figure 3. 8. A model shows that Lrg1 acts as a molecular switch regulating Cek1 activity
negatively via the GTPase Cdc42.
(A). Lrg1 disruption turns on GTPase Cdc42 activity in vivo, which is represented by higher level of
GTP-bound Cdc42. This further phosphorylates/activates the canonical downstream Ste11-Hst7Cek1 cascade. Hyperactivated Cek1 is shown in this study to stimulate β (1,3)-glucan exposure
and compromise fungal virulence. (B). Lrg1 is speculated to act as GTPase Cdc42 GAP, which
stimulates its intrinsic GTPase activity. Cdc42 is therefore favorably disposed to GDP-bound state
to suppress Cek1 phosphorylation.
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mutant (cho1Δ/Δ), ace2Δ/Δ, cek1Δ/Δ, kre5 Δ/Δ, phr1 Δ/Δ [11, 15, 30, 51, 52].
However, all these mutants display pleotropic phenotypes. Therefore, it is hard to
differentiate the effect of β (1,3)-glucan exposure versus the role that other types
of defects play on fungal virulence. Also, β (1,3)-glucan of the mutants is exposed
even before the fungal cells are injected into the mouse tail. This raises a problem
that the mutants with β (1,3)-glucan exposed might be recognized and cleared by
the immune systems more rapidly, even before the systemic infection is
established.
In this communication, we made the PtetOFF-STE11ΔN467 mutant that
addressed the above-mentioned disadvantages. Ste11 sits upstream and
specifically regulates Cek1 activity in C. albicans [53]. The truncated STE11ΔN467
mutant without the N-terminal inhibitory domain displays great induction of Cek1
activity and higher level of β (1,3)-glucan exposure [17]. The PtetOFF promoter can
be further used to control Ste11ΔN467 expression, by adding/removing the inhibitor
doxycycline as needed. The STE11ΔN467 mutant when induced to hyper-activate
Cek1 has decreased virulence in vivo, reflected by significantly greater mouse
survival over 21 days compared to other control groups, and an ~100 fold
decreased in fungal burdens in mouse kidneys (Figure 3. 6 and Figure 3. 7). This
suggests that the exposed β (1,3)-glucan might contribute to the attenuated fungal
virulence, due to its higher visibility to immune receptors via Dectin-1 potentially.
Regardless of the mechanism, virulence is compromised, thus hyperactivation of
Cek1 via a variety of different pathways may be useful for improving immune
recognition of C. albicans and adjunctive therapy.
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Appendix
Table S.3. 1. C. albicans strains used in this study
Strain

Parent

Genotype

Source
reference

SC5314

Clinical

Prototrophic wild type

[54]

isolate
YLC337

SC5314

cho1Δ/Δ

[38]

DAY286

SC5314

ura3::imm434/ura3::imm434

[55]

iro1/iro1::imm434
his1::hisG/his1::hisG arg4/arg4
lrg1Δ/Δ

DAY286

ura3::imm434/ura3::imm434

[25]

iro1/iro1::imm434
his1::hisG/his1::hisG arg4/arg4
lrg1::Tn7-UAU1/lrg1::Tn7-URA3
TC14

lrg1Δ/Δ

lrg1Δ/Δ:: PENO1-LRG1

This study

TC41

lrg1Δ/Δ

lrg1Δ/Δste11Δ/STE11

This study

TC48

TC41

lrg1Δ/Δste11Δ/Δ::PtetOFF-STE11ΔN467

This study

TC128

DAY286

DAY286 with 6×myc-Rho1

This study

TC131

lrg1Δ/Δ

lrg1Δ/Δ with 6×myc-Rho1

This study

TC132

lrg1Δ/Δ::R

lrg1Δ/Δ:: R with 6×myc-Rho1

This study

TC147

DAY286

DAY286+PtetOFF-STE11ΔN467

This study

TC44

DAY286

DAY286 with GFP-Rac1

This study

TC158

lrg1Δ/Δ

lrg1Δ/Δ with GFP-Rac1

This study

CAF2-1

SC5314

URA3/ura3::imm434

[55]

IRO1/iro1::imm434
Ca79

CAF2-1

RAS1/RAS1/PMAL2-RAS1G13V

[40]

TC159

DAY286

DAY286+PENO1-RAS1G13V-1

This study

TC160

DAY286

DAY286+ PENO1-RAS1G13V-2

This study
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or

Table S.3. 2. Plasmids used in this study
Strain Name

Description

Source

pYLC146

FLP-CaNAT, chloraR

This study

pBT1

CaNAT-PENO1, ampR

[35]

pTC7

pENO1+CaLRG1, ampR

This study

pExpArg-

pExpArg-pACT1GFPRID

pACT1GFPRID

[46]

pTC33

pExpArg-pACT1GFPRID+NATR

[17]

pTC55

pGEX+RIDHIS in DH5α, ampR

This study

pTC57

pGEX+RIDHIS in BL21, ampR

This study

pTC71

pYLC146+STE11-KO, chloraR

This study

pYGS1244

TetO-Myc-RHO1-UTR*-TetR/CIP10U

[24]

pTC73

pYGS1244+HYGROR

This study

pTC76

pExpArg-pACT1GFPRAC1+NATR

This study

pTC78

pENO1+CaRAS1G13V, ampR

This study

pWTF1

PtetOFF+HYGROR

[39]
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Table S.3. 3. Primers used in this study
Name

Sequence

TCO57

TTTCCACAATCAAACATCCAA

Description
Primer-R sits at the C-terminus of STE11 to check if PTETOFF- STE11ΔN467
is replaced the 2nd allele of STE11 in TC41

TCO69

AAAAGCGGCCGCATGAAGCATTCGTTTGATAC

Primer-F to amplify CaLRG ORF and Terminator

TCO68

AAAAGAGCTCGGTTTAGATTAAGCAGAGTT

Primer-R to amplify CaLRG ORF and Terminator

TCO92

AAAGCGGCCGCTCGATATTGCTAGAGGCAAA

Primer-F to amplify Hygromycin resistance B gene with NotI flanking

TCO93

AAAGCGGCCGCATTTTATGATGGAATGAATGG

Primer-R to amplify Hygromycin resistance B gene with NotI flanking

TCO139

AAAAGGATCCTTAGAACCAGGTGGTCAAAT

Primer-F to amplify RID domain located at 1111-1908bp of CaPKC1
ORF flanking with BamHI

TCO140

AAAAGTCGACCCGACGTCTAGTAGAAGGA

Primer-R to amplify RID domain located at 1111-1908bp of CaPKC1
ORF flanking with SalI

TCO155

AAAAGGTACCGATGAACAGGTATTAGTATCA

Primer-F to amplify 500bp of CaSTE11 promoter with KpnI flanking

TCO156

AAAACTCGAGGACTGTTTGTTAGATTTGAGT

Primer-R to amplify 500bp of CaSTE11 promoter with XhoI flanking

TCO157

AAAAGCGGCCGCCCATTAATTATGTCGAAACAA

Primer-F to amplify 500bp of CaSTE11 terminator with NotI flanking

TCO158

AAAAGAGCTCCAAGTAGGTTCACTGTAGAT

Primer-R to amplify 500bp of CaSTE11 terminator with SacI flanking

TCO159

AGGAGAGATTAAAACTTGGA

Primer-F to check if the pYLC146+STE11 KO construct was integrated
into chromosome

TCO162

ATATAGAAAACCTAATACATTAGTTCGTGTGTAT

Primer -F to amplify tetracycline-repressing promoter flanking by 60-mer

ATGGTACTCAAATCTAACAAACAGTCCTTGGACT

homology of STE11 promoter

CTTGAATCCGCGG
TCO163

AATCCTATGCAATGCAGTTCCCCCACTTAATGAT

Primer -R to amplify tetracycline-repressing promoter flanking by 60-mer

TTTGACGATATTATGGATCTCGAATCCATGACTG

homology of STE11 ORF located at 1402-1461bp

CACCAGCTCCGGTACCACT
TCO181

CTACTCGATTGAGTAATAGA

Primer-F sits at PminiOP4 of pWTF1 to check if pWTF1 replaced the
STE11 promoter and the N-terminal 467 aa.

124

Table S.3. 3. Continued
Name

Sequence

TCO57

TTTCCACAATCAAACATCCAA

Description
Primer-R sits at the C-terminal of STE11 to check if pWTF1 replaced the
STE11 promoter and the N-terminal 467 aa.

TCO165

AAATCTAGAATTTTATGATGGAATGAATGG

Primer-R to amplify Hygronyocin B resistance gene with XbaI flanking

TCO168

CTGTTCTTTCATGGTATTCT

Primer-F sits at -117bp of the STE11 promoter to check if PTETOFFSTE11ΔN467 was integrated into the chromosome

TCO169

ACTGATTTATTCAATTGATGG

Primer-R sits within the pTDH3 of pWTF, and is to check if PTETOFFSTE11ΔN467 was integrated into the chromosome

TCO170

AAAACGGACCGTGTACCCATACGATGTCCCAGA

Primer-F to amplify RAC1 ORF with RsrII flanking

CTACGCAATGAGAAGCATTAAATCAGTCGTAG
TCO175

AAAAACGCGTCCCATGATTATAATATAGTACATT

Primer-R to amplify RAC1 ORF with MluI flanking

TTTTAGCTCTC
TRO993

TTGGTGATGGTCCAGTCTTGT

Primer-F at the EGFP region of pTC76 to check if EGFP and RAC1
ligated in a correct orientation
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Figure S.3. 1. Loss of Lrg1 decreases GTPase Rac1 activity.
(A) Active GTP-bound GFP-tagged Rac1 was pulled-down using GST-CRIB as a probe, followed
by Western blotting with anti-GFP antibody. The amount of total Rac1 was also detected from whole
cell lysates by using anti-GFP antibody. (B). The GFP-Rac1 band in the pull-down lanes was
quantified by Image J and normalized to the total GFP-Rac1. This data represents 2 blots. *,
P=0.0154.
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Figure S.3. 2. The hyperactive Ras1G13V does not display Cek1 phosphorylation.
The RAS1G13V mutant under regulation of constitutively expressing enolase promoter was cultured
overnight in YPD at 30 °C and diluted back to OD600 at 0.2 for 3 hours growth. Cells were collected,
and Western blotting was performed with anti-P-p44/42 antibody to assess Cek1 phosphorylation.
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Figure S.3. 3. Cek1 MAPK is hyper-phosphorylated when the PtetOFF-STE11ΔN467 construct is
induced.
The PtetOFF-STE11ΔN467 strain was cultured overnight in YPD medium at 30°C in the presence of
doxycycline, washed with PBS, diluted back to 0.2 and grown for 3 hours into log phase. Western
blotting was performed on the Candida cell extracts to evaluate the activation state of MAPKs.
Phospho-p44/42 antibody was used as the primary antibody to detect the level of phosphorylated
Cek1 and Mkc1 MAPKs. The lrg1Δ/Δ mutant was used as a control. The overnight lrg1Δ/Δ culture
without doxycycline was diluted back to OD600 0.2 and grown for 3 hours.
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Figure S.3. 4. An overnight culture of PtetOFF-STE11ΔN467 exhibits increased β (1,3)-glucan
exposure when induced.
The PtetOFF-STE11ΔN467 strain was cultured overnight in YPD medium at 30°C in the presence or
absence of doxycycline. The overnight culture was stained with anti-β (1,3)-glucan antibody and
PE-conjugated secondary antibody. Flow cytometry was then performed to quantify the level of β
(1,3)-glucan exposure shown in the mutants. **, P=0.0043, *, P=0.0158.
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Figure S.3. 5. The growth rate of different Candida strains was measured to determine if
hyperactivation of Cek1 MAPK affects cellular growth.
Cells were grown overnight in YPD at 30°C plus doxycycline, diluted back to OD600 of 0.1 and
transferred to fresh YPD with or without doxycycline. A growth curve was generated with three
replicates for each condition. The growth rate of STE11ΔN467 at each timepoint without (w/o)
doxycycline was compared with that of wild-type under the same condition by using Two-way
ANOVA (**, p=0.0024; ****, p<0.0001).
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CHAPTER IV: Genetic Analysis of Genes Expressed
during β (1,3)-glucan Exposure Induced by Cek1
Hyperactivation
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This chapter is part of a manuscript that includes Chapter III that we are preparing
to submit.
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Abstract
A full molecular model to explain β (1,3)-glucan exposure has not yet been
developed, although a growing body of data indicates it correlates with cell wall
repair processes. Activation of Cek1 is consistent with this. To investigate how
Cek1 activation could contribute to this, the gene expression profile controlled by
hyperactive Cek1 needs to be determined. To achieve this goal, we utilized the
Cek1-hyperactivating mutant (PtetOFF-STE11ΔN467), where the N-terminus inhibitory
domain of Ste11 is deleted, and the C-terminus is under the regulation of the
tetracycline repressible promoter. We found that the STE11ΔN467 mutant displays a
statistically significant increasing β (1,3)-glucan unmasking 4 hours after subculturing into conditions without doxycycline. Total RNA was thus extracted from
wild-type and PtetOFF-STE11ΔN467 strains based on timing parameter. The RNA
samples were sequenced via the Illumina MiSeq platform, and 109 genes were
identified to be differentially expressed more than 2-fold in STE11ΔN467 inducing
condition compared to other control conditions. These genes are enriched for cell
wall construction/repair, including chitin production, and the β-glucan biosynthesis
process. Several signal transduction genes were also found to be expressed
differentially. Of note, the Cek1-regulated transcription factor Cph1, required for
hyphal development, is induced ~9-folds under Cek1-inducing condition. This
suggests that Cph1 might be the downstream effector mediating cell wall
unmasking induced by Cek1 hyperactivation. Moreover, Cek1 is induced to be
hyper-phosphorylated when treated with the anti-fungal caspofungin, and
disruption of CPH1 decreases the level of β (1,3)-glucan exposure caused by the
drug. This highlights the significance of Cek1-Cph1 in cell wall remodeling for
therapeutic applications. Our data also provides groundwork to further assess
potential

cell

wall

proteins

causing

β

(1,3)-glucan

exposure

when

overexpressed/repressed, which can then be considered as future drug targets.
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Introduction
Cek1 is a well-known MAP kinase involved in cell wall biogenesis, morphological
alterations, and fungal virulence [1-5]. Disruption of CEK1 attenuates hyphal
development on certain agar media when mannitol is used as the carbon source,
or on glucose media while the nitrogen source is limited. The cek1Δ/Δ mutation
also adversely affects the serum-induced mycelial colony diameters and growth
rate [1] and compromises fungal virulence in the mouse mastitis and systemic
infection models [1, 2].
Recently, Cek1 activity was identified to be key to controlling β (1,3)-glucan
exposure. Loss of Cek1 causes exposure of certain cell wall components, including
β (1,3)-glucan, α (1,2)- and β (1,2)-mannosides, via transcriptionally regulating a
significant number of cell wall biogenesis genes (PGA13, IHD1, etc.) and stress
response genes (HSP21, DDR48, etc.) [6, 7]. The cek1Δ/Δ mutant stimulates the
host immune response more effectively compared to the wild-type, via a dectin-1
receptor-dependent fungal recognition mechanism [7]. This mutant is also better
recognized by the galectin‑3 receptor, a member of β‑galactoside‑binding protein
family [8]. On the other hand, we previously identified that hyper-activated Cek1
promotes β (1,3)-glucan exposure [9]. Like cek1Δ/Δ, the mutant containing Cek1
hyperactivation is recognized more effectively by murine macrophages than wildtype, and fungal virulence is attenuated in the mouse model of systemic infection
(Figure 3. 5, Figure 3. 6, and Figure 3. 7). However, the genetic mechanisms
causing β (1,3)-glucan exposure in this mutant are unknown.
Cek1 has two downstream transcription factors Cph1 and Ace2, where
Cph1 impacts hyphal growth and white-opaque switching and Ace2 affects cell
wall glycosylation [1, 8]. Disruption of ACE2 was reported to cause severe β (1,3)glucan exposure [10]. Conversely, transcriptional upregulation of ACE2 is thought
to be responsible for increased β (1,3)-glucan masking driven by lactate treatment
[10]. This is possibly due to the regulation of Ace2 on homeostasis of cell wall
glycostructure in order to cover the glucan layer underneath [8]. Cph1 is also
involved in C. albicans cell wall construction [11-13]. The CPH1 over-expressing
mutant exhibit pseudo-filament formation under yeast growth condition, and
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several

transcriptionally

upregulated

cell

wall

genes

driven

by

Cph1

hyperexpression under this condition were also induced in a wild-type strain grown
under hyphal-culturing condition [13]. Given that C. albicans hyphae intrinsically
display a higher level of β (1,3)-glucan exposure, it is possible that Cph1
overexpression under yeast condition might drive cell wall to transition to a hyphallike structure. Altogether, this indicates that the cell wall dysfunction resulted from
Cek1 activity imbalance might be mediated through these two downstream
effectors transcriptionally.
To determine the genetic profile induced by Cek1 hyperactivation which
might result in β (1,3)-glucan exposure, we performed RNA-seq on the PtetOFFSTE11ΔN467 mutant which has been confirmed to hyper-activate Cek1 when
induced (Figure S.3. 3). Our transcriptome analysis identified a group of genes that
are enriched for cell wall synthesis and responses to chemicals/stress and are
increased in expression by more than 2-fold in the hyperactive Cek1 mutant
compared to control groups. The transcription factor Cph1 is among them and is
up-regulated ~9-fold, which might impact cell wall architecture.

Methods
Strains and plasmids
All the strains in this chapter were described in Table S.4. 1.
Growth conditions
The media used to culture Candida cells was yeast extract-peptone-dextrose
(YPD) medium (1% yeast extract, 2% peptone, and 2% dextrose (Thermo Fisher
Scientific)) [14]. Doxycycline (Sigma-Aldrich, USA) was added at the working
concentration of 0.5 µg/mL as the repressor for the tetracycline-repressing
promoter.
Western blotting
To extract proteins from PtetOFF-STE11ΔN467 mutant, the strain was cultured
overnight in the presence of doxycycline, and sub-cultured in fresh YPD
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±doxycycline and grown for 4 hours to mid-log phase. To extract proteins from
Candida cells being treated with caspofungin, the wild-type DAY286 cells were
cultured without caspofungin overnight, and then transferred to in the fresh YPD
medium without the drug for 3 hours into log phase. Then, a ½ MIC of caspofungin
(63ng/ml) was added to the culture for further incubation for 30min, 1 hr and 2 hrs.
Western Blotting was performed as previously described [9].
To detect the phosphorylation of Cek1 and Mkc1 MAPKs, rabbit antiPhospho-p44/42 antibody (Cell Signaling Technology, Inc., USA) at 1:2000 dilution
was utilized. The expression of total Mkc1 was detected with the primary rabbitanti- Mkc1 Ab at a 1:1000 dilution (provided by Dr. Jesus Pla at Universidad
Complutense de Madrid, Spain). The expression of total Cek1 was measured with
a rabbit-anti- Cek1 Ab at a 1:1000 dilution (a gift from Dr. Mira Edgerton at The
State University of New York). The secondary antibody for Phospho-p44/42 Ab,
Mkc1 Ab and Cek1 Ab was IRye800CW goat anti–rabbit IgG (H+L) conjugate
(green, 1:10,000 dilution; LI-COR Biosciences). Tubulin was probed as a control
with rat anti-tubulin primary antibody (Bio-Rad Laboratories Inc., USA) at a 1:1000
dilution and IRDye 680RD Goat-anti-Rat IgG (H+L) (red, 1:10,000 dilution; LI-COR
Biosciences) as a secondary antibody.
Flow cytometry
To stain the STE11ΔN467 strain under the regulation of PtetOFF promoter over-time,
overnight cultures in YPD with doxycycline were diluted back to 0.2, and cells were
collected after 1hr, 2hrs, 4hrs and 6hrs grown in the fresh YPD medium without
doxycycline. To stain Candida cells treated with caspofungin, the overnight culture
without the drug was sub-cultured for 3 hours. The staining protocol and gating
strategy was followed as described in [9]. Flow cytometry data were obtained for
100,000 gated events per strain and experiments were performed in triplicate, and
the data were analyzed using the FlowJo software package with version 10.11
(FlowJo LLC, OR, USA).
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RNA extraction
The RNA extraction protocol was modified from [15]. 15 ml of yeast overnight
culture were collected and washed 3 times with PBS. 750 µl of TES buffer (Tris-Cl
(10 mM, pH 7.6), EDTA (10 mM), Sodium dodecyl sulfate (SDS) (0.5%, w/v)),
which was prepared with RNAse-free water (RPI, Corp. USA) and 750 µl of acid
phenol at pH 4.5 (Thermo Fisher, USA) were added to the pellet and an equal
volume of 150-212μm acid-washed glass beads (Millipore-Sigma, USA) were
added to each tube. Cells were mechanically disrupted in a Biospec MiniBeadBeater (Bio Spec Product Inc., USA) with 4 rounds of 1 min homogenization
at 4°C and 2 min intervals for each cycle on ice. Samples were placed in a 65°C
heat block for 30min and vortexed thoroughly every 10mins. The mixture was
centrifuged for 5 min at 13,000 ×rpm at room temperature, and the aqueous layer
was transferred to a fresh tube containing 700 µl of acid phenol at pH 4.5 and spun
for 5 mins. The aqueous layer was transferred and washed twice with 600 µl of
neutral pH phenol (Thermo Fisher, USA), followed by washing with 600 µl of
chloroform until the interface was clean. The supernatant was further transferred
to the tube containing 150 µl of 3M sodium acetate, followed by adding 1 ml 100%
ethanol, and the mixture was placed in -80°C freezer overnight to precipitate the
nucleic acid out of solution. The pellet was collected by centrifugation at
13,000×rpm at 4°C for 10mins, and further washed with 500 µl of 70% ice-cold
ethanol. The pellet was dried at room temperature and resuspended in 100 µl of
RNase-free water. DNA was removed by using Turbo DNA-free kit (Thermo Fisher,
USA) following manufacturer’s instructions.
RNA Samples were analyzed by the 2100 series bioanalyzer (Agilent
Technologies, USA) for quality at the University of Tennessee Genomics Core,
followed by cDNA library preparation and sequencing. Barcoded cDNA libraries
were prepared with a TruSeq Stranded mRNA Sample Preparation Illumina kit
according to manufacturer’s specifications (Illumina, Inc., USA). The libraries’
qualities were validated by bioanalyzer (Agilent Technologies, USA), and then
arranged on a flow cell from the MiSeq reagent kit v3 (150×cycle) (Illumina, Inc.,
USA), and sequenced on the Illumina MiSeq M04398 machine.
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Bioinformatic Analysis
All the operations were performed on CLC Genomics Workbench v.12.0 software
(Qiagen, Germany). Trimming was performed with a quality score limit set as 0.01
and ambiguity set as 0. The read length to be discarded is set to below 50. The
hits were mapped to the assembly 22 of the C. albicans reference strain SC5314
[16]. Genome annotations were performed using the corresponding GFF file and
annotated with the GFF file tool which is available on CLC Genomics Workbench
v.12.0 software. The mapping parameters for mismatch cost, insertion cost,
deletion cost, length fraction, and similarity fraction used at default values, which
were 2, 3, 3, 0.8, 0,8, respectively. Expression values for each gene were
calculated from unique gene reads (maximum number of hits for a read is set to 1)
and normalized by gene length and sequencing depth yielding the expression
value of transcripts per million (TPM). To determine if gene expression values are
correct, the TPM reads of five housekeeping genes (TEF1, ACT1, TUB1, ENO1,
and PMA1) were evaluated to calculate the average for each condition, which was
further plotted as shown in [17]. To identify differentially expressed genes between
treatment and control, P-values of individual genes were adjusted for false
discovery rate (FDR), and genes with an FDR adjusted p-value < 0.05 in the
treatment group were considered differentially expressed.

Expression values

exceeding a factor of 2 (fold change), either higher or lower than that in control
were considered of significantly different expression.

Results
The PtetOFF-STE11ΔN467 mutant displays increased β (1,3)-glucan over-time
To investigate how Cek1 activation could contribute to β (1,3)-glucan exposure,
the gene expression profile resulting from hyper-activated Cek1 was measured.
First, we determined the parameters for this experiment. The PtetOFF-STE11ΔN467
strain ±doxycycline was compared to the isogenic wild-type in identical conditions.
To determine the time-point when the STE11ΔN467 mutant starts to display β (1,3)glucan exposure, we cultured Candida cells overnight with doxycycline to repress
Ste11ΔN467 expression, followed by dilution into fresh YPD medium without
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doxycycline to switch on STE11ΔN467 expression up to 6 hours. The Candida cells
were then subjected to immunofluorescent staining by using anti-β (1,3)-glucan
antibody, and subsequent flow cytometry to quantify the exposure level over time.
As seen in Figure 4. 1A, the STE11ΔN467 mutant began to display statistically
significant increased unmasking 4 hours sub-cultured in the medium without
doxycycline. Interestingly, the time-point when unmasking became significant
correlates well with the Western blotting results where Cek1 began to display
increased phosphorylation after doxycycline was removed 4 hours (Figure 4. 1B).
on this, we extracted total RNA from the wild-type and PtetOFF-STE11ΔN467 strains 4
hours after sub-culturing into ±doxycycline conditions.
β (1,3)-glucan exposure induced by hyper-activation of the Cek1 cascade
correlates with upregulation of cell wall synthesis genes
Based on these timing parameters, we extracted total RNA from the wild-type and
PtetOFF-STE11ΔN467 strains 4 hours after sub-culturing into ±doxycycline conditions,
with each condition represented by three biological replicates (12 total samples).
RNA sequencing was performed using the Illumina MiSeq platform, which
generated a total of 59 million 75bp paired-end reads from 12 libraries. A principal
component plot (PCA) was created by using the RNA Analysis Package in CLC
Genomics Workbench software to determine the variabilities between replicates
Based and different treatment samples. As seen in Figure 4. 2, the two wild-type
groups (± doxycycline) clustered tightly, suggesting that doxycycline does not
cause undesired effect on wild-type. The PtetOFF-STE11ΔN467 strain was found in
two distinct clusters based on the presence and absence of doxycycline, which
both separated from wild-type. The STE11ΔN467 strain +doxycycline grouped away
from wild-type and this may be because of basal expression of STE11ΔN467, which
would explain the modest increase in TNF-α elicited by macrophages by these
cells compared to wild-type, even in the presence of doxycycline (Figure 3. 5B).
To be certain that the expression levels of genes overall were consistent, we
examined 5 housekeeping genes that are known to have differential expression
levels. We found that those housekeeping genes were highly consistent between
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Figure 4. 1. The PtetOFF -STE11ΔN467 strain exhibits β (1,3)-glucan exposure in a timedependent manner in the absence of doxycycline.
A. The STE11ΔN467 mutant was cultured overnight in YPD at 30°C in the presence or absence of
doxycycline. Aliquots of the overnight culture (O/N+ and O/N-) were taken as 0 timepoint controls
and stained with mouse anti-β (1,3)-glucan antibody and goat-anti-mouse PE-conjugated
secondary antibody. An aliquot of the overnight PtetOFF-STE11ΔN467 culture treated with doxycycline
was washed three times with PBS and diluted back to 0.2 in fresh YPD without doxycycline to
switch on Ste11ΔN467 expression and was grown for 1hr, 2hrs, 4hrs, and 6hrs. Cells were collected
at the indicated time points and stained as described above. All the stained cells were subject to
the flow cytometer to quantify the β (1,3)-glucan exposure level. Samples were tested three times
with 2 replicates each time. **, P<0.008. B. Cells were cultured as described in A, and then total
protein was isolated, and Western blotting was performed to evaluate the MAPKs phosphorylation
by using phospho-p44/42 antibody and total Cek1 and tubulin as controls.
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Figure 4. 2. PCA plot displays the clustering of samples within each group.
PCA plot was created by using RNA Analysis Package in CLC Genomics Workbench software (V12.0) to determine the variabilities between
replicates and different treatment samples.
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Figure 4. 2. Continued
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the samples (Figure 4. 3). In STE11ΔN467 inducing-condition (-doxycycline), 109
genes are commonly regulated by a > 2-fold change in expression value,
compared to the other three conditions (wild-type±doxycycline and STE11ΔN467
+doxycycline) (Figure 4. 4A). Among the commonly regulated 109 genes, 16
genes are down-regulated, and 93 genes are up-regulated (Figure 4. 4B). The
commonly regulated genes were listed in Table S.4. 2. Although Cek1 activation
is associated with hyphal formation, there are only a few genes that are
conventional hyphal-specific proteins. A number of genes commonly associated
with hyphal formation like members of the Als family and Ece1 are not upregulated.
However, 13 genes that are involved in cell wall construction are upregulated
(Figure 4. 4B and Table 4. 1). These genes are enriched for cell wall or extracellular
genes (14% of upregulated genes were secreted genes compared to 5% secreted
genes in the total Candida genome, indicating that there was 2× fold enrichment
in cell wall genes in our data set). 26 genes are responsive to chemicals and stress,
including OPY2 and RBT4 and 10 genes encode signal transduction proteins
(CPP1, BUD5, RGA2, HAC1, WSC2, CPH1 etc.). In the category of downregulated genes, it is worth noting that Eng1 expression was decreased ~2 fold in
the STE11ΔN467-inducing condition. Eng1 is an endo-β (1,3)-glucanase, which has
been reported to keep glucan masked by removing the exposed β (1,3)-glucan in
the fungal pathogen Histoplasma capsulatum. Altogether, these data suggest that
the β (1,3)-glucan unmasking could be caused by Cek1 hyper-activation through
inappropriate expression of cell wall repair machinery.
In addition, our data suggest that Cph1 is likely responsible for these effects.
Cek1 has two known downstream transcription factors, Cph1 and Ace2, but they
display distinct profiles in our data. Cph1 is up-regulated 8.4-fold in STE11ΔN467
yeast condition compared to that of wild-type. Cph1 is important for Candida
albicans filament development on certain solid media [18] and is involved in the
switching from white cells to the mating-competent opaque cells [19]. In contrast,
Ace2, involved in cell wall glycosylation, morphogenesis and virulence [8, 20] does
not display altered transcripts when Cek1 is hyperactivated. This indicates Cph1
is likely the transcription factor responsive to Cek1-inducing condition.
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Figure 4. 3. Housekeeping genes expression was similar among different Candida strains.
The TPM reads of five housekeeping genes (TEF1, ACT1, TUB1, ENO1, and PMA1) were used to
calculate the average for each condition to determine if gene expression values are correct.
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Figure 4. 4. Differentially expressed genes in STE11ΔN467-inducing condition are enriched for cell wall repair genes.
(A). Venn diagram shows that 109 genes are differentially expressed in the PtetOFF-STE11ΔN467 mutant when Cek1 is induced (STE11 –
doxycycline) compared to the other three control groups (wild-type± and STE11+doxycycline). Genes with a false discovery rate (FDR)
adjusted p-value < 0.05 were considered differentially expressed. (B). Heat-maps were generated for genes with expression values
exceeding a factor of 2 (fold change) in STE11ΔN467 inducing condition (STE11 –doxycycline) compared to the other three controls
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Figure 4. 4. Continued
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Table 4. 1: Commonly regulated genes induced by STE11ΔN467 –doxycycline vs. Wild-type±
and STE11ΔN467 +doxycycline
Names

Gene Ontology terms
•

Function

Cell Wall Organization

CEK1, CHS2, CPH1, CRH11, ENG1*, HAC1, HWP1,
KRE6, PGA13, PGA31, RLM1, WSC2, XOG1
BRG1, C1_03870C_A, C1_10710C_A*, C3_02290W_A,
CEK1, CPH1, CPP1, DDR48, FGR41*, GPX1, HAC1,

Stress/Chemical Response

MDR1*, MEP1, OPY2, PMS1, RLM1, STE11, WSC2,
C7_01170C_A*, DAG7, GFA1, PGA23, PGA31, RBT4,
RLM1, TNA1*

•

Component
CRH11, CSH1, DDR48, ENG1*, HWP1, IFF11, KRE1,

Cell Wall and Extracellular Regions

PGA13, PGA30, PGA31, XOG1, C4_01800W_A*, DAG7,
FGR41*, RBT4,SAP7

*: transcriptionally down-regulated genes
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Cek1 activity is induced by caspofungin treatment
β (1,3)-glucan exposure has been reported to correlate with activation of Cek1
pathway under various conditions, such as phosphatidylserine synthase (Cho1)
disruption and hyperactivation of the GTPases Cdc42 and Rho1 [9]. Caspofungin,
an antifungal drug inhibiting β (1,3)-glucan biosynthesis, causes β (1,3)-glucan
exposure even at sublethal condition [21]. However, the mechanism regarding β
(1,3)-glucan exposure induced by caspofungin insult has not yet been discovered.
Here we evaluated if the correlation between β (1,3)-glucan unmasking and Cek1
phosphorylation holds true under caspofungin treatment. As shown in Figure 4. 5,
the Cek1 MAPK is induced to be activated 30 mins after incubation with ½ MIC of
caspofungin, and the induction increases over-time. This suggests that Cek1
activation might contribute to β (1,3)-glucan exposure, at least partially, under the
caspofungin insult. This further indicates that improper activation of Cek1 seems
involved in cell wall remodeling in different situations.

Discussion
In this chapter, we provided the transcriptome analysis to address the genetic
mechanism regarding β (1,3)-glucan exposure induced by Cek1 hyperactivation.
Our RNA-Seq results reveal that several categories of genes are expressed
differentially when Ste11-Cek1 are hyperactivated, and they include cell walls
genes, signal transduction genes, and stress genes (Table S.4. 2). Cph1, one of
two well-known downstream transcription factors that is phosphorylated/activated
by Cek1, is significantly up-regulated in STE11ΔN467 inducing conditions. Cph1 is
important for C. albicans filament development [18], and white-to-opaque
switching [19]. The Cph1-overexpressing mutant under yeast conditions induces
pseudo-hyphal structure, and several hyphal-specific genes are also induced
transcriptionally [13]. Lowman et al. reported that C. albicans hyphal glucan
exhibited a novel glucan structure, where hyphal glucan has a unique cyclical
structure which intrinsically display higher levels of β (1,3)-glucan exposure and
immunogenicity [11]. Our data shows that CPH1 is induced ~9 fold, and it is
possible that the β (1,3)-glucan structure might transition to a more hyphal glucan
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Figure 4. 5. Caspofungin treatment over-activates the Cek1 MAPK.
C. albicans wild-type DAY286 strain was cultured at 30°C in YPD medium overnight. The next day
the overnight culture was diluted back to OD600 of 0.2 in fresh YPD medium for 3 hours growth into
the log phase, followed by ½ MIC of caspofungin treatment (+) for 30 min, 1 hr and 2hrs,
respectively. The culture was collected and proceeded to the Western blotting procedure. The
antibody to detect phosphorylated Cek1 was phospho-p44/42, which can also detect the
phosphorylated Mkc1. Tubulin was detected as the loading control.
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structure even under yeast-conditions, and therefore display more glucan
exposure. Alternatively, Cek1 is upregulated in response to caspofungin treatment
and the changes in exposure may be related to aberrantly induced cell wall repair.
The cek1ΔΔ mutant displays β (1,3)-glucan exposure, hyper-sensitivity to
agents that disturb the cell wall such as Congo red, and the N-glycosylation
inhibitor tunicamycin [7, 22, 23]. This mutant also exhibits α (1,2)- and β (1,2)mannosides exposure, suggesting the glycostructure is defective upon CEK1
disruption. This characteristic facilitates the immune recognition by the receptor
galectin-3. Ace2, a second downstream transcription factor of Cek1, is required for
cell wall glycosylation, and causes β (1,3)-glucan exposure when disrupted [8, 10].
Interestingly, Ace2 is not induced transcriptionally when Cek1 is hyperactivated.
Thus, Cek1 may be able to deploy specific transcription factors for unique
adaptation responses based on the nature of the insult.
Cek1 activity is regulated tightly by multiple stimuli in C. albicans. Several
conditions

induce

Cek1

phosphorylation,

including

disruption

of

the

phosphatidylserine synthase Cho1[9], growth resumption from the overnight
culture to fresh media [24], being treated with fungicidal salivary histatin 5 (Hst5)
protein [25]. We found that Candida cells treated with caspofungin also exhibit
Cek1 hyperphosphorylation in a time-dependent manner (Figure 4. 5). Given the
correlation of Cek1 activation and resultant cell wall remodeling [9], this might
explain, at least partially, the mechanism through which β (1,3)-glucan is
unmasked stimulated by caspofungin. This indicates the significance of Cek1
activity in regulating cell wall structure.
Overall, our RNA-seq profile on the Cek1-overactivating mutant provides
groundwork for further understanding the genetic mechanisms of β (1,3)-glucan
exposure caused by this mutation. We hypothesize that differential expression of
some of those genes cause β (1,3)-glucan exposure, including Cph1. Genetic work
can be done by Cph1 overexpression to evaluate if the mutation leads to cell wall
remodeling and increases immunogenicity. Several cell wall associated proteins
are also of interest, including chitin synthases (Chs2, 3 and 8), given the correlation
between increased chitin levels and β (1,3)-glucan exposure [26, 27]. The same
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genetic strategy can be performed on these target genes by overexpression to
assess their involvement in causing cell wall unmasking.
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Appendix
Table S.4. 1. C. albicans strains used in this study
Strains

Parent

Genotype

Source or reference

DAY286

Wild-type

ura3::imm434/ura3::imm434

[28]

iro1/iro1::imm434 his1::hisG/his1::hisG
arg4/arg4
TC147

DAY286

DAY286+PtetOFF-STE11ΔN467

Table S.3. 1

SN50

Wild-type

ura3::imm434/ura3::imm434

[29]

iro1/iro1::imm434 his1::hisG/his1::hisG
arg4/arg4
cph1ΔΔ

SN50

SN50-cph1ΔΔ

[29]
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Table S.4. 2. Genes that were differentially regulated in STE11ΔN467 –doxycycline
Gene Name
PBR1
PGA13

C2_09880C_
A
XOG1

C2_02220C_
A
RBT4

C7_02280W_
A
PGA31
SAP7

KRE1

Function
Protein of unknown function; required for cohesion, adhesion, and
RPMI biofilm formation; induced by alpha pheromone in white cells;
fluconazole-induced; Spider biofilm induced
GPI-anchored cell wall protein involved in cell wall synthesis; required
for normal cell surface properties; induced in oralpharyngeal
candidasis; Spider biofilm induced; Bcr1-repressed in RPMI a/a
biofilms
Putative protein of unknown function; Plc1-regulated; transcript
induced by Mnl1 under weak acid stress; flow model, rat catheter,
Spider biofilm induced
Exo-1,3-beta-glucanase; 5 glycosyl hydrolase family member; affects
sensitivity to chitin and glucan synthesis inhibitors; not required for
yeast-to-hypha transition or for virulence in mice; Hap43-induced;
Spider biofilm induced
Protein of unknown function; F-12/CO2 early biofilm induced
Pry family protein; required for virulence in mouse systemic/rabbit
corneal infections; not filamentation; mRNA binds She3, is localized to
hyphal tips; Hap43-induced; in both yeast and hyphal culture
supernatants; Spider biofilm induced
Ortholog of C. parapsilosis CDC317: CPAR2_808370, C. dubliniensis
CD36: Cd36_72070, Candida orthopsilosis Co 90-125:
CORT_0C00800 and Candida albicans WO-1 : CAWG_05577
Cell wall protein; putative GPI anchor; expression regulated upon
white-opaque switch; induced by Congo Red and cell wall
regeneration; Bcr1-repressed in RPMI a/a biofilms
Pepstatin A-insensitive secreted aspartyl protease; self-processing;
expressed in human oral infection; Ssn6p-regulated; role in murine
intravenous infection; induced during, but not required for, murine
vaginal infection; N-glycosylated
Cell wall glycoprotein; beta glucan synthesis; increases glucan content
in S. cerevisiae kre1, complements killer toxin sensitivity; caspofungin
induced; Spider/rat catheter/flow model biofilm induced; Bcr1repressed in RPMI a/a biofilms
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vs. WT.
–doxy
1,269.77

Fold Change
vs. WT
vs.
+doxy
STE11ΔN467+doxy
1,276.88
333.46

114.57

93.25

22.48

59.07

32.66

14.68

51.34

55.89

37.56

47.72

46.24

18.21

40.37

31.85

43.55

39.92

43.07

19.01

36.75

44.22

17.82

36.55

16.76

14.56

34.49

25.71

18.03

Table S.4. 2. Continued
vs. WT.
–doxy
33.04

Fold Change
vs. WT
vs.
+doxy
STE11ΔN467+doxy
31.96
17.09

27.47

28.28

24.06

23.68

36.82

8.76

21.41

28.04

5.53

20.45
18.17

23.8
20.69

11.02
8.74

16.15

13.23

13.55

15.68
15.46

15.16
17.02

11.93
12.49

13.1

13

7.97

Putative adhesin-like protein; macrophage-induced gene

13.06

14.56

14.35

Hyphal cell wall protein; host transglutaminase substrate; opaque-, aspecific, alpha-factor induced; at MTLa side of conjugation tube;
virulence complicated by URA3 effects; Bcr1-repressed in RPMI a/a
biofilms; Spider biofilm induced
Secreted protein required for normal cell wall structure and for
virulence; member of the IFF family; Hap43p-repressed gene
Protein of unknown function; Spider biofilm induced

13.05

6.29

4.22

12.7

17.03

9.93

12.04

12.56

11.25

Gene Name

Function

C7_02260W_
A

Ortholog of C. parapsilosis CDC317: CPAR2_808350, C. dubliniensis
CD36: Cd36_72060, Candida orthopsilosis Co 90-125:
CORT_0C00820 and Candida albicans WO-1 : CAWG_05575
Secretory protein; a-specific, alpha-factor induced; mutation confers
hypersensitivity to toxic ergosterol analog; fluconazole-induced;
induced during chlamydospore formation in C. albicans and C.
dubliniensis
Protein with weak similarity to S. cerevisiae Fus2p; induced by alpha
pheromone mating factor in MTLa/MTLa opaque cells
Glycosylphosphatidylinositol (GPI)-anchored cell wall protein; required
for filamentous growth at acidic pH; expression repressed by Rim101
and activated by Nrg1; Hap43-induced
Putative LDG family protein; F-12/CO2 early biofilm induced
Secreted potein; Hap43-repressed; fluconazole-induced; regulated by
Tsa1, Tsa1B under H2O2 stress conditions; induced by Mnl1p under
weak acid stress; Spider biofilm induced
Pry family pathogenesis-related protein; oral infection upregulated
gene; mutant has reduced capacity to damage oral epithelial cells
Protein of unknown function; Spider biofilm induced
Putative GPI-anchored protein of unknown function; Rim101repressed; Cyr1-regulated; colony morphology-related gene regulation
by Ssn6
Protein of unknown function; Spider biofilm repressed

DAG7

FAV1
RBR1
LDG3
C6_02100W_
A
C1_07040C_
A
MRV8
PGA23
CR_05330W_
A
C1_05970W_
A
HWP1

IFF11
C4_04380C_
A
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Table S.4. 2. Continued
Gene Name
FAV2

C4_03500C_
A
KCH1

ALK8

CPH1

C5_03440W_
A
CPP1

CSH1

C5_04940W_
A
STE11
C4_01330W_
A

Function
Adhesin-like protein; induced by mating factor in MTLa/a opaque cells,
in cyr1 null, in filaments; regulated by Nrg1, Rfg1, Tup1, Tec1, Efg1,
Ntd80, Rob1, Brg1; induced in oralpharyngeal candidasis; Spider
biofilm induced
Protein of unknown function; regulated by Tsa1, Tsa1B in minimal
media at 37 degrees C
Ortholog of Kch1 a potassium transporter; mediates K+ influx and
activates high-affinity Ca2+ influx system during mating pheromone
response in S. cerevisiae; induced by alpha pheromone in SpiderM
medium
Alkane-inducible cytochrome P450; catalyzes hydroxylation of lauric
acid to hydroxylauric acid; overproduction causes fluconazole
resistance in WT and causes multidrug resistance in a cdr1 cdr2
double mutant; rat catheter biofilm repressed
Transcription factor; for mating, filamentation on solid media,
pheromone-stimulated biofilms; in pathway with Ess1, Czf1; required
with Efg1 for host cytokine response; regulates galactose metabolism
genes; rat cathether biofilm repressed
Protein of unknown function
VH1 family MAPK phosphatase; regulates Cst20-Hst7-Cek1-Cph1
filamentation pathway; negatively regulates mating, represses yeasthyphal switch; required for virulence in mice; yeast-enriched; induced
by alpha pheromone in SpiderM medium;
Aldo-keto reductase; role in fibronectin adhesion, cell surface
hydrophobicity; regulated by temperature, growth phase, benomyl,
macrophage interaction; azole resistance associated; Spider biofilm
induced; rat catheter biofilm repressed
Maltase; induced during growth on sucrose; induced by alpha
pheromone in SpiderM medium; early-stage flow model biofilm indced
Protein similar to S. cerevisiae Ste11p; mutants are sensitive to
growth on H2O2 medium
Protein of unknown function; Spider biofilm induced
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vs. WT.
–doxy
10.33

Fold Change
vs. WT
vs.
+doxy
STE11ΔN467+doxy
7.52
10.97

9.13

8.58

36.84

8.95

12.59

9.23

8.84

7.53

4.37

8.46

9.24

7.52

7.98

8.3

6.92

6.7

8.03

6.9

6.61

8.4

5.01

6.57

6.29

5.56

6.56

6.02

8.53

6.45

4.56

2.52

Table S.4. 2. Continued
Gene Name
PRM1
CR_09930W_
A
C6_04190C_
A
CR_04770C_
A
PTR2
GFA1

GST3
C4_02260C_
A
CRH11

WSC2
PGA58
MNN12

Function
Putative membrane protein with a predicted role in membrane fusion
during mating; Hap43p-repressed gene; protein induced during the
mating process
Protein of unknown function; induced by alpha pheromone in SpiderM
medium
Protein of unknown function; Spider biofilm induced
Ortholog of C. dubliniensis CD36 : Cd36_30140, C. parapsilosis
CDC317 : CPAR2_204040, Candida tenuis NRRL Y-1498 :
CANTEDRAFT_114703 and Debaryomyces hansenii CBS767 :
DEHA2G22880g
Oligopeptide transporter involved in uptake of di-/tripeptides; highly
induced during chlamydospore formation in both C. albicans and C.
dubliniensis
Glucosamine-6-phosphate synthase, homotetrameric enzyme of
chitin/hexosamine biosynthesis; inhibited by UDP-GlcNAc, FMDP, Nacyl peptide, kanosamine-6-P; functional homolog of S. cerevisiae
Gfa1p; Cagrowth-phase regulated; catalytic Cys
Glutathione S-transferase; expression regulated upon white-opaque
switch; induced by human neutrophils; peroxide-induced; induced by
alpha pheromone in SpiderM medium; Spider biofilm induced
Protein of unknown function; repressed by prostaglandins; Hap43induced, Spider biofilm induced
GPI-anchored cell wall transglycosylase, putative ortholog of S.
cerevisiae Crh1p; predicted glycosyl hydrolase domain; similar to
Csf4p and to antigenic A. fumigatus Aspf9; predicted Kex2p substrate;
caspofungin-induced
Putative cell wall integrity and stress response protein; mRNA binds
She3; Spider biofilm induced
Putative GPI-anchored protein; transcription is positively regulated by
Tbf1p
Predicted alpha-1,3-mannosyltransferase activity with a role in protein
glycosylation
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vs. WT.
–doxy
6.16

Fold Change
vs. WT
vs.
+doxy
STE11ΔN467+doxy
5.83
7.85

5.99

5.11

4.88

5.92

6.05

3.84

5.83

6.28

2.89

5.73

5.02

2.27

5.65

7.04

4.98

5.52

5.73

2.45

5.48

17.53

6.59

4.95

4.45

3.31

4.74

5.31

2.99

4.59

4.42

2.97

4.25

4.88

3.61

Table S.4. 2. Continued
Gene Name
C1_09430W_
A
C1_03870C_
A
C6_00810C_
A
KAR4
CR_00090C_
A
OPY2
MNN14
C2_05040C_
A
C6_04420W_
A
CHS8

C1_11730W_
A
CHS2

PGA54

vs. WT.
–doxy
4.24

Fold Change
vs. WT
vs.
+doxy
STE11ΔN467+doxy
5.89
4.82

4.23

4.46

4.99

4.21

2.98

3.56

Transcription factor; required for gene regulation in response to
pheromones; ortholog of S. cerevisiae Kar4; role in karyogamy;
opaque-specific, a-specific; induced by alpha factor
Protein of unknown function; stationary phase enriched protein;
induced upon yeast-hypha transition; benomyl or caspofungin
induced; Hap43-repressed; Spider biofilm induced
Predicted transmembrane protein; role in cell wall biogenesis; required
for Cek1 phosphorylation; Spider biofilm induced
Predicted alpha-1,3-mannosyltransferase activity with a role in protein
glycosylation; Hap43-repressed; Spider biofilm induced
Ortholog(s) have cellular bud neck, fungal-type vacuole localization

4.21

3.62

2.99

4.17

3.76

2.01

4.14

4.11

2.81

4

3.91

2.57

3.94

3.83

3.47

Protein of unknown function; GlcNAc-induced protein; Spider biofilm
induced; rat catheter biofilm repressed
Chitin synthase required for synthesis of long-chitin fibrils;
nonessential; 8 or 9 membrane spanning regions; mRNA present in
yeast and hyphae; induced during cell wall regeneration; flow model
biofilm repressed
Protein with SEL-1 like protein domain; early-stage flow model biofilm
induced
Chitin synthase; nonessential; required for wild-type chitin deposition
in hyphae; transcript regulated during dimorphic transition; Chs1 and
Chs2, but not Chs3, are inhibited by the protoberberine HWY-289;
flow model biofilm repressed
GPI-anchored protein; Hog1-repressed; induced in cyr1 or efg1
mutant or in hyphae; colony morphology-related gene regulation by
Ssn6; induced in RHE model; mRNA binds She3; regulated in Spider
biofilms by Tec1, Egf1, Ntd80, Rob1, Brg1

3.94

2.64

2.84

3.65

3.74

2.66

3.64

3.63

2.81

3.56

4.08

3.26

3.47

3.69

3.42

Function
Putative membrane protein; induced by alpha pheromone in SpiderM
medium; Hap4-induced gene; Spider biofilm induced
Predicted heme-binding stress-related protein; Tn mutation affects
filamentous growth; induced during chlamydospore formation in C.
albicans and C. dubliniensis; Spider biofilm induced
Protein of unknown function; Hap43-repressed gene
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Table S.4. 2. Continued
Gene Name

Function

GPX1
C7_02250W_
A

Putative thiol peroxidase; rat catheter and Spider biofilm induced
Ortholog of C. dubliniensis CD36 : Cd36_72050, C. parapsilosis
CDC317 : CPAR2_301140, Candida tenuis NRRL Y-1498 :
CANTEDRAFT_135055 and Debaryomyces hansenii CBS767 :
DEHA2E07678g
Similar to cell-wall mannoproteins; induced in low iron; induced in cyr1
homozygous null; regulated by osmotic and oxidative stress via Hog1;
Spider biofilm induced
Secreted protein; fluconazole-induced

C1_07990C_
A
C2_10150W_
A
CR_07850W_
A
RLM1
C1_04010C_
A
BUD5
UAP1

BRG1

AXL2

Ortholog of C. dubliniensis CD36 : Cd36_33530, C. parapsilosis
CDC317 : CPAR2_201980, Candida tenuis NRRL Y-1498 :
CANTEDRAFT_134293 and Debaryomyces hansenii CBS767 :
DEHA2A10164g
Putative transcription factor; required for wild-type resistance to cell
wall perturbation, caspofungin treatment; regulates caspofungin
induction of PGA13
Protein with a NADP-dependent oxidoreductase domain; transcript
induced by ketoconazole; rat catheter and Spider biofilm induced
Predicted GTP/GDP exchange factor for Rsr1; rat catheter biofilm
induced
UDP-N-acetylglucosamine pyrophosphorylase, catalyzes biosynthesis
of UDP-N-acetylglucosamine from UTP and N-acetylglucosamine 1phosphate; functional homolog of S. cerevisiae Qri1p; alkaline
upregulated
Transcription factor; recruits Hda1 to hypha-specific promoters; Tn
mutation affects filamentation; Hap43-repressed; Spider and flow
model biofilm induced; required for Spider biofilm formation; Bcr1repressed in RPMI a/a biofilms
Ortholog of S. cerevisiae Axl2; a plasma membrane protein involved in
determination of budding pattern; O-glycosylated by Pmt4; mutant is
viable
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vs. WT.
–doxy
3.42
3.35

Fold Change
vs. WT
vs.
+doxy
STE11ΔN467+doxy
3.75
2.03
4.17
2.87

3.25

3.7

3.17

3.1

2.84

2.92

3.1

2.65

2.03

3.07

3.23

2.31

2.99

3.89

2.27

2.91

3.18

2.1

2.9

4.31

3.82

2.85

4.05

2.76

2.8

4.24

3.54

Table S.4. 2. Continued
Gene Name
YKE2

C6_02210W_
A
CHS7

RGA2
MRV3
C2_07790C_
A
C7_01940C_
A
PMS1
C1_05440C_
A
DFI1
CR_09090C_
A
C4_01420W_
A

Function
Possible heterohexameric Gim/prefoldin protein complex subunit; role
in folding alpha-tubulin, beta-tubulin, and actin; transcript induced by
yeast-to-hypha switch; regulated by Nrg1, Tup1; Spider and flow
model biofilm induced
Protein of unknown function; oxidative stress-induced via Cap1;
induced by alpha pheromone in SpiderM medium
Protein required for wild-type chitin synthase III activity; similar to (but
not functional homolog of) S. cerevisiae Chs7p, which effects ER
export of Chs3p; induced cyr1 mutant hyphae and ras1 yeast-form
cells; Spider biofilm induced
Putative GTPase-activating protein (GAP) for Rho-type GTPase
Cdc42; involved in cell signaling pathways controlling cell polarity;
induced by low-level peroxide stress; flow model biofilm induced
Ortholog of Candida albicans WO-1 : CAWG_04793
Protein of unknown function; induced by alpha pheromone in SpiderM
medium
Pheromone-regulated protein (Prm10) of S. cerevisiae; colony
morphology-related gene regulation by Ssn6; induced by Mnl1 under
weak acid stress; possibly essential gene, disruptants not obtained by
UAU1 method; Spider biofilm induced
Putative DNA mismatch repair factor; ortholog of S. cerevisiae PMS1
which is an ATP-binding protein involved in DNA mismatch repair
Protein of unknown function; flow model biofilm induced; Spider
biofilm induced
Cell-surface associated glycoprotein; promotes activation of Cek1 in a
matrix-dependent manner; N-glycosylated; Spider biofilm induced
Ortholog of C. dubliniensis CD36 : Cd36_34510, Candida tropicalis
MYA-3404 : CTRG_05938 and Candida albicans WO-1 :
CAWG_02183
Ortholog of C. dubliniensis CD36 : Cd36_41430, Candida tropicalis
MYA-3404 : CTRG_00187 and Candida albicans WO-1 :
CAWG_03642
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vs. WT.
–doxy
2.78

Fold Change
vs. WT
vs.
+doxy
STE11ΔN467+doxy
3.28
2.18

2.67

2.4

2.21

2.58

2.6

2.68

2.54

2.55

2.4

2.54
2.53

2.42
3.05

2.08
2.97

2.53

2.37

2.26

2.5

3.33

2.94

2.45

2.14

2.01

2.43

2.63

2.28

2.36

2.92

2.01

2.3

2.59

2.15

Table S.4. 2. Continued
Gene Name
HGC1

C3_02290W_
A
KRE6

HAC1

PTP2
ENG1

C7_01170C_
A
C1_11990W_
A
C2_06800C_
A
C4_02080W_
A
C1_10710C_
A

Function
Hypha-specific G1 cyclin-related protein involved in regulation of
morphogenesis, biofilm formation; Cdc28-Hgc1 maintains Cdc11 S394
phosphorylation during hyphal growth; required for virulence in mice;
regulated by Nrg1, Tup1, farnesol
Protein similar to S. cerevisiae Ydr282cp; transposon mutation affects
filamentous growth; Hap43p-repressed gene
Essential beta-1,6-glucan synthase subunit; change in mRNA length,
not abundance, at yeast-hypha transition; alkaline induced by Rim101,
on cell wall regeneration; Spider biofilm induced; Bcr1-repressed in
RPMI a/a biofilms
bZIP transcription factor; role in unfolded protein response and control
of morphology; transcript undergoes atypical splicing at C terminus
under ER stress; induced during mating and by caspofungin; mRNA
binds She3; Spider biofilm induced
Predicted protein tyrosine phosphatase; involved in regulation of MAP
kinase Hog1 activity; induced by Mnl1 under weak acid stress; rat
catheter and Spider biofilm induced
Endo-1,3-beta-glucanase; ortholog of S. cerevisiae Dse4 needed for
cell separation; caspofungin, fluconazole repressed; repressed by
alpha pheromone in SpiderM medium; flow model biofilm induced; rat
catheter biofilm repressed
Putative oxidoreductase; mutation confers hypersensitivity to toxic
ergosterol analog; rat catheter and Spider biofilm induced
Putative cell wall adhesin-like protein; repressed in core caspofungin
response and by alpha pheromone in SpiderM medium; transcript
reduced in ace2 mutant; flow model, rat catheter and Spider biofilm
repressed
Protein of unknown function; Spider biofilm induced
Protein with a mitochondrial carrier protein domain; possibly an
essential gene, disruptants not obtained by UAU1 method; Spider
biofilm repressed
Protein similar to S. cerevisiae Yor378w; MFS family transporter;
transposon mutation affects filamentous growth; null mutants are
viable; fungal-specific (no human or murine homolog)
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vs. WT.
–doxy
2.29

Fold Change
vs. WT
vs.
+doxy
STE11ΔN467+doxy
3.29
2.56

2.25

2.18

2.61

2.24

2.7

2.34

2.12

2.32

2.59

2.11

2.22

2.45

-2.09

-2.14

-2.79

-2.17

-4.89

-4.56

-2.22

-2.06

-3.17

-2.28

-2.94

-2.31

-2.35

-3.3

-3.21

-2.52

-2.4

-2.35

Table S.4. 2. Continued
Gene Name

Function

C1_05830W_
A
TRP4

Ortholog(s) have trans-aconitate 3-methyltransferase activity and
cytosol localization
Predicted enzyme of amino acid biosynthesis; upregulated in biofilm;
regulated by Gcn2p and Gcn4p; S. cerevisiae ortholog is Gcn4p
regulated
Protein with a dienelactone hydrolase domain; Hap43-repressed gene

C4_01800W_
A
FGR41
MEP1

HOM3
C6_03390W_
A
MDR1

RNR22

Putative GPI-anchored adhesin-like protein; transposon mutation
affects filamentous growth; Spider biofilm repressed
Ammonium permease; Mep1 more efficient permease than Mep2,
Mep2 has additional regulatory role; 11 predicted transmembrane
regions; low mRNA abundance; hyphal downregulated; flow model
biofilm induced
Putative L-aspartate 4-P-transferase; fungal-specific (no human or
murine homolog); regulated by Gcn2 and Gcn4; early-stage flow
model biofilm induced
Mitochondrial dicarboxylate transporter; possibly an essential gene,
disruptants not obtained by UAU1 method
Plasma membrane MDR/MFS multidrug efflux pump; methotrexate is
preferred substrate; overexpression in drug-resistant clinical isolates
confers fluconazole resistance; repressed in young biofilms; rat
catheter biofilm induced
Putative ribonucleoside diphosphate reductase;colony morphologyrelated gene regulation by Ssn6; transcript regulated by tyrosol and
cell density; Hap43-repressed; Spider biofilm induced
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vs. WT.
–doxy
-2.58

Fold Change
vs. WT
vs.
+doxy
STE11ΔN467+doxy
-4.53
-3.84

-2.59

-2.91

-2.15

-2.59

-2.9

-3.18

-2.68

-2.85

-2.71

-2.87

-3.76

-2.46

-2.87

-3.4

-3.53

-2.89

-2.5

-2.78

-3.12

-3.09

-2.47

-3.32

-2.98

-3.71

CHAPTER V: Conclusion and Future Direction
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Conclusion
Altogether, the findings in this dissertation demonstrate the central role of the Cek1
MAPK in regulating cell wall β (1,3)-glucan masking in C. albicans. Davis et al.
identified that loss of the phosphatidylserine (PS) synthase enzyme (Cho1) results
in β (1,3)-glucan exposure in this organism. However, the mechanism by which
loss of PS synthase leads to cell wall unmasking remained to be defined. To
address this, in Chapter II I began using biochemical methods to identify the
potential protein(s) causing this phenotype. Several proteins comprising molecular
signaling pathways, which regulate fungal cell wall synthesis, are hyper-activated
when the PS synthesis enzyme is disrupted. We hypothesized that one or a few of
these signaling proteins may contribute to increased β (1,3)-glucan exposure in
the cho1Δ/Δ mutant. I further discovered that when the protein kinase Cek1 is
activated by itself, β (1,3)-glucan is exposed. The increased β (1,3)-glucan
exposure exhibited from the strain containing hyper-activated Cek1 is shown to be
immunologically relevant, reflected by stronger pro-inflammatory anti-fungal
immune responses induced from murine macrophages. The GTPase Cdc42 is a
central regulator of cell growth and morphological development. Cdc42 activity is
found to be induced in the cho1Δ/Δ mutant, and genetic work demonstrated that
hyperactivated Cdc42 results in the up-regulation of Cek1 activity. Based on these
observations, we propose a model that Cho1 or its biochemical product PS impacts
GTPase Cdc42 activity, which controls downstream Cek1 phosphorylation and
thus induces β (1,3)-glucan exposure.
Chapter III demonstrated a novel signaling cascade controls Cek1 activity,
which is composed of a protein called Lrg1, which represses β (1,3)-glucan
exposure and Cek1 activity, and its cognate small GTPase is Cdc42. The
discovery that Lrg1 inhibits Cdc42 activity in C. albicans is novel and unexpected
because Lrg1 was thought to act on another GTPase Rho1, a major regulator for
cell wall biosynthesis. Activated Cdc42 further relays the activation signal to the
downstream Cek1 pathway. This work uncovers a new aspect of basic biology of
signaling transduction leading to Cek1 activation and β (1,3)-glucan exposure in
C. albicans. The mouse model of systemic infection, which mimics the human
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disseminated fungal disease, revealed that the hyper-activation of Cek1
attenuates fungal virulence within the host and leads to better fungal clearance
from the mouse kidney, which is the primary organ that C. albicans infects. Thus,
we propose a model where loss of LRG1 results in Cek1 over-activation, which
further leads to more β (1,3)-glucan exposure, and the cell wall remodeling
increases immune detection within the host and results in more rapid immune
clearance.
Chapter IV described the genetic mechanisms responsible for the
modulation of Cek1 activation on β (1,3)-glucan exposure in C. albicans. RNA-seq
analysis was used to elucidate the whole genome transcriptional profiles regulated
by activated Cek1 during β (1,3)-glucan unmasking. This strategy demonstrates
that

several

cell

wall

associated

genes

are

differentially

manipulated

transcriptionally when Cek1 is activated. Of interest, chitin production is
significantly induced at the genetic level, e.g. CHS2, CHS3, CHS8 and PGA31 are
upregulated. PGA31 is a chitin production-relevant gene [1]. Given the relationship
of chitin hyper-production and (1,3)-glucan exposure [2], this implies that chitin
levels might impact cell wall unmasking in the Cek1-overactivating mutant. Cek1
downstream transcription factor Cph1 is also suggested to mediate cell wall
dysfunction transcriptionally, as its transcript is induced significantly in the CEK1
hyper-activating mutant. However, this is speculation and further research will be
conducted to assess these hypotheses.

Future direction
To determine genetic target(s) downstream Cek1 causing β (1,3)-glucan
exposure
The work in this dissertation has described an entirely new physiological role of
Cek1 activation in regulating cell wall architecture and the resultant
immunomodulation. Cek1 disruption has already been proved to impact C.
albicans cell wall structure by exposing polysaccharides including β (1,3)-glucan,
β (1,2)-mannosides to their cognate immune receptors, and thus boost immune
responses that aid in clearance of the pathogen more rapidly [3, 4]. In this
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dissertation, we provide evidence that hyper-activated Cek1 is also able to cause
cell wall structure problems, as evidenced by massive β (1,3)-glucan exposure,
which causes induction of immune detection, as confirmed by in vitro cytokine
secretion (Figure 2. 3 and Figure 3. 5), and efficient pathogen clearance as
suggested by the in vivo mouse model (Figure 3. 6 and Figure 3. 7). These
observations are quite interesting, but also raise some important questions, e.g.
what major regulating factors are involved in mediating cell wall architecture
defects driven by unbalanced Cek1 activity? Research is still underway to pinpoint
the gene(s) causing β (1,3)-glucan exposure induced by Cek1 activation, but our
transcriptome analysis does reveal a few potential targets (Figure 4. 4). Of
particular interests, Cph1, a Cek1 downstream transcription factor, is induced ~9
fold in the Cek1 activating mutant. Given the fact that the Cph1-overexpressing
mutant exhibits pseuodohyphal structure under yeast-condition (cultured in YPD
liquid at 30°C), and filaments have more β (1,3)-glucan exposure naturally [5, 6], it
seems likely that the increased cell wall unmasking induced by Cek1 overactivation
under yeast condition results from the transcriptional regulation mediated by Cph1.
To test this, a Cph1-overexpressing mutant would need to be created to evaluate
its impact on β (1,3)-glucan exposure. Second, the hyphal glucan of C. albicans
was reported to exhibit a unique biochemical structure, which has “cyclical chain”
architecture and an unexpected 2,3-linkage [6]. While the structural significance of
the cyclical chain is not fully understood, it was speculated that this might be
partially responsible for higher levels of cell wall unmasking. We hypothesize that
the β (1,3)-glucan structure under the yeast condition when Cek1 is hyperactivated
is transitioned to the hyphal β (1,3)-glucan structure. This can be determined by
using nuclear magnetic resonance (NMR) and gas chromatography–mass
spectrometry (GC-MS), and this work can be achieved potentially by collaboration
with Dr. Michael Kruppa at East Tennessee State University.
It was reported that C. albicans hyphae damaged by neutrophils exhibit
increased β (1,3)-glucan, and this is mediated through delocalized CHS3 [2]. There
is also a correlation between chitin overproduction and β (1,3)-glucan unmasking
[7, 8]. Based on this, it seems likely that several transcriptionally up-regulated chitin
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synthases might impact cell wall structure when Cek1 is hyperactivated. To
address this speculation, it is necessary to perform genetic analysis by
overexpression of those targets individually independent of Cek1. The level of β
(1,3)-glucan exposure would be assessed by performing immunofluorescent
staining with anti- β (1,3)-glucan antibody. If individual mutation results in mild but
not significant increased unmasking, it is possibly that these proteins need to be
together to have a synergistic effect. To test this possibility, we can try to
overexpress those targets together (Chs2, Chs3 and Chs8) in wild-type, and the
immunofluorescent assay would be performed to evaluate the impact on cell wall
exposure. Second, the endo-β (1,3)-glucanase (Eng1) was determined to enhance
the virulence of fungal pathogen H. capsulatum by removing surface-exposed β
(1,3)-glucan from immune detection [9]. The transcript of C. albicans ENG1
homolog is down-regulated by 2-fold when Cek1 is hyperactivated (Figure 4. 4 and
Table 4. 1). Although CaEng1 is primarily responsible for cell separation during
budding [10], we cannot rule out the possibility that it might also impact β (1,3)glucan structure as HcEng1 does. To assess this, it is necessary to quantify the
level of β (1,3)-glucan exposure between the ENG1 disrupted mutant vs. wildtype.
To identify signals involved in caspofungin-driven β (1,3)-glucan exposure
Caspofungin is a well-known fungicidal drug with the mechanism of inhibiting β
(1,3)-glucan biosynthesis. It also exposes this polysaccharide to the surface and
therefore facilitates immune detection even at a sub-lethal concentration.
However, the direct mechanisms by which cell wall structure is disordered by
caspofungin treatment are unclear. Our results imply that the Cek1 signaling
cascade is one signaling pathway responding to casponfugin. This was suggested
by hyperactivation of Cek1 when incubated with caspofungin at ½ MIC, and the
induction gets more pronounced over time (Figure 4.5). This is promising as it
reveals one potential target leading to β (1,3)-glucan exposure induced by
caspofungin. Future work can be done to evaluate if two downstream transcription
factors (Ace2 and Cph1) are involved in cell wall unmasking responsive to
caspofungin.
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Of interest, a genome-wide expression profile based on a microarray assay
reveals that after Candida cells are exposed to ½ MIC of caspofugin for 3 hours,
480 gene were found to be regulated in response to the drug, and 3% of the genes
are involved in cell wall maintenance [11]. Several targets overlap with our RNASeq data when Cek1 is hyperactivated, e.g. CRH11, PHR1, and KRE1 whose
transcripts are upregulated, while SCW11 and ENG1 are down-regulated in both
studies. Moreover, Xu et al. studied the in vivo response to caspofungin, where the
fungal gene expression profile was measured 2hr after drug administration in mice
that had already been infected by C. albicans for 24hr. 12 genes were found to be
induced that are enriched for cell wall or secreted proteins, particularly of GCA2,
PGA13, PGA31, PIR1 and RBR2 were also found in our RNA-Seq data when Cek1
is hyperactivated. This highlights the significance of the Cek1 hyperactivation in
restructuring the cell wall architecture in response to caspofungin. The
abovementioned targets would need to be manipulated genetically in a wild-type
background based on their expression profile. For instance, the individual deletion
mutant would be made for those displaying upregulated transcripts in both
caspofungin treatment and Cek1 overactivation situations. Further research would
assess if the mutant rescues cell wall β (1,3)-glucan exposure after being exposed
to caspofungin.
Several other signaling proteins are known to be responsive to caspofungin
treatment, e.g. Mkc1, and Hog1 MAPKs. Therefore, it would be necessary to assay
the rescue effect of the HOG1 or MKC1 disrupted mutant on β (1,3)-glucan
exposure when induced by caspofungin. However, if none of those targets are
involved in the caspofungin-driven β (1,3)-exposure, we would set off an extensive
screen on the deletion mutant library on hand with ~700 nonessential gene
mutants. The goal is to find the genetic network that is responsible for cell wall restructure stimulated by caspofungin.
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To disentangle signaling rewiring that involves GTPases and associated
molecules
The findings of this dissertation have provided a greater general understanding of
signaling transduction/rewiring in pathogenic C. albicans. There are several
unanticipated findings in Chapters II and III. For instance, Cdc42 activity was
shown to be stimulated when PS synthase enzyme Cho1 was deleted (Figure 2.
4). We originally hypothesized that Cdc42 activity might be down-regulated due to
the delocalization of GFP-Cdc42 in the cho1Δ/Δ mutant (Figure 2. 5). This
phenotype was also seen in the model yeast S. cerevisiae where loss of Cho1
delocalizes Cdc42 from polarized growth site to an internal membrane [12].
However, an in vitro study in S. cerevisiae showed that PS stimulates the GAP
activity for ScCdc42, suggesting that loss of PS has less stimulation on Cdc42
GAP activity and thus results in the increased Cdc42 activity [13]. Likewise, the
mechanisms through which Cdc42 activity is stimulated by CHO1 deletion in C.
albicans could be investigated in a similar way in vitro. To do this, radio-labeled [γ32P]

GTP-bound CaCdc42 needs to be incubated with PS, along with its GAPs,

e.g. Rga1, or Rga2. The GTP hydrolysis would then be assayed by measuring the
radioactivity of [γ-32P] GTP-bound Cdc42 after incubation. Some other
phospholipids such as phosphatidylethanolamine and phosphatidylinositol can be
used as controls to assess if the stimulation effect on Cdc42 GAPs activity is PSdependent. Moreover, other GTPase GAPs, e.g. Sac7 as GAP for Rho1, can also
be assayed to evaluate if PS is a universal inhibitor on GAPs.
In Chapter III, Lrg1 inhibits GTPases Cdc42 and Ras1 activity in vivo (Figure
3. 3), even though Lrg1 was originally suggested to act as a Rho1 activity repressor
in this organism [14]. Research would demonstrate if Lrg1 functions as GAP for
Cdc42, Ras1 and/or Rho1 by performing in vitro GTPases assay. In this
experiment, Lrg1 protein will be incubated with [γ-32P] GTP-bound GTPases, and
the radioactivity of [γ-32P] GTP-bound GTPases after incubation will be measured.
To analyze if the CaLrg1 GAP homolog domain (representing amino acids 11831375) exhibits true GAP activity, genetic manipulation will delete the rhoGAP
domain and the inhibition on GTPase activity of Cdc42 or Ras1 by the
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lrg1ΔrhoGAP mutant will be analyzed via biochemical assay in vitro as
abovementioned. Furthermore, we found that hyper-activated Ras1 does not
induce Cek1 phosphorylation (Figure 3. 3), although the epistasis evidence
suggests Ras1 acts upstream of Cek1 [15].
To explore the roles of Lrg1 in regulating C. albicans cell wall architecture
Besides acting as a rho-GAP, Lrg1 has been shown to impact cell polarity, cell
fusion, Mkc1 MAPK activity and β (1,3)-glucan biosynthesis etc. in S. cerevisiae
[16, 17]. In N. crassa, LRG1 have also been studied and suggested to regulate
polar tip growth [18]. In contrast, little is known about the function of Lrg1 in the
pathogenic C. albicans. It was described that Lrg1 negatively controls filamentation
in this organism [14]. In this dissertation, we further elaborated that CaLrg1
controls β (1,3)-glucan exposure by negatively regulating Cek1 MAPK cascade,
and the lrg1Δ/Δ mutant displays higher immunogenicity suggested by stronger proinflammatory cytokines production from murine macrophages (Figure 3. 1, Figure
3. 2, and Figure 3. 5). It seems likely that Lrg1 influences cell wall structure;
however, questions remain regarding the mechanisms by which Lrg1 does so at
the biochemical level. For instance, while loss of LRG1 induces β (1,3)-glucan
exposure, we are not clear if it is due to a greater level β (1,3)-glucan being
produced. Also, it is not clear if loss of LRG1 impacts chitin synthesis or localization
in C. albicans, although it does so in N. crassa. Research can be done by staining
Candida cells with aniline blue for β (1,3)-glucan and calcofluor white for chitin,
respectively, to analyze their contents and localization. Moreover, it would be
interesting to analyze the localization of Lrg1 in vivo by tagging it with GFP, and
probe the deliver machinery of cell growth components, e.g. actin cytoskeleton
simultaneously, which would help understand the correlation between Lrg1
localization and new cell wall component deposition. Last, it was predicted by
SMART.EMBL.DE that CaLrg1 contains two Zinc-binding LIM domains which
generically help bind protein partners in eukaryotes; however, it not known how
these two domains act specifically in C. albicans. It was suggested that NcLrg1
contains three LIM domains which are required for localizing LRG1 to the growth
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sites. It is possibly that these two domains act similarly in C. albicans, but research
would need to be conducted by deleting these two LIM domains in CaLRG1, and
localization of the mutated LRG1 can be assessed by tagging with GFP.
To elaborate the mechanisms by which β (1,3)-glucan exposure impacts
fungal virulence in vivo
As described in Figure 3. 6 we determined that increased β (1,3)-glucan exposure
seems to compromise fungal virulence, as evidenced by significantly longer mouse
survival rates and faster pathogen clearance in mouse kidneys. This suggests that
the phenotype of β (1,3)-glucan exposure is immunologically relevant. To
demonstrate if the enhanced killing ability in vivo is due to higher levels of
unmasked β (1,3)-glucan exhibited from the Cek1-hyperactivating mutant, ex vivo
staining by using anti-β (1,3)-glucan antibody on homogenized tissues, e.g. kidney,
liver would need to be done. Moreover, immune cell recruitment and cytokine
profiles by flow cytometry are also necessary to demonstrate if immune responses
are boosted in response to the exposed β (1,3)-glucan. This work can be achieved
potentially through collaboration with Dr. Sparer, whose lab has established the
techniques at the Microbiology Department at UT. Finally, it is valuable to evaluate
if the enhanced immune responses are dependent on Dectin-1 and this can be
studied by using dectin-1 deficient mice.
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